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ABSTRACT
Extensive laboratory studies established unequivocally that green tea 
effectively protects against chemical carcinogenesis. In the present study the ability of 
tea, both green and black, to modulate the initiation stage of carcinogenesis was 
investigated.
Aqueous extracts o f green tea caused a marked inhibition of the mutagenicity 
of model chemical carcinogens. Two mechanisms were responsible for this effect, 
namely the inhibition of the cytochrome P450-dependent bioactivation of the 
carcinogens, and scavenging of the reactive intermediates. A comparison of the 
antimutagenic potential of green, black and decaffeinated black tea revealed that all 
three types of tea were effective antimutagens and no difference in potency was 
evident.
In order to evaluate the role of flavanols in the antimutagenic potential of 
green tea, aqueous extracts were fractionated into four distinct fractions, each of 
which was fully defined with respect to its content of individual flavanols. The ability 
of each fraction to antagonise the mutagenicity of model carcinogens could not be 
correlated with any of the tea flavanols indicating that these compounds are unlikely 
to play a major role in the antimutagenic effect of green tea.
Exposure of rats to green tea aqueous extracts (2.5 %, w/v) for four weeks 
stimulated the hepatic 0-dealkylation of ethoxy-, methoxy- and pentoxy-resorufm, 
lauric acid hydroxylation, and increased the apoprotein levels of CYP1A2 and 
CYP4A1. The same treatment enhanced peroxisomal palmitoyl Co A oxidation and 
the apoprotein levels of the trifunctional protein in liver homogenate. O f the Phase II 
enzyme systems studied, treatment with green tea enhanced only the glucuronidation 
of 2-aminophenol. The 0-demethylation of methoxyresorufm and CYP1A2 levels 
were also induced by black tea, but not by decaffeinated black tea indicating that 
caffeine is most likely responsible for the increase in the expression of this 
cytochrome P450 protein. Similarly, the glucuronidation of 2-aminophenol was 
elevated following treatment with black tea but not black decaffeinated tea.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 CHEMICAL CARCINOGENESIS
Among the various causes of cancer, chemical exposure is considered as a 
principal factor in the aetiology of carcinogenesis. As first observed by Sir Percival Pott 
in 1775, a correlation exists between the incidence of scrotal cancer among chimney 
sweeps and their exposure to soot and coal tar. It has been long clear that the majority of 
human cancers resulted from exposure to environmental carcinogens, including both 
naturally-occurring and synthetic chemicals. Subsequently, epidemiological evidence has 
revealed the contribution of potent carcinogenic compounds, such as 4-aminobiphenyl 
and other aromatic amines, in human carcinogenesis ( McManus , 1989 ).
1.1.1 Classification of Carcinogenic Chemicals
Carcinogens may be classified according to their biological effect into three basic 
categories. The first, genotoxic carcinogens are those compounds that interact covalently 
with nucleic acids, thus causing DNA damage. In fact, most of chemical carcinogens are 
genotoxic agents and may function as direct-acting or primary carcinogens when they are 
chemically reactive to interact directly with cellular constituents, as originally postulated 
by Miller & Miller ( 1981 ). Many foreign compounds, however, are procarcinogens, i.e. 
they require metabolic activation to generate electrophilic metabolites that readily react 
with nucleophilic sites on the DNA ( loannides et al., 1992 ). Alternatively, it has been 
recognised over the past years that cancer initiation may arise not only because of direct 
interaction between a chemical and cellular DNA, but also as a biological consequence 
resulting from the indirect interaction of the chemical with nuclear DNA (Gatehouse et al., 
1988). The latter known as epigenetic carcinogens are those chemicals which elicit their 
carcinogenicity primarily without altering the genetic basis of DNA, and thus they are 
non-mutagenic compounds. Some of these non-genotoxic carcinogens may therefore 
exhibit their potential carcinogenic action by enhancing intrinsic carcinogenic processes 
and others exerting effects that appear to culminate indirectly in genetic alteration. 
Peroxisome proliferators represent a class of epigenetic carcinogens involved in chemical
carcinogenesis in small rodents. Exposure to certain lipid-lowering drugs and phthalate 
esters has led to an increase in the number of peroxisomes (Reddy et al.,1983). 
Peroxisome proliferators elicit specific induction of cytochrome P-450(CYP4A), which 
exhibits high specificity for co-oxidation of fatty acids. Peroxisome proliferation is also 
accompanied by selective increases in the specific activities of some peroxisomal 
enzymes, particularly those involved in the ^-oxidation of fatty acids. The increased 
activity of these enzymes results in a large increase in the production of hydrogen 
peroxide, as well as free oxygen radicals that cause DNA damage.The carcinogenic effect 
of peroxisome-proliferating agents is attributed to their ability to produce reactive oxygen 
species that interact directly with DNA. Therefore, the induced carcinogenicity by 
peroxisome proliferators is apparently related to the biological consequences of these 
substances, eventually leading to DNA damage. Chemicals which possess the potential of 
increasing human cancer risk have been identified as both genotoxic and epigenetic 
carcinogens, but the peroxisome proliferators so far appear to be active only in rodents.
1.1.2 Mechanism Of Chemical Carcinogenesis
It is now widely accepted that chemical carcinogenesis is a multistage process 
comprising three recognisable steps, namely initiation, promotion and progression ( 
Figure 1.1 ). Initiation is the first step involved in the carcinogenic process in which the 
normal cell is transformed to a neoplastic cell . This conversion may occur either via 
genetic alteration caused by a highly reactive metabolite ( ultimate carcinogen ) generated 
from the precarcinogen metabolism, interacting with nucleophilic sites on a cellular 
informational macromolecule such as DNA, RNA and protein (Miller & Miller, 1981). 
Therefore, electrophilicity is a necessary event in the initiation phase of the carcinogenic 
process. Alternatively , non-electrophilic intermediates are involved in the mechanism of 
epigenetic chemical carcinogenesis ( Miller, 1978 ).
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Figure 1.1 The multistage sequences of the carcinogenic process 
From Miller and Miller (1977).
It is recognised that promotion is the second stage of the carcinogenic process, 
where tumour cells are produced as a result of neoplastic cell growth, and this 
proliferation may be facilitated by a promoter. Many tumour promoters have been found 
to be either very weak carcinogens or non-carcinogenic chemicals despite their ability to 
enhance tumour development when administered repeatedly, following a low dose of an 
initiator, as pointed out by Timbrell ( 1991 ). For example, tetradecanoylphorbolacelate 
has a pronounced promoting effect when applied to mouse skin pretreated with a low 
dose of a well-known carcinogen such as dimethylbenzanthracene ( Wang et al., 1989a ).
Progression is the last stage, in which the preneoplastic lesion is converted to a malignant 
tumour . Such process is characterised by phenotypic changes that may appear due to 
increased growth rate, i.e. invasion of healthy tissue and formation of métastasés. 
Therefore, tumour promotion and progression are two phases associated with cell 
proliferation , and the mechanisms underlying the chemical carcinogenesis seem to be a 
combination of genetic and epigenetic alterations affecting the configuration of the normal 
cell.
1.2. BIOTRANSFORMATION OF CHEMICAL CARCINOGENS
Since many xenobiotics absorbed into biological systems are lipophilic in nature, 
biotransformation is a necessary route to convert such compounds into water-soluble, 
more polar substances, and consequently more readily excretable metabolites. 
Biotransformation is a stage generally recognised as a detoxication process, although in 
some cases metabolism of a foreign compound leads to more toxic intermediates. Safrole, 
for example, is converted by metabolism to electrophilic and carcinogenic sulphuric acid 
esters which are responsible for tumour induction ( Miller, 1994 ). The toxic potential of a 
foreign compound is therefore influenced by metabolism.
Metabolism, in general, can be divided basically into two phases, namely phase I 
and phase II reactions. Insertion of a reactive functional group to the original molecule is a 
major aspect of phase 1 reactions; subsequently conjugation of the final metabolite with 
endogenous substrates occurs in phase 2 reactions.
1.2.1 Phase I Metabolism
The metabolic reactions in phase I metabolism are principally classified into four 
types : oxidation, reduction, hydrolysis and hydration. Oxidation reactions are the major 
pathways responsible for the activation of many chemical carcinogens. Most oxidation 
reactions are catalysed by well-characterised drug metabolising enzymes such as the 
cytochromes P450 monooxygenase system ( Nebert et al., 1985 ). In addition, however, 
other enzymes are also associated with the oxidation of xenobiotics including the 
FAD-containing monooxygenases ( Ziegler, 1984, 1985; Damani, 1988 ) and 
peroxidases ( Larsson et al., 1988 ). Reduction is another reaction involved in the phase I 
metabolism. The reaction is catalysed by various subcellular reductases located in the 
microsomal and cytosolic fractions, as well as gut bacteria reductases. The reduction of 
nitro and azo groups is an important metabolic pathway of nitrobenzene ( Gibson and 
Skett, 1991) and of azo compounds like the food colour tartrazine respectively ( Timbrell, 
1989 ). Phase I metabolism can also be mediated by hydrolysis, such as the metabolic 
conversion of esters and amides to their active forms. Moreover, hydration of epoxides to 
dihydrodiols is also classified as a phase I reaction.
1.2.2 Phase II Metabolism
Phase II -mediated metabolism is normally associated with conjugation reactions. 
These reactions are well-characterised and involve the addition of a polar group to the 
foreign compound or its metabolite, produced from phase I metabolism. Conjugation 
reactions can be categorised into three major types: sulphation, glucuronidation, and 
glutathione conjugation. Interaction of sulphate with hydroxyl groups is a major route 
involved in the conjugation of xenobiotics and endogenous compounds. Sulphation 
reactions are catalysed by the cytosolic sulphotransferase enzymes and utilise the 
coenzyme 3 '-phosphoadenosine-5 '-phosphosulphate ( PAPS ). Although the sulphation 
reaction is considered to be a detoxication reaction, sulphate conjugation may be 
responsible for the metabolic activation of some compounds such as 2- 
acetylaminofluorene ( Mulder et al., 1988 ). Addition of glucuronic acid to the xenobiotic 
molecule is another essential route associated with phase II metabolism. The
glucuronidation reaction is normally catalysed by the microsomal glucuronosyl transferase 
isoenzymes. Glutathione has been shown to possess an important protective role in the 
body, primarily through interaction with reactive compounds, thus facilitating the 
removal of the active intermediates. Glutathione conjugation reaction is catalysed by one 
or more of a group of glutathione-S-transferases. Glutathione may also react chemically 
with an electrophile, leading to an excretable conjugate which can be readily eliminated. It 
is important to realise that the metabolism of chemical carcinogens can be catalysed by a 
number of enzyme systems simultaneously in the same species, underlying the different 
metabolic routes utilised in the metabolism and, therefore, the several metabolites 
produced with various toxic effects.
1.3 METABOLIC ACTIVATION OF TOXIC COMPOUNDS
It is well recognised that metabolism is a crucial step in the bioactivation process 
of many toxic compounds including mutagens and carcinogens ( Kato, 1986; Kato, 
1994; Jack et al., 1994 ). Most known chemical carcinogens and mutagens are 
metabolised to electrophilic reactants in order to manifest their toxicity and carcinogenicity 
, primarily through oxidation reactions ( Guengerich et al., 1985 ). The generated reactive 
intermediates may then bind covalently with essential cellular components to manifest 
their toxicity. Alternatively, they may interact with reactive oxygen species which can also 
interact with DNA or initiate a lipid peroxidation process ( Figure 1.2 ). A lot of effort 
has,therefore, been devoted to investigating the most likely metabolic pathways 
responsible for the activation of precarcinogens, and their binding to cellular 
macromolecules.
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Figure 1.2 Role of metabolic activation in chemical toxicity
Sims and Grover (1974) demonstrated the metabolism of polycyclic aromatic 
hydrocarbons to biologically active epoxide metabolites that were subsequently converted 
to more active species, such as diol epoxides, by epoxide hydrolase, which express their 
toxic effect. It has been established that epoxidation is a major pathway involved in the 
bioactivation of polycyclic aromatic hydrocarbons, including the extensively studied 
carcinogens benzo(a)pyrene and 7,12-dimethylbenzanthracene (Shen et al., 1985). 
Bioactivation is also an essential event in the metabolism of other chemical carcinogens 
such as nitrosamines. Dimethylnitrosamine is a well-documented example of a 
hepatotoxin that requires metabolic activation to exhibit its toxicity ( Mailing , 1971 ). 
Similarly, two cyclic nitrosamines, nitrosopyrrolidine and nitrosopiperidine, were
activated readily to mutagens in the Ames test by hepatic preparations derived from 
Aroclor 1254-induced hamster ( Hyde et al., 1987 ).
Aromatic amines are another major class of environmental chemicals that induce 
carcinogenicity and mutagenicity only after metabolic activation. Heterocyclic aromatic 
amines, including the food mutagens IQ and Glu-P-1, are metabolically converted to their 
reactive intermediates through N-oxidation ( Hans et al., 1991 ). The initial activation 
step was found to be catalysed by various enzyme systems ( Kato, 1986; Wild et al., 
1987; Thomas et al., 1989 ), derived from various experimental animal models and man ( 
Cindy et al., 1993 ). The activation of occupational carcinogens, represented by 2- 
aminoanthracene and 2-aminofluorene to their active forms was also indispensable 
prerequisite in their carcinogenic action, and is catalysed also by enzyme systems other 
than cytochrome P450-dependent mixed-function oxidase systems ( Ayrton et al., 1992; 
Leist et al., 1992 ) .
1.4 CYTOCHROMES P-450 AND CHEMICAL CARCINOGENESIS
Of the various drug-metabolising enzyme systems, the cytochromes P-450 (CYP) 
appear to be the most important enzyme system involved in the metabolic activation of 
many chemicals. The cytochromes P-450 are ubiquitous haemoproteins localised mainly 
in the endoplasmic reticulum and encountered in both prokaiyotic and eukaryotic cells 
( Gonzalez, 1990; Guengerich, 1991; Kawajiri and Fujii-Kuriyama, 1991 ). Along with 
xenobiotic metabolism, cytochromes P-450 possess an important role in the metabolism 
of endogenous substrates such as vitamins, steroids and eicosanoids ( Daniel et al., 1989 
; Lewis , 1992 ). In fact , these enzymes comprise a multifamily of isoenzymes that 
differs in their substrate specificities and molecular characteristics as shown in table 1.1. 
The cytochrome P-450 families involved in xenobiotic metabolism are CYPl, CYP2, and 
CYP3 and to a lesser extent CYP4 which is associated primarily with fatty acid 
metabolism ( Lewis, 1994 ). One of these families, namely CYPl ( cytochromes P448 )
is one of the most important cytochrome P-450 families responsible for the activation of 
chemicals to reactive intermediates such as epoxides, diol epoxides, hydroxylamines, 
nitrenium ions, and carbonium ions that interact with DNA and therefore cause cell 
damage, immunotoxicity, mutation and cancer ( loannides and Parke, 1987 ). Among the 
various classes of chemicals known to be selectively activated by CYPl are the 
poycyclic aromatic hydrocarbons, aromatic amines and amides, heterocyclic aromatic 
amines and other carcinogens. The carcinogenic nitrosamines, however, are 
metabolically activated primarily by the alcohol-inducible enzyme system CYP2E 
subfamily ( loannides and Parke, 1990 ) as illustrated in table 1.2.
TABLE 1.1 Summary of Inducible Families of Hepatic Cytochrome P-450 
Proteins Involved in Xenobiotic Metabolism
Family Subfamily Typical substrate Role in bioactivation Inducibility
CYPl A Caffeine
Phenacetin
Very extensive Very high
CYP2 A Testosterone
Coumarin
Very limited Yes
B Cyclophosphamide
Hexobarbitone
Limited High
C Tolbutamide
Mephenytoin
None Poor
D Debrisoquine
Dextromethorphan
None No
E Carbon tetrachloride 
Halothane
Yes Yes
CYP3 A Erythromycin
Cyclosporin
Limited Yes
CYP4 A Laurie acid None Yes
Modified from loannides et al. (1994).
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TABLE 1.2 Metabolic Activation Of Chemical Carcinogens By Rat 
Hepatic Cytochrome P-450 Proteins .
Carcinogen CytochromeP-450 Protein
AaC ( 2-amino-9H-pyrido [2,3-b]indol ) l A l , 1A2
2-Acetylaminofluorene l A l , 1A2
AflatoxinBi 1A2, 2B1,2C11,
2C12, 3A4
2-Aminoanthracene lA l , 1A2
o-Aminoazotoluene 1A2
4-Aminobiphenyl 1A2
2-Aminofluorene lAl,  1A2
Benzo(a)pyrene 1A1,2B1
4,4'-(bis) Methylene chloroaniline (MOCA) 1A2, 2B1
1,2,3,4-Dibenzanthracene lA l , 1A2,2B1
7,12-Dimethylbenz(a)anthracene lA l
N,N-Dimethylnitrosamine 2E1
N-Nitrosopyrrolidine 2E1
N-Nitrosopiperidine 2E1
Glu-P-1 1A2
Glu-P-2 lA l , 1A2
IQ l A l , 1A2
MeAaC lA l , 1A2
MelQ ( 2-amino-3,4-dimethylimidazo[4,5-f]quinoline ) lA l , 1A2
MelQx ( 2-amino-3,8-dimethyIimidazo[4,5-f]quinoxaline ) lA l , 1A2
3-Methylcholanthrene lA l
N-Methyl-4-aminoazobenzene lA l , 1A2
2-Naphthylamine 1A2
Trp-P-1 ( 3-amino-l,4-dimethyl-5H-pyrido[4,3-b]indole ) lAl,  1A2
Trp-P-2 ( 3-amino-l-methyl-5H-pyrido[4,3-b]indole ) lA l , 1A2
Data from Guengerich (1988).
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Other families of cytochrome P-450, such as CYP3 and CYP4, have also been associated 
to a lesser extent with toxicity including carcinogenicity . However , it has been revealed 
that a small number of chemical carcinogens may be activated by CYP3 in man 
(Guengerich, 1992). In contrast, metabolism by CYP2B subfamily, the phenobarbitone- 
inducible P450 family, is generally linked to the detoxication of chemicals to inactive 
species that are readily excretable metabolites (Figure 1.3).
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Figure 1.3 Role of cytochromes P450 in the detoxication and activation 
of chemicals and carcinogens.
To some extent, this variation in the biotransformation process can be explained by the 
fact that the active site of CYPl family accepts large planar molecules which it metabolises 
in conformationally- hindered positions to form epoxides and other oxygenated 
metabolites that are poor substrates for epoxide hydrolase as well as for other conjugating
1 2
enzymes. Conversely, metabolic oxidation of nonplanar molecules by other subfamilies 
(e.g. CYP2B, CYP3A) generates metabolites that are readily conjugated leading to 
detoxication (loannides and Parke, 1990 ).
1.5 OCCURRENCE OF ENVIRONMENTAL CARCINOGENS
One of the most important environmental factors in the incidence of various types 
of human cancer is exposure to chemical carcinogens. Two parameters appear to modulate 
the magnitude of chemical exposure, namely diet and exposure to occupational chemicals. 
Diet is considered as one of the most important factors ahead of cigarette smoking ( Doll 
and Peto, 1981 ). The potential carcinogenic risk arising from dietary factors is likely to 
be associated with different classes of harmful compounds present in food. Carcinogenic 
chemicals encountered in the diet may be present either as inherent components of thé 
food, as food additives, as contaminants, or as chemicals produced during the cooking 
process ( Abbott, 1992 ).
Preliminary studies in the 1970s demonstrated the mutagenic activity of charred 
parts of broiled fish and meat in the Ames test ( Sugimura et al., 1977 ; Nagao et al., 
1977 ). Over the past few years, a wide variety of potent environmental mutagens with 
different structural moieties were identified including nitrosamines, polycyclic aromatic 
hydrocarbons, aromatic amines and heterocyclic aromatic hydrocarbons( figure 1.4 ).
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Figure 1.4 Chemical Structure of some Environmental Carcinogens.
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As reported by Preussmann et al. ( 1979 ), processing of cured meat products 
resulted in the formation of nitrosamines such as nitrosopyrrolidine and nitrosopiperidine. 
Alternatively, nitrosamines and other nitroso compounds are also formed endogenously in 
the presence of nitrite and nitrate encountered in the diet ( Ames, 1983 ). In fact, different 
nitrosocompounds were formed as a result of the reaction of either nitrate or nitrite with 
nitrosamine precursors, secondary and tertiary amines as well as amides, under acidic 
conditions (Walker, 1990). Further studies revealed the identity of another group of 
chemical carcinogens, that is polycyclic aromatic hydrocarbons. According to Lijinsky et 
al. ( 1964 ), these compounds are produced when foods are broiled or fried at high 
temperatures due to the incomplete combustion of organic compounds. Benzo(a)pyrene is 
one of these carcinogens that are formed as a result of pyrolysis when meat or fish is 
either broiled or smoked. However, frying any food in repeatedly used fat is another 
source of benzo(a)pyrene formation ( Doll and Peto, 1981 ).
Furthermore, a number of structurally-related heterocyclic aromatic amines have 
been isolated from cooked proteinaceous food ( Figure 1.5 ). The heterocyclic amine IQ 
was first isolated from grilled fish, cooked beef and beef extracts ( Kasai et al., 1980; 
Hayatsu et al., 1983; Felton et al., 1984 ). Moreover, Glu-P-1 and Glu-P-2 were isolated 
from glutamic acid pyrolysate as reported by Yamamoto et al.( 1978 ). In addition to 
dietary carcinogens, humans are also exposed to synthetic toxicants through their use in 
industrial products such as dyes, drugs and pesticides. Such exposure is exemplified by 
aromatic amines, including 2 -aminoanthracene and 2 -aminofluorene, which are 
extensively used in the occupational environment as dye intermediates.
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1.6 TOXICITY OF ENVIRONMENTAL CHEMICALS
It is now recognised that exposure to environmental chemicals plays an important 
role in human cancer development . Many of these compounds were found to be 
mutagenic and they are metabolically activated to unveil their biological activities ( 
Tsutomu and Yasuko, 1988 ; Kato, 1986 ). As well as being mutagenic, it was 
established that most of the chemicals discussed have been shown to be carcinogenic in 
rodents ( Mailing, 1971; Preussmann et al., 1979; Anthony, 1985; Hiroko et al., 1991 ). 
The initial activation step mechanism of these mutagens is usually catalysed by 
cytochromes P-450, and the resultant metabolite is metabolically converted by several 
enzyme systems such as epoxide hydrolase, sulphotransferase, and N-acetyltransferase
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depending upon the structure of the reactive intermediate ( Yamazoe et al., 1984 ; Michael 
, 1989 ; Tsutomu et al., 1988 ; Kato et al., 1994 ). As previously mentioned and 
following Klaunig (1992), initiation of carcinogenic activity is a multistage process 
associated with the generated electrophilic reactants, the proximate carcinogen which can 
either interacalate with DNA and / or be further metabolised to a more reactive metabolite, 
the ultimate carcinogen, that readily combines with DNA and other macromolecules .
Metabolism studies demonstrated that the bay-region diol epoxides are the 
metabolites most closely associated with the carcinogenic potential of a variety of 
polycyclic aromatic hydrocarbons. For example, the carcinogenicity of the potent 
carcinogen benzo(a)pyrene was essentially correlated with the ultimate carcinogen 
benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide, the bioactivated metabolite which binds to 
DNA resulting in tumour initiation and promotion as pointed out by Sims et al. ( 1974 ). 
Moreover, monitoring the carcinogenic activity of aromatic amines, and particularly 
heterocyclic amines, is of obvious concern due to their contribution as a possible health 
risk factor in the progression of human cancer incidence ( Gooderham et al., 1989; 
Turesky, 1990 ). Carcinogenic action induced by aromatic amines and heterocyclic 
amines has been shown to be associated with their N-hydroxylated derivatives, the 
proximate carcinogen. As indicated in figure 1.6, further metabolism of the proximate 
carcinogen usually resulted in the formation of a highly reactive intermediate, the 
nitrenium ion, that functions as the ultimate carcinogen and is the principal entity capable 
of interacting with DNA leading to mutation and consequently the initiation of the 
carcinogenic process ( Kato, 1986 ). One of these compounds, the heterocyclic amine IQ 
was shown to be carcinogenic in different animal models ( Hiroko et al., 1991 ), and this 
carcinogenicity had been shown to be related to its N-hydroxy derivative, the proximate 
carcinogen formed through a N-hydroxylation mechanism, which can directly interact 
with DNA as demonstrated by Okamoto et al. ( 1981 ). Additional studies established that 
the generated N-hydroxy derivative is further metabolised by cytosolic enzymes to 
yield the ultimate mutagen and carcinogen ( Abu-Shakra et al., 1986; Kato, 1994 ).
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Figure 1.6 Bioactivation of aromatic amines
Evidence that some of the environmental chemicals induce multi-organ carcinogenesis is 
summarised in the following table :
Table 1.3 Carcinogenicity of food carcinogens in rats
Compound Target organ
IQ Liver, lung , small and large intestine ,
Zymbal gland clitoral gland , skin.
MelQ Large intestine , Zymbal gland , skin , oral cavity
mammary gland.
MelQx Liver, Zymbal gland , skin , clitoral gland .
Trp-P-1 Liver.
Trp-P-2 Liver.
Glu-P-1 Liver, small and large intestine, Zymbal gland,
clitoral gland.
Glu-P-2 Liver, small and large intestine , Zymbal gland ,
clitoral gland.
Data from Hiroko et al. ( 1991 ) .
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1.7 Diet And Cancer
There is now a growing awareness that the continuous increase in human cancer 
risk is attributable to environmental factors and general life-style, although the specific 
causes of cancer incidence vary in several countries. Among these factors diet is now 
recognised as one of the important factors influencing the occurrence of human cancer 
(Ames, 1983). Doll (1990) speculates that about 30-70 % of all cancer deaths in the 
United States are attributable to dietary factors. The contribution of diet as a crucial cause 
of cancer development is related to many carcinogenic chemicals encountered in human 
diet, that are naturally-occurring substances or being generated during the cooking 
process, in addition to food contaminants and food additives. However, increased risk of 
colo rectal cancer and breast cancer have been correlated to the high intake of dietaiy 
fat ( Ramel, 1986 ).
On the other hand, dietary components play a substantial role in reducing the 
impact of environmental carcinogens and thereby protecting humans from exposure to 
such agents ( Ramel, 1986 ). In fact, epidemiological studies established an inverse 
relationship between certain diets and the incidence of some human cancers ( Ames , 1983 
). These studies have demonstrated that increasing consumption of vegetables, fruits and 
cereals, along with reducing fat-rich product consumption, is associated with relatively 
low risks of cancer ( Overvik and Gustafsson, 1990 ). The observed anti carcinogenic 
activity is believed to be due to vitamins A, C, E and ^-carotene, fibre and minerals, in 
suppressing tumour development despite the fact that many dietary constituents might 
interfere in their protective effect ( Ames, 1983 ; loannides et al., 1992 ). Most fruits and 
vegetables contain a wide array of naturally-occurring phenolic compounds, such as 
flavonoids, that are of particular importance in dietary modulation of chemical 
carcinogenesis ( Brown, 1980 ). In view of these findings, some forms of human cancer 
could be avoidable by changing dietary habits since effective elimination of exposure to 
many toxic chemicals is not, at present, achievable.
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1.8 INHIBITORS OF MUTAGENESIS AND CARCINOGENESIS
It is gradually appreciated that chemical mutagenesis and carcinogenesis can be 
inhibited by a large number of synthetic and naturally-occurring chemicals. The latter 
inhibitors occur widely in food and are predominantly of plant origin, being either 
nutrients such as vitamins, fibre and minerals, or anutrients which comprise a wide array 
of chemicals including polyphenols, flavonoids and anthraquinones ( Huang et al., 1983 ; 
Ames, 1984; Das et al., 1985; Steele et al., 1985 ). A large number of anutrients are 
minor constituents of some of the commonly consumed vegetables, fruits, spices and 
beverages like coffee and tea. It has been reported by Wattenberg ( 1983 ) that most 
dietary cancer chemopreventive agents are phenolics compounds with diverse chemical 
structures as illustrated in figure 1.7.
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Figure 1.7 Chemical Structure of some Dietary Antimutagens and 
Anticarcinogens
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A wide variety of inhibitors of carcinogenesis manifest their preventive effect 
through one or more mechanisms of action . Consequently , two categories of 
chemopreventive agents have been recognised according to the stage in the carcinogenic 
process at which they are effective (Ramel et al., 1986). Stage 1 category includes 
inhibitors acting extracellularly whereas stage 2  category comprises those agents that act 
intracellularly. As described by Kada et al. ( 1985 ), these inhibitors can also be 
recognised as desmutagens and bio-antimutagens respectively according to whether the 
antimutational events involved in the anticarcinogenesis process occur outside or inside 
the cell. Chemopreventive compounds of stage 1 group are those agents which elicit their 
protective activity by preventing exogenous mutagens from damaging DNA via 
impediment of the formation of genotoxic chemicals from precursor compounds. Another 
stage 1 class of inhibitors prevent the uptake of mutagens or their precursors into the cell. 
Blocking agents are other types of inhibitors of mutagenesis recognised normally as stage 
2 inhibitors. These chemicals invoke their protective effect by preventing the genotoxic 
compounds from reaching or reacting with indispensable target sites in the cell, thus 
neutralising the ultimate mutagen and / or carcinogen thereby preventing the damage of 
DNA and other critical macromolecules. Blocking agents may be classified further into 
three categories on the basis of their mechanisms of action (figure 1 .8  ).
Protection against chemical mutagenesis and carcinogenesis may be achieved by 
various mechanisms: (A) inhibiting the carcinogenic and mutagenic potential directly 
either chemically or enzymically. Toxic chemicals are effectively deactivated as a result of 
scavenging their reactive electrophilic form by direct interaction with such 
chemopreventive substances. Additionally, the reactive intermediates of chemicals may be 
themselves inactivated following conjugation with nucleophiles present in the cell such as 
the simple tripeptide glutathione, through the nucleophilic-SH group of the cysteine, thus 
impeding their interaction with cellular constituents, (B) inhibiting the conversion of 
promutagen and procarcinogen to their reactive intermediates through inhibition of the 
metabolic activation, thus reducing the formation of the genotoxic chemicals from their
2 1
precursors, (C) adsorbing the mutagenic and carcinogenic chemicals by high molecular 
weight substances or dietary fibres. On the other hand , carcinogen inhibitors of the stage 
2  group are called suppressing agents and exert their influence by preventing the evolution 
of the neoplastic process in cells that otherwise would become malignant. Inhibition of 
mutagenesis and carcinogenesis, in most cases, occurs inside the cell, though some 
inhibitory actions on the metabolic activation of mutagens may take place outside the 
target cell. Examples of the different types of inhibitors are given in Table 1.4.
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Adapted from Ramel (1986).
22
TABLE 1.4 Examples of various carcinogenesis inhibitors.
(1) Compounds preventing the formation of carcinogens from their precursors
Reductive acids
Tocopherol
Phenols
ascorbic acid
a-tocopherol, y-tocopherol 
gallic acid, propyl gallate
(2) Blocking agents 
Phenols 
Indoles
Aromatic isothiocyanates 
Coumarins 
Monoterpenes 
Diterpenes
Organosulphur compounds
BHA, BHT , caffeic acid, ferulic acid, 
indole-3-carbinol, indole-3-acetonitrile 
benzyl isothiocyanate, phenyl isothiocyanate 
coumarin, limettin 
limonene, carvone 
kahweol palmitate
diallyl sulphide, diallyl disulphide, allyl mercaptan 
, allyl methyl disulphide
(3) Suppressing agents 
Retinoids 
Selenium salts
Cyanates and isothiocyanates 
Methylated xanthines
retinyl palmitate, retinyl acetate
sodium selenite, selenium dioxide, sodium selenide
sodium cyanate, tert-butyl isocyanate,
benzyl isothiocyanate
caffeine
Modified from Ramel et al.(1986) & Wattenberg (1990).
Certain dietaiy minerals, vitamins, and plant phenolic compounds act as effective 
inhibitors of chemical mutagenesis and carcinogenesis through several mechanisms of 
action (Wattenberg, 1985). It is well-established that the majority of commonly consumed
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plant phenolics in human diet possess multifunctional biochemical activities and act as 
antioxidants, free radical scavengers, inhibitors of nitrosation formation, metal chelators, 
and hydrogen peroxide generators and, furthermore, they are capable of modulating drug- 
metabolising enzymes ( Huang and Ferraro, 1992; Osawa, 1992 ). Antioxidants include 
vitamins C and E which have been shown to be associated with inhibiting the formation 
of nitroso carcinogens in vitro and in vivo ( Ames, 1983; Kahl, 1986 ). Similar effect has 
also been reported with respect to plant phenolics, such as caffeic acid, femlic acid and 
gallic acid, utilised as protective agents against nitrosamines carcinogenesis (Stich et al.,
1984). Inhibition in the metabolic activation of benzo(a)pyrene was correlated to vitamin 
A and E treatment ( Narbonne et al., 1990 ). Vitamin E has also been shown to inhibit
7,12-dimethylbenzanthracene-induced skin tumorigenesis and similarly diminish oral 
mucosal carcinogenesis in mice ( Huang and Ferraro, 1992 ).
Another dietary antioxidant which may act by protecting body fat and lipid 
membranes is p-carotene ( Ames, 1983 ). Carotenoids are present mainly in green and 
yellow vegetables and have been implicated in anticarcinogenesis in rodents and possibly 
in humans ( Ramel, 1986 ). Moreover, epidemiological studies have revealed a correlation 
between increased consumption of vitamin A and p-carotene and reduced cancer 
multiplicity in different organs ( Doll, 1990 ).Other dietaiy components, including 
selenium, express their anticarcinogenic effectiveness by scavenging the oxygen radicals 
generated by the metabolism of certain mutagens and carcinogens . Selenium is of 
particular importance in destroying lipid hydroperoxides and endogenous hydrogen 
peroxide, being an essential constituent of glutathione peroxidase ( Ames, 1983 ). 
Epidemiological studies have revealed that selenium deficiency is a possible risk factor in 
human cancer, and a low selenium dietary intake has been associated also with 
cardiovascular disease ( Ramel, 1986 ). Selenium salts were also reported to significantly 
inhibit the induction of mammary tumours by virases, and multi-organ tumours induced 
by a wide variety of carcinogens in experimental animals ( Ames, 1983 ).
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The contribution of synthetic and naturally-occurring phenolics in preventing 
chemically-induced carcinogenesis or mutagenesis has also been established ( Wattenberg 
et al., 1980; Stich et al., 1984 ). Plant polyphenols have been demonstrated to be efficient 
inhibitors of mutagenicity and carcinogenicity induced by a variety of environmental 
carcinogens, including polcyclic aromatic hydrocarbons ( Huang et al., 1983 ; Das et al., 
1987; San and chan, 1987 ). Earlier studies indicated that ellagic acid, one of the 
widespread dietary polyphenols, strongly inhibited the mutagenicity of bay-region diol 
epoxides, the ultimate carcinogenic forms of polycyclic aromatic hydrocarbons in the 
Ames test ( Sayer et al., 1982 ; Wood et al., 1982 ). A similar effect has also been 
described for synthetic analogues of ellagic acid such as dibenzo[b,d]pyran-6 -one 
( Josephy et al., 1990 ). Daniel and Stoner ( 1991 ) have reported that ellagic acid 
abolished nitrosobenzylmethylamine-induced oesophageal tumorigenesis in rats. 
Carcinogenesis induced by 4-nitroquinoline-l-oxide in rat tongue was diminished by a 
series of plant phenols including ellagic acid ( Tanaka et al., 1993 ). Further studies have 
established the ability of ellagic acid to inhibit the in vivo mutagenicity of the food 
mutagen IQ, caused by the non-selective destruction of cytochromes P450 ( Ayrton et al., 
1992 ). Numerous plant-derived compounds such as anthraquinones and flavonoids have 
been found to possess antimutagenic and possibly anticarcinogenic potentials 
(Ames, 1984). Preliminaiy findings showed that the mutagenicity emerged from the 
reactive form of benzo(a)pyrene , 7,8-dihydroxy-9,10-epoxybenzo(a)pyrene, was 
effectively reduced by anthraflavic acid, a naturally-occurring plant phenolic flavonoid 
(Huang et al., 1983). Subsequent studies with anthraflavic acid revealed that the 
mutagenicity of IQ was inhibited in vitro as a result of suppressed metabolic activation by 
CYPl family (Ayrton et al., 1988 ). On the other hand, synthetic phenolic antioxidants, 
including BHA and BHT, have been shown to inhibit tumorigenesis caused by polycyclic 
aromatic hydrocarbons such as 7,12dimethylbenz(a)anthracene in several animal models 
( Huang and Ferraro , 1992 ).
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Several other active chemopreventive substances in food have also been described of 
which indoles, organosulphur compounds, aromatic isothiocyanates and monoterpenes 
are of great importance in carcinogen deactivation ( Wattenberg, 1990 ). Phenolic 
flavonoids such as quercetin and rutin were also found to be potent inhibitors of 
azoxymethanol-induced colonic neoplasia ( Deschner, 1992 ). Other dietary phenolic 
compounds such as curcumin, a food colouring agent present in turmeric and curry 
powders, and carnosol and camosic acid occurring in rosemary( Figure 1.9 ) have been 
established as biologically active constituents possessing anticarcinogenic activity ( Huang 
and Ferraro, 1992 ). Finally some beverages also contain a large number of naturally- 
occurring phenolic components with strong antimutagenic and anticarcinogenic 
properties, like chlorogenic acid in coffee and catechin polyphenols in tea ( Huang and 
Ferraro, 1992 ).
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Figure 1.9 Chemical S tru ture  of Some N aturally-O ccurring P lant 
Phenolic Compounds
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1.9 TEA
Tea is derived from the Camellia sinensis species of the Theaceae family 
(Graham, 1992). Tea is the most commonly consumed beverage, aside from water, 
worldwide. Considering human consumption, tea can be classified into two major 
varieties, namely green tea and black tea. Of the estimated 2.5 million metric tons of dried 
tea manufactured in 1989, green tea and black tea constituted 20 % and 80 % respectively 
(Wang et al.,1992 ). Green tea is consumed primarily in Asian countries, in particular 
China, Japan, and a few countries in North Africa while black tea is consumed in 
Western nations and some Asian countries including the Middle East where tea is the 
major beverage. In addition to its physiological effects, green tea has been consumed in 
large quantities because of its pharmacological activities, such as antipyretic and diuretic, 
as well as protecting blood vessels and reducing serum cholesterol levels ( Wang et al., 
1989; Xu et al., 1992 ). Green tea is produced by steaming and diying fresh tea leaves at 
elevated temperatures. Alternatively, black tea manufacture involves the enzymatic 
fermentation of crushed tea leaves by polyphenol oxidase leading to the formation of 
theaflavins , thearubigins and other oligomers ( Wang et al.,1992 ).
1.9.1 Tea Composition
Despite the variation in tea composition depending on the origin of the leaf and on 
the manufacturing conditions, tea leaves are basically composed of polyphenols and 
methylxanthines as well as organic acids and other components ( Graham, 1992 ). The 
chemical structure of some types of tea polyphenols are illustrated in Figure 1.10. Green 
tea contains numerous types of polyphenols, of which the flavan-3-ols and the flavonols 
and their glycosides are the most important constituents ( Graham, 1992 ). Many of the 
green tea polyphenols are flavan-3-ols, commonly known as catechins, constituting up to 
30 % of the dry matter ( Wang et al., 1992 ). The various types of catechins are listed in 
Table 1.5 and their structures are shown in Figurel.lO. Other types of flavonoids and 
their glycosides are listed in Table 1.6.
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Figure 1.10 Chemical Structure Of Green Tea Polyphenols
In comparison to green tea catechins, thearubigins and theaflavins, besides gallic 
acid and (-)-epigallocatechin gallate, are the predominant polyphenols in black tea ( 
Huang and Ferraro, 1992 ). The composition of both green and black tea beverages is 
presented in Table 1.7. The thearubigin fraction consists of an incompletely characterised 
group of complex polyphenols resulting from catechin oxidation which are red-brown in 
colour and of a heterogeneous structure ( Huang and Ferraro, 1992 ). Phenolic 
compounds are ingested in considerable amounts by humans since they are present to 
such extent in tea. Based on this fact, the estimated total consumption of polyphenolic 
substances consumed is in the range of 0.3 to 1 g / day / person, assuming that 20 % to 
30 % of the dry solids in tea extracts are polyphenolic catechins ( Huang and Ferarro, 
1992).
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TABLE 1.5 Types of Green Tea Catechins
Flavan-3-ols Group % of Tea Dry Weight
(+)-Catechin 1 -2
(-)-Epicatechin 1-3
(-)-Epicatechin gallate 3-6
(+)-Gallocatechin 1-3
(-)-Epigallocatechin 3-6
(-)-Epigallocatechin gallate 7-13
Adapted from Graham ( 1992 ).
TABLE 1.6 Flavonols and Flavonol Glycosides in Green and Black Tea
Flavonol Group Green Tea Black Tea
(mg/g Dry Leaf) (mg/g Dry Leaf)
Quercetin 0.40 -
Myricetin 0.34 -
Kaempferol 0.52 -
Rutin 1.58 1.32
Quercetin-G 1 .0 0 0.76
Kaempferol-G 1.33 0.70
Quercetin-G2 3.17 -
Kaempferol-G 1 2.30 -
Isoquercetrin 1.82 -
Kaempferol-G2 4.30 -
Kaempferol-G3 - 1 .0 1
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G= 3-glucosyl(l->3)rhamnosyl(l->6)galactoside, Gl= 3-rhamnoglucoside 
G2= 3-rhamnodiglucoside, G3= 3-O-rutinoside 
Adapted from Balentine ( 1992 ) .
TABLE 1.7 Composition of Green and Black Tea Beverages.
Component Green Tea Black Tea
% of Diy Extract Solids % of Dry Extract Solids
Catechins 34.0 4.2
Theaflavins - 1 .8
Thearubigins - 17.0
Flavonols 0.4 -
Flavonol glycosides 4.4 1.4
Protein 7.6 10.7
Amino acids 5.3 4.8
Caffeine 6.9 7.1
Carbohydrates 12.5 13.5
Organic acids 9.5 1 1 . 0
Adapted from Balentine ( 1992 ) .
1.9.2 TEA PHENOLS AND CANCER PREVENTION
1.9.2.1 Epidem iological Studies
Epidemiological investigations have revealed inconsistent and inconclusive 
results concerning the protective effect of tea polyphenols against carcinogenesis ( Wang 
et al.,1992 ). In an early case-control study in Nagoya, Japan it was concluded that green 
tea and black tea consumption did not increase the risk of stomach cancer even though a
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significant positive correlation was found in London (Wang et al., 1992). Further studies 
in Kyushu , Japan showed that individuals consuming green tea in large quantities and 
more frequently tended to have a lower risk of gastric cancer (Kono et al., 1988). Another 
survey, also carried out in Japan, indicated that the incidence of death from cancers, 
especially stomach cancers, was lower than the national Japanese average among 
inhabitants of both sexes from Shizuoka Prefecture, where green tea is a stable dietary 
product (Oguni et al., 1988). A similar epidemiological picture emerged in the Fujian 
Province of China ( Wang et al., 1989 ). Other studies have demonstrated that the 
mortality ratios from lung cancer among males in Japan is much lower than those in the 
United States, presumably due to the variation in dietary habits between these two 
countries where the prevalence of green tea consumption in Japan is an intriguing factor in 
inhibiting mutagenesis and carcinogenesis ( Xu et al., 1992 ). Additional epidemiological 
investigations indicated a contribution by green tea consumption in reducing colon cancer 
risk (Hayatsu et al, 1992).
1.9.2.2 Evidence of The Antimutagenic And Anticarcinogenic Action of 
Tea Polyphenols.
Several laboratory studies worldwide demonstrated the cancer chemopreventive 
effect of different varieties of tea in various test systems utilising a diverse class of 
carcinogens as well as ultraviolet radiation. Water extracts of green tea have been shown 
to suppress mutagenesis in a number of bacterial strains in the Ames test. It has been 
reported that spontaneous mutation in 1125 Bacillus Subtilis carrying a mutation in DNA 
polymerase 111 was effectively reduced by epigallocatechin-3-gallate ( EGCG ), the major 
constituent of green tea polyphenol catechin derivatives ( Kada et al., 1985 ). Stich and 
Rosin (1984) demonstrated that tea infusions suppressed the mutagenicity of a model 
nitrosation system, at concentrations similar to or even below that of ascorbic acid which 
is effectively used to block nitrosation. Green tea catechins have been shown to inhibit the 
mutagenic response of nitrosation products of methyl urea and salted fish in Salmonella 
typhimurium TA 1535 ( Stich et al., 1984 ) and to inhibit significantly the reverse
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mutations induced by benzo(a)pyrene, 2 -aminofluorene, afïatoxin B i, and coal tar in S . 
typhimurium TAIOO and / or TA 98 (Wang et al., 1989). In addition, green tea extract 
markedly inhibited the mutagenicity of N"-methyl-N"-nitroso-N-nitroguanidine (MNNG) 
in both E.Coli and S.typhimurium ( Jain et al., 1989 ). Experimental results also 
showed an inhibitory effect of green and black tea on endogenous nitrosation in humans 
( Wang and Wu, 1989 ).
In addition to tea infusions, tea polyphenols have also been shown to afford 
protection against mutagenesis, tumour promotion and chemical carcinogenesis in animal 
experimental systems . Subsequent in vivo studies indicated that green tea extracts 
decreased the incidence of forestomach and oesophagus carcinogenesis induced by 
sarcosine and NaN02 in mice ( Chang et al., 1991 ). Furthermore, it has been reported 
that green tea polyphenols possess a substantial anti-skin tumour-initiating activity against
7,12-dimethylbenz[a]anthracene (DMBA), 3-methylcholanthrene (3MC), and the ultimate 
form of benzo(a)pyrene, benzo(a)pyrene7,8-diol-9-10epoxide (BPDE) in different 
animals and using tumour protocols employing various routes of administration ( Kahn et 
al., 1988; Wang et al., 1989a ). Protection against complete carcinogenesis caused by 
3MC was observed following topical application of green tea polphenols onto the skin of 
BALB/c mice ( Wang et al., 1991). Topical application of green tea epicatechins clearly 
showed a protective response against UVB radiation-induced skin photocarcinogenesis in 
female SKH-1 hairless mice ( Wang et al., 1991; Conney et al., 1992). Further studies 
demonstrated that the promotion activity of 12-O-tetradecanoy 1 phorbol-13-acetate (TPA) 
was significantly inhibited by green tea extracts and by its phenolic component 
EGCG ( Wang et al., 1992 ). As reported by Xu et al.( 1992 ), administration of several 
types of tea infusion, polyphenolic extracts of green tea or EGCG resulted in a significant 
reduction in oesophagus and duodenum tumours induced by N-nitrosobenzylmethylamine 
and N-ethyl-N'-nitro-N-nitrosoguanidine respectively.
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Other studies showed that both, green tea and black, tea extracts inhibited 
mutagenesis and carcinogenesis caused by nitrosamines like N-nitrosodiethylamine and 4- 
(methylnitrosamino)-1 -( 3-pyridyl)-1 -butanone in A/J mice ( Wang et al., 1992 ; Xu et 
al., 1992 ). Furthermore, EGCG efficiently decreased the mutagenicity of Trp-P-2 and 
suppressed the direct-acting mutagenesis of N-OH-Trp-P-2 and N-OH-Glu-P-1 in FM3A 
mice ( Hayatsu, 1992 ). Moreover; EGCG has been shown to possess protective effect 
against DNA single strand breaks caused by Glu-P-1 in vitro ( Hayatsu , 1992 ). 
Furthermore, EGCG was also an efficient suppressive agent towards the binding of 
topically applied polycyclic aromatic hydrocarbons to epidermal DNA in SENCAR mice ( 
Katiyar et al., 1992 ). Recently, tumour promotion induced by TPA in DM BA-initiated 
SENCAR mouse skin has been reported to be potently reduced when green tea 
epicatechins applied topically ( Katyar et al., 1993 ). Finally, recent studies revealed the 
ability of green tea and black tea to decrease the mutagenic activity of two typical 
carcinogenic heterocyclic amines IQ and PhIP ( Weisburger, 1994 ).
1.9.2.3 Suggested Mechanisms of action of The Anticarcinogenic And 
Antimutagenic Activités of Tea Polyphenols.
Various possible mechanisms accounting for the chemopreventive action of green 
tea polyphenols have been put forward. However , the specific defence mechanism 
whereby green tea extracts elicit their biological effects remains unclear. It is believed that 
tea polyphenols have multifunctional biochemical activities capable of preventing 
tumours. Simultaneously they act through inhibiting the responsible enzymes for the 
carcinogen activation , preventing the interaction of the ultimate carcinogen metabolite 
with cellular DNA, stimulating the detoxication enzymes involved in carcinogen 
elimination, or trapping the generated free radicals.
The inhibitoiy action of tea polyphenols might be related to their capacity to alter 
the metabolic pathways of chemical carcinogens, that includes inhibition of the 
metabolising enzymes associated with the bioactivation of procarcinogens. In fact, the
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inhibitory effect of (+)-catechin on rat hepatic ethoxyresorufin 0 -deethyIase has been 
shown to be due to a decrease in NADPH-cytochrome c reductase activity (Steele et al.,
1985). Tea polyphenols also may act as inducers for the enzymes responsible for 
detoxication pathways, such as the glutathione-S-transferases ( Das et al., 1985 ). Further 
studies by Wang et al.(I988) showed that even though in vitro green tea epicatechin 
derivatives were able to inhibit microsomal monooxygenase activities and the NADPH- 
dependent reduction of cytochrome c as well as suppressing of epoxide hydrolase activity 
in vivo, there was no effect of green tea phenols on phase I enzyme activities and only 
slight increases in the activity of phase II enzymes such as glutathione-S-transferase and 
NADPH quinone reductase was evident These results suggested that modulation of 
carcinogen metabolism may not be the major mechanism in vivo responsible for the 
inhibition in DNA adduct formation by green tea polyphenols. Alternatively, it is possible 
that interaction of green tea polyphenols with electrophilic species and scavenging of 
reactive radical species may also contribute to the reduced binding of the polycyclic 
aromatic hydrocarbons ( PAHs) to epidermal DNA, since most chemical carcinogens can 
be converted by cellular enzymes to highly reactive electrophilic forms. This may be one 
of the principal mechanisms of the antitumourigenic effects of green tea components ( 
Wang et al., 1989a ). However, the antimutagenic potential of green tea polyphenols may 
partly relate to their ability to perturb the metabolism of PAH by interacting with 
cytochrome P-450 which in turn results in the inhibition in PAH-DNA binding ( Wang et 
al., 1989b ).
The antimutagenic and anticarcinogenic properties of several antioxidants 
frequently reflects their potency to neutralise various free radicals generated as a result of 
xenobiotic metabolism. Green tea polyphenols are strong antioxidants, with the capacity 
of scavenging hydrogen peroxide (H2 Q2 ) and the superoxide anion (0"2) and, therefore, 
preventing oxygen radical and H2 0 2 -induced cytotoxicity and mutagenicity ( Ruch et al., 
1989 ). Xu et al. (1992 ) have suggested that the mechanism by which green tea and 
EGCG inhibit tobacco-specific nitrosamine 4 -(methylnitrosamino)-l-(3 -pyridyl)-l-
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butanone (NNK)-induced lung tumourigenesis is due, at least partly, to their and oxidant 
properties. The antioxidant activity of tea components may also be important in the 
protection afforded by tea towards cellular oxidative damage such as lipid peroxidation 
and DNA single strand breakage. These insults may contribute to carcinogenesis at both 
the initiation and post-initiation stages. EGCG displayed a suppressive effects against 
H2 Q2 production and oxidative DNA damage ( Bhimani and Frenkel, 1991 ). Other 
investigations indicated that (4-)-catechin was able to diminish NNK-induced DNA single 
strand breaks in rat hepatocytes, both in vitro and in vivo ( Liu and Castonguay, 1991 ).
Ho and his co-workers (1992) evaluated the antioxidant properties of tea 
polyphenol extracts and of their purified constituents. Green tea extracts exhibited 
stronger antioxidant activity than the semi-fermented tea extracts. Most tea components 
including gallic acid showed strong antioxidant activities. It was also noted that the green 
tea polyphenols EGCG, ECG, and EGC inhibited the lipoxygenase pathway of 
arachidonic acid metabolism , and this effect appears to interfere with the promotion 
rather than the initiation stage in the carcinogenic process (Ho et al., 1992). Thus, 
inhibition of lipoxygenase is another possible mechanism through which tea catechins act 
as anticacinogens. Recent studies also established the antioxidative activity of theaflavins 
and thearubigins, two types of polyphenolic components purified from black tea extract. 
The basic structural formulae of these components are shown in Figure 1.11. These 
findings imply that black tea can inhibit lipid peroxidation and, therefore, could be a 
possible inhibitory mechanism against carcinogenesis (Yoshino et al., 1994).
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1.10 AIMS OF THE PRO JECT
While a large number of compounds have been shown to prevent the incidence of 
carcinogenesis, the mechanism by which some of these chemicals function has not been 
completely understood. Therefore, the objectives of the present project are as follows:
(1) To evaluate anthracene as a possible antimuatagen against the food mutagen IQ.
(2) To evaluate the potential of green tea to suppress the in vitro mutagenicity of model 
carcinogens in the Ames mutagenicity test, and investigate the underlying 
mechanisms.
(3) To investigate whether long-term administration of aqueous extracts of green tea 
modulates the hepatic levels of the xenobiotic-metabolising cytochrome P450 
proteins and of the major Phase II activities.
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(4) To compare the antimutagenic potential of green, black and decaffeinated black tea
against selected food mutagens.
(5) To assess the role of caffeine and flavanols in the antimutagenic activity of green tea.
(6 ) To evaluate the contribution of caffeine and flavanols on the modulation of the hepatic 
cytochromes P450 and Phase II enzyme systems.
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CHAPTER 2
MATERIALS AND METHODS
3 8
2.1 CHEMICALS
Dimethylsulphoxide was purchased from Fisons Scientific Equipment , 
Loughborough , Leicestershire. Nutrient broth No.2 was obtained from Oxoid, 
Basingstoke, Hampshire, while Lab. M Agar No. 1 and lauric acid were products 
of Amersham, Bury, U.K. Vogel Boner E plates were supplied by Becton Dickinson 
Ltd., Glasgow, Scotland, whereas the sterile polyethylene Universal tubes (30 ml) and 
the sterile screw cap polyethylene tubes (10 ml) were purchased from Bibby Sterilin 
Ltd., Staffordshire. Polycarbonate centrifuge tubes (10 ml) were obtained from Beckman 
Ltd., Berkeley , California , U.S.A. and polyethylene centrifuge tubes (50 ml) were 
purchased from MSE Scientific Instruments, Crawley, Sussex. All glass 
homogenisation tubes were supplied by Jencons scientific Ltd., Leighton Buzzard, 
Bedfordshire, U.K. The Salmonella typhimurium strains TA 97, TA98, TAIOO , TA 
1530 were generously donated by Prof. B.N. Ames, University of California , Berkeley 
, USA.
Ampicillin, menadione , L-histidine , d-biotin , p-nitrophenol , 4-nitrocatechol , 
erythromycin, acetyl acetone , lauric acid , 6 -nicotinamide adenine dinucletide phosphate 
(NADP) , NADPH , glucose-6 -phosphate , glucose-6 -phosphate dehydrogenase , 
cytochrome c , bovine serum albumin , Folin-Cioalteau phenol reagent , hydrogen 
peroxide , co-enzyme A , FAD , NAD , nicotinamide , dithiothreitol ( DTT ) ,3 ,4 - 
dichloronitrobenzene ( DCNB ) , l-chIoro-2,4-dinitrobenzene (CDNB ) , reduced 
glutathione, 2-naphthol, 2 -mercaptoethanol, adenosine3 -phosphate5 -phosphosulphate 
(PAPS), N-naphthylethylanediamine, Triton X-100, UDP-glucuronic acid, 4- 
methylumbelliferone, hypoxanthine, xanthine oxidase, superoxide dismutase, imidazole, 
glutathione reductase, sodium dodecyl sulphate,bromophenoI blue, N ,N ,N 'N '- 
tetramethylethylenediamine (TEMBD), benzo(a)pyrene, benzo(a)pyrene 4,5-oxide, 
benzo(a)pyrene 4,5- diol, nitrosopyrrolidine , nitrosopiperidine, dimethylnitrosamine, 2-
39
ami noanthracene, 9-aminoacridine, N-methyl-N'-nitrosoguanidine (MNNG), isoniazid , 
nitroquinoline N-oxide were all products of Sigma Chemical Company , Poole , Dorset 
Titanyl sulphate, 2-aminofluorene and 2-aminophenol were obtained from Aldrich 
Chemical Company Ltd., Gillingham , Dorset. Ethoxyresorufin , methoxyresorufin , 
pentoxyresorufin and resorufin were products of Molecular Probes, Eugene, Oregon, 
USA. Aroclor 1254 was provided by Robens Institute of Health and Safety , Guildford , 
Surrey .
Anthracene was purchased from Koch Light Labs Ltd., U.K. Both 2-amino-
3-methylimidazo[4,5-f]quinoline (IQ) and 2 -amino-6 -methyldipyrido[l,2 -a: 3,2'- 
d]imidazole (GIu-P-1) were obtained from Wako Pure Chemical Industrials Ltd., 
Germany, whereas 7,12-dimethyIbenzanthracene was purchased from ITT Research 
Institute, Chicago, Illinois U.S.A. Sodium cacodylate, osmic acid, glutaraldehyde, and 
epon 812 were all purchased from TAAB Laboratories Equipment Ltd., Aldermaston, 
Berks. TLC plates, silica gel 60, were supplied by MERCK, Darmstadt, Germany.
Peroxidase-linked donkey anti-sheep IgG was also purchased from Sigma 
Chemical Company Ltd., Poole, Dorset, while antibodies to rat CYP4A1 and to the 
trans-2-enoyl CoA hydratase trifunctional protein ( an indication of peroxisomal 
proliferation ) were generous gifts from Prof. G.G Gibson ( University of Surrey, 
Guildford ) and Dr. D.L. Cinti ( Department of Pharmacology, University of 
Connecticut Health Center, Farmigton, USA ). Nitrocellulose sheets ( 0.45 pim pore size 
) were obtained from Anderman and company, Kingston upon Thames, Surrey. 
Chromatography paper was purchased from Whatman International Ltd., Maidstone. 
Vertical slab-gel electrophoresis Unit was supplied by Sigma Chemical Company , Poole 
, Dorset.
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2.2 METHODS
2.2.1 Animal Pretreatment
Male Wistar albino rats (150 -180 g) were purchased from the Animal Breeding 
Unit, University of Surrey, Guildford, U.K. The rats were housed in groups of five, in 
polycarbonate cages on sawdust bedding, in a controlled room temperature of 21+ 2 °C, 
relative humidity of 50 % and light / dark cycle of 12 hours. The animals were allowed 
LAD no.l standard quality control food, obtained from Special Diet Services, and tap- 
water ûk/ during the experimental periods.
2.2.2 Preparation of Hepatic Subcellular Fractions
The preparation of whole liver homogenate and other subcellular fractions was 
achieved according to the method of loannides and Parke ( 1975 ). The animals were 
killed by cervical dislocation, the fur was swabbed thoroughly with 70 % (v/v) ethanol 
and the skin was cut using sterile pointed scissors. The liver was excised and washed 
with ice -cold sterile 1.15 % (w/v) KCl to remove excess blood. The liver was then 
transferred to a preweighed universal tube and subsequently weighed, scissors-minced in 
3 volumes of 1.15 % (w/v) ice -cold KCl. The minced liver was homogenised in a Potter 
- Elvehjem apparatus with a teflon pestle. The homogenate volume was adjusted to 25 % 
(w/v) by further addition of homogenising medium. The final homogenate was mixed 
well by gentle inversion of the measuring cylinder and transferred to a pre-cooled and 
sterile centrifuge tube. An aliquot of the homogenate was kept at -20 °C and the remaining 
was centrifuged for 20 minutes at 10 000 g, at 4 °C, using a Beckman J2-21 centrifuge. 
Following centrifugation, the post-mitochondrial supernatant ( S9 fraction ) was decanted 
and stored in 2 ml portions, in small plastic tubes, at -20 °C until required. Microsomal 
fraction was prepared by centrifugation of the post-mitochondrial supernatant employing 
a Beckman L7 Ultracentrifuge, at 105 000 g for 60 minutes at 4 °C, the resultant 
supernatant ( the soluble fraction ) was stored for 48 hours at -20 °C. Microsomal 
suspension was prepared simply by resuspending the microsomal pellet in ice-cold 1.15 
% (w/v) KCl and gently homogenising with a motor-driven homogeniser immediately
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before use . For mutagenicity assays using the Ames test, all solutions and apparatus 
used were previously autoclaved at 120 °C for 20 minutes.
2.2.3 D eterm ination of Protein
The procedure for protein content determination is based on the method of Lowry 
et al. (1951), with reference to a standard curve of bovine serum albumin. Protein 
concentration is essentially determined using Folin -Ciocalteau phenol reagent after 
alkaline copper treatment. The reaction between the alkaline copper-phenol reagent and 
tyrosine and tryptophan residues of the protein sample results in the formation of 
coloured complex which can be detected spectrophotometericaly. For each sample, the 
protein concentration was determined in duplicate as well as the standards curve and 
blanks. Whole homogenate was diluted (1: 200), microsomal suspension (1: 25), 
cytosolic fraction (1:100) , with 0.5 M NaOH. An aliquot ( 0.5 ml ) of the diluted 
sample was added to 0.5 ml NaOH (0.5 M ) followed by 5 ml of freshly prepared 
copper reagent [ 1 % C uS04 5H2Ü ( 0.5 ml ), 2 % K, Na tartrate ( 0.5 ml ) , and 2 % 
Na2C03 ( 50 ml ) ] and then mixed thoroughly by vortexing. The mixture was allowed to 
stand for 10 minutes. Folin-Ciocalteau phenol reagent (diluted with water 1:1) was 
finally added (0.5 ml ) and immediately mixed. The blue colour was read at 720 nm, 
after 30 minutes incubation, in a Kontron Uvikon 860 spectrophotometer.
2.2.4 Ames M utagenicity Test
One of the most sensitive and simple bacterial mutagenicity assays used for 
detecting chemical carcinogens and mutagens is the Ames test. The Salmonella 
mutagenicity test was carried out according to the procedure described by Maron and 
Ames (1983). The test utilises various strains of constructed Salmo?iella typhimurium 
that contain different types of histidine mutations. Thus, the histidine-requiring strains 
can be reverted back to prototrophy by several mutagens through frameshift or base-pair 
substitution. The bacterial tester strain TA 98, for instance, detects frameshift mutagens 
while base-pair substitution mutagens are detected by TA 100. In addition to the histidine
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mutation, these tester strains also contain other mutations such as rfa resulting in the 
partial loss of the lipopolysaccharide barrier coating the surface of the bacteria. Deletion 
of a gene coding for the DNA excision repair system (UVrB) is another mutation that 
increases the strain sensitivity. The standard Salmonella typhimurium strains also contain 
the R-factor plasmid, pkMlOl e.g. TA 97 , TA 98 , TA 100. Alternatively, TA 102 strain 
contains the multicopy plasmid ( pAQl ), in addition to the R-factor, that enhances its 
ability to detect weak mutagens by increasing chemical and spontaneous mutagenesis. It 
is important that all sample preparations and the test are carried out under a class 2 flow 
hood.
2.2.4.1 Growing B acteria l C ultures
Frozen permanent copies of Salmonella typhimurium strains were stored at -80
°C. Tester strain cultures were grown in nutrient broth No.2 to a density of 1-2 xlO^ 
per ml by inoculating 10 ml of nutrient broth (25 g in IL distilled water + 25 mg
ampicillin, depending on whether the strain used contained the pKMlOl plasmid). This
was achieved by scraping the surface of the frozen permanents with flame-sterilised and
cooled platinum loop and dipping it into the nutrient broth. The freshly inoculated broth
cultures were then incubated for 12 hours at 37 °C in a shaking waterbath. Fresh
overnight cultures were used in the mutagenicity assays.
2 2.4.2 C onfirm ing Genotypes o f  Tester Strains
The genotypes of the bacterial strains used in the Ames test were checked in order 
to ensure that the bacterial strains still retained their mutations. All tests were performed in 
duplicate and confirmation was achieved as follows :
i) H istidine R equirem ent Test
Strains of Salmonella typhimurium were tested for the mutation in the histidine
operon yy checking growth in the presence and absence of histidine. The test was 
carried out by spreading 0.1 ml of a solution containing 0.1 M L-histidine and 0.5 mM 
biotin on the surface of minimal agar plates. Bacteria were streaked on plates with and
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without the histidine. The plates were incubated overnight at 37 °C and examined for 
growth. Growth was observed only on the histidine /biotin plates,
ii) Crystal Violet Test
Tester strains carrying the deep rough (rfa) mutation are more permeable to large 
molecules due to the partial loss of the lipopolysaccharide coat on the bacterial surface. 
Therefore, this characteristic is confirmed by testing their sensitivity to the toxic effect of 
a high molecular weight compound such as crystal violet The test was simply performed 
by adding 0.1 ml of the bacterial culture to 2 ml of nutrient agar, containing O.IM L- 
histidine and 0.5 mM biotin, and poured onto minimal agar plates . After the agar had 
solidified, a sterile filter paper disc was placed in the middle of the plate. An aliquot of 40 
piL of crystal violet ( Img/ml) solution was dispersed in the centre of the disc and 
incubated at 37 °C overnight After 12 hours incubation, a clear zone of inhibition around 
the disc was evident, indicating the presence of the rfa mutation.
iii) Ampicillin Resistance Test
It is important that each bacterial strain carrying the R-factor should be tested for 
the presence of ampicillin resistance since the bacteria loose the plasmid (pkMlOl) with 
time, which confers ampicillin resistance. An aliquot of 0.1 ml bacterial culture was 
added to 2 ml of top agar, containing 0.1 M L-histidine and 0.5 mM biotin, and poured 
onto minimal agar plates. A sterile filter paper disc was placed in the middle of the plate 
after agar solidification; 40 pih of ampicillin ( 8 mg/ml in 0.02N NaOH ) was loaded on 
the disc. The plates were incubated at 37 °C overnight. Following incubation, non-R- 
factor strains show a growth inhibition zone around the disc, whereas R-factor-containing 
strains do not.
iv) Viability Test
The test is constructed in order to ensure that cultures inoculated from new frozen 
permanents were grown to a density about of 1-2 x 10^ cells / ml. Fresh overnight 
bacterial culture (0.1ml ) was added to 10 ml of nutrient broth and mixed. The diluted 
culture (0.1 ml) was transferred to 10 ml nutrient broth and mixed. A third dilution was
44
carried out as above and then 0 .1  ml of the final dilution was transferred into a tube 
containing 2 ml of top agar fortified with high histidine / biotin ( 0.1 M L-histidine and 
0.5 mM biotin ), mixed and poured onto minimal agar plates. The plates were incubated 
for 24 hours at 37°C. Hnally, the number of colonies were counted using a Gallenkamp 
colony counter and the viability (number of bacteria cells /ml ) of the original culture was 
calculated.
v) Spontaneous Reversion Rate
Tester S. typhimurium strains were routinely checked for their spontaneous 
reversion in mutagenicity assays, expressed as the number of histidine revertants per plate 
in the absence of a mutagen. The number of histidine revertants, arising spontaneously 
during 48 hours incubation, varies with different kinds of mutation in the histidine 
operon. Thus, the spontaneous reversion rate is a characteristic factor in strain 
identification . To check the spontaneous reversion frequency, bacterial culture (0.1 ml ) 
was added to 2 ml of top agar containing low histidine /biotin (0.5 mM L-histidine and 
0.5mM biotin). Activation system (0.5 ml) or phosphate buffer (0.5 ml) was added, 
immediately vortexed and poured onto minimal agar plates. The plates were incubated for 
48 hours at 37 °C, after which the number of colonies was counted using a Gallenkamp 
colony counter and designated as the spontaneous reversion rate.
2.2.4.3 Preparation o f the Activation System
The metabolising enzyme system was prepared from different hepatic preparations 
such as the S9 fraction, isolated microsomes and cytosol, as required in the bacterial 
reverse-mutadon test Fresh activation system was prepared for each mutagenicity assay 
and kept on ice for several hours without loss of activity. A 10 % (v/v) activation system 
was used in the majority of the mutagenicity assays, which was prepared as follows :
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0.2M Potassium phosphate buffer, pH 7.4 50 % (v/v)
0.33MKC1 10% (v/v)
0.08MMgCl2 10% (v/v)
Cofactor solution 20 % (v/v)
S9 or microsomes or cytosol 10 % (v/v)
The cofactor solution contained NADP (20 pmo\ts / ml) and fortified with glucose-6 - 
phosphate (25 //moles / ml) in 0.2 M potassium phosphate buffer ( pH 7.4 ). Sterilisation 
of the cofactor solution was performed by passing it through 0.2 pcm sterile filter. When 
the microsomal fraction was utilised as the activating enzyme system , glucose-6 - 
phosphate dehydrogenase ( 1 unit / plate ) was added. In experiments where nitrosamines 
acted as test compounds, the concentration of the activation system was increased to 25 
% (v/v) at the expense of the buffer.
2.2.4.4 The Plate Incorporation Test
To every 1(X) ml of molten top agar [ 0.6 % (w/v) agar contains 0.5 % (w/v) 
NaCl ], an aliquot of 10 ml low histidine / biotin ( 0.5 mM biotin and 0.5 mM L-histidine 
) was added and mixed. Top agar ( 2 ml ) was then distributed into sterile capped test 
tubes, kept in a waterbath 45 °G. The test compound was added, in a maximum volume 
of 0.1 ml dissolved in DMSO or water, or the positive control or the relevant volume of 
the vehicle. Depending on the type of the tester strain and the test compound used, 
various positive controls were included in the presence and absence of a metabolic 
activation system ( Table 2.1 ). Fresh overnight bacterial culture ( 0.1 ml ) and the 
activation system ( 0.5 ml ) were added following the administration of the test 
compound. The mixture was immediately vortexed and poured onto minimal agar 
plates. Once the agar had set, the plates were inverted and incubated at 37 °C for 48
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hours. The number of revertants colonies were counted using a Gallenkamp colony 
counter afterwards.
TABLE 2.1 Diagnostic positive controls for various Salmonella 
typhimurium strains in the presence and absence of metabolic activation .
Bcterial
Strain
with 59 activation system without 39 activation system
Mutaqen Concentration Mutagen Concentration
TA 97 
TA 98 
TAIOO 
TA 102 
TA 104
2-Aminoanthracene
2-Aminoanthracene
2-Aminoanthracene
2-Aminoanthracene
2-Aminoanthracene
5 pg /  plate 
5 pg /  plate 
5 pg /  plate 
5 pg /  plate 
5 pg /  plate
9-Aminoacridine
2-Nitrofluorene
MNNG*
NQO**
NQO**
50 pg /  plate 
2 pg /  plate 
1 pg /  plate 
5 pg /  plate 
5 pg /  plate
* MNNG = N-methyl-N'-nitro-N-nitrosoguanidine 
** NQO = nitroquinoline-N-oxide
2.2.4.S The Preincubation Test
The activation system ( 0.5 ml ) was first dispensed into sterile capped test tubes. 
The test compound, at the required concentration which never exceeded 100 //I / plate, 
and overnight culture of the tester strain were added to the activation system. The mixture 
was the incubated for 20 - 30 minutes at 37 °C, as indicated in each chapter, in a shaking 
waterbath. Molten top agar (2 ml) maintained at 45 °C was added to the preincubation 
mixture. The mixture was vortexed and poured onto minimal plates which were then 
incubated for 48 hours at 37 °C. The number of colonies formed as a result of histidine 
revertants were counted using a Gallenkamp colony counter.
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In some mutagenicity experiments, modification of the Ames test procedure was 
employed in order to investigate the possible inhibitory action mechanism of the 
mutagenicity of the test compound, as a result of direct interaction of an antimutagen with 
the mutagen reactive metabolite. The test was assayed on the basis of two preincubation 
intervals. Briefly, the activation system (0.5 ml) and the test mutagen were incubated 
along with overnight bacterial suspension (0.1 ml ) for 20 minutes at 37 °C in a shaking 
waterbath. The enzyme-mediated activation was then terminated by the addition of 100 
pL / plate of menadione ( 900 //M ). Subsequently, either phosphate buffer (0.5 ml / 
tube) or the appropriate concentration of the test antimutagen was added. The mixture was 
incubated for a further 2 0  minutes, as described above, after which 2  ml of top agar kept 
at 45 °C was added, inunediatelymixed and then poured onto minimal agar plates. 
Following 48 hours incubation at 37 °C, the number of histidine revertants was counted 
using using a Gallenkamp colony counter.
2.2.5 Characterisation of Mixed Function Oxidase Enzyme Activities
2.2.5.1 Cytochrome P-450
Spectral determination of the total cytochrome P-450 content was based on the 
fact that the reduced haemoprotein forms a complex with carbon monoxide which elicits a 
characteristic maximum absorption spectrum at 450 nm. The method is essentially that 
of Omura and Sato ( 1964 ).
Reagents :
Potassium phosphate buffer ( 0.1 M , pH 7.6 at 4 C )
Sodium dithionite 
Carbon monoxide
Assay Procedure :
Microsomal suspension 25 % (w/v) was diluted 1: 6  with phosphate buffer. A few 
grains of sodium dithionite were then added and mixed gently using vortex mixer. The 
sample was divided into two spectrophotometer cuvettes and placed a in Kontron Uvikon
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860 spectrophotometer, after which the baseline was recorded between 390 and 500 nm. 
Carbon monoxide was bubbled through the contents of the sample cuvette for 30 sec 
with an approximate flow rate of one bubble per second. The difference spectrum 
between 390-500 nm was immediately recorded. Cytochrome P450 content was 
calculated using the molar extinction coefficient of 91 mM~l cm"^.
2.2.5.2 NADPH-cytochrome c reductase
NADPH -cytochrome c reductase is a microsomal flavoprotein enzyme involved 
in the electron transfer from NADPH to cytochrome P-450. The enzyme activity was 
determined utilising exogenous cytochrome c as an artificial electron acceptor since the 
reductionof cytochrome c by NADPH-cytochrome c reductase reflects the cytochrome P- 
450 reduction. The principle of the method is that the reduced form of cytochrome c has a 
maximum absorbance at 550 nm. The enzyme activity was measured essentially by the 
method of Williams and Kamin (1962).
Reagents :
Tris-HCl buffer (0.1 M, pH 7.5 )
Cytochrome c ( 0.1 mM in Tris-HCl buffer )
NADPH ( 0.03 M in 1% w/v Na HCO3 )
Assay Procedure :
Tris-HCl buffer was mixed with 25 % (w/v) microsomal preparation and 
cytochrome c in both a sample and a reference cuvette as shown :
Sample Cuvette Reference Cuvette 
Tris-HCl buffer 1.7 ml 1.8 ml
Cytochrome c 1 ml 1 ml
Microsomal suspension 50 jiL  50 /d
NADPH 0.1 ml -------
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The two cuvettes were placed in a Uvikon 860 spectrophotometer and the baseline was 
recorded at 550 nm. The reaction was then commenced by the addition of NADPH to the 
sample cuvette. Following NADPH addition, the content was rapidly mixed and the 
absorbance change was recorded at 550 nm for 1-2 minutes. The initial velocity was 
taken as direct measurement of cytochrome c reduction and the enzyme activity was 
calculated using a molar extinction coefficient of 18.5 mM"l cm“l.
2.2.S.3 Ethoxyresorufin O-deethylase
The rate of ethoxyresorufin dééthylation to resorufin by microsomal enzymes, a 
reaction catalysed by cytochrome P-450 ( CYPlAl ), was measured according to the 
method used by Burke and Mayer ( 1974 ).
Reagents :
Tris-HCl buffer ( 0.1 M ; pH 7.8 )
Ethoxyresorafin ( 0.53 mM in DMSO )
Resorufin (0.1 mM in DMSO )
NADPH ( 50 mM in 1% W/V NaHCOg )
Assay Procedure :
Tris-HCl buffer maintained at 37 °C was mixed with 25 % w/v microsomal suspension 
and the substrate ethoxyresorufin as indicated below in a fluorimeter cuvette :
Tris-HCl buffer 2 ml
Microsomal suspension 50 pi\
Ethoxyresorufin 3 pi\
The cuvette was placed in a Perkin-Elmer LS-5 luminescence spectrophotometer, set to an 
excitation wavelength of 510 nm and an emission wavelength of 586 nm with excitation
5 0
and emission slit widths 10 and 2.5 nm respectively. After establishing a baseline, the 
reaction was initiated by addition of 10 /d NADPH and the initial linear rate of the 
reaction was recorded. Calibration of the fluorimeter was performed by addition of 
aliquots of 5 jû resorufin (0.1 mM in DMSO) to the incubation mixture.
2 2.5.4 M ethoxyresorufin 0 -dem eth ylase
The O-demethylation rate of methoxyresorufin to resorufin is catalysed selectively 
by the CYP1A2 protein. The method employed in the determination of the enzyme 
activity was similar to that in section 2.2.5.3.
Reagents :
Tris-HCl buffer ( 0.1 M ; pH 7.8 )
Methoxyresorufin ( 1 mM in DMSO )
Resorufin (0.1 mM in DMSO )
NADPH ( 50 mM in 1 % w/v NaHCOs )
Assay Procedure :
Microsomal suspension 25 % (w/v) was mixed with tris-HCl buffer, mantained at 37 °C, 
and the substrate in a 3ml fluorimeter cuvette as follows :
Tris-HCl buffer 2 ml
Microsomal suspension 50 //I
Methoxyresorufin 5 //I
A baseline was constructed using a Perkin - Elmer LS-5 luminescence spectrophotometer 
set to an excitation wavelength of 510 nm and an emission wavelength of 586 nm, with 
excitation and emission slit widths of 10 and 2.5 nm respectively. The reaction was 
commenced by addition of 10 //L NADPH, after which the initial linear rate of the
5 1
reaction was monitored immediately . Calibration was achieved by adding 5 jiL  aliquots 
of resorufin (0.1 mM) to the incubation mixture in the absence of NADPH.
2.2.5.5 Pentoxyresorufin 0-depen ty lase
Measurement of pentoxyresorufin dealkylation was based on the procedure 
described by Lubet et ai. (1985). The reaction is recognised as being selectively catalysed 
by the CYP2B isoform.
Reagents:
Tris-HCl buffer ( 0.1 M ; pH 7.8 )
Pentoxyresorufin ( 1 mM in DMSO )
Resorufin ( 0.1 mM in DMSO )
NADPH ( 50 mM in 1 % w/v NaHCOg )
Assay Procedure :
As described below , the following reaction mixture was prepared in a 3 ml fluorimeter 
cuvette :
Tris-HCl buffer 2 ml
Microsomal suspension 50 /d
Pentoxyresorufin 5 p \
Following baseline establishment, the reaction was initiated by addition of 10 pL  
NADPH and the fluorescence change was monitored using a Perkin-Elmer LS-5 
luminescence spectrophotometer set to an excitation wavelength of 510 nm and an 
emission wavelength of 586 nm with excitation and emission slit widths of 10 and 2.5
5 2
nm respectively. The fluorimeter was calibrated by the addition of 5 p\ aliquots resorufin 
(0.1 mM ) to a cuvette comprising assay buffer and microsomes.
2.2.5 6 Metabolic Activation o f Glu-P-1
The Glu-P-1 mutagenesis assay was employed in order to determine the metabolic 
activation of the food mutagen Glu-P-1 to its reactive metabolite followed by test 
compound incorporation in vitro, the reaction being catalysed exclusively by the 
cytochrome P-450 IA2 ( CYP1A2 ) haemoproteins. The method used was essentially that 
of Maron and Ames ( 1983 ).
Reagents :
Top agar ( 0.6 % w/v agar ; 0.5 % w/v NaCl )
Low histidine / biotin ( 0.5 mM biotin ; 0.5 mM histidine )
Glu-P-1 ( 1 //g /100 //L in DMSO )
Microsomal suspension ( 25 % w/v )
Assay Procedure :
An aliquot of 2 ml molten top agar containing 10 % (v/v) low histidine / biotin was placed 
into sterile test tubes kept at 45 °C. Glu-P-1 ( 100 pL  ) and the appropriate concentration 
of the test compound were then incorporated with agar solution. Following the addition 
of test compound, fresh overnight culture of TA98 (0.1 ml ) was added . Microsomal 
activation system (10 % v/v) derived from variously treated animals ( 0.5 ml ) was mixed 
with the above mixture and immediately poured onto Vogel Bonner E plates. Once the 
agar had set, the plates were incubated at 37 ®C in for 48 hours. Spontaneous reversion 
rate was determined using plates comprising only the activation system and bacteria. The 
resultant colonies were counted using a Gallenkamp colony counter.
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2.2.S.7 p-Nitrophenol Hydroxylase
The hydroxylation of p-nitrophenol to nitrocatechol via microsomal-mediated 
metabolism was carried out essentially by the method of Reinke and Moyer ( 1985 ), as 
modified by McCoy and Koop ( 1988 ). The reaction is catalysed by the cytochrome P- 
450 (CYP2E1) isoform.
Reagents :
Potassium phosphate buffer ( 0.2 M ; pH 6 .8  )
Ascorbic acid ( 1 mM )
p-Nitrophenol ( 1 mM in phosphate buffer )
4-Nitrocatechol ( 0.5 mM in phosphate buffer)
NADPH ( 10 mM in 1 %w/v NaHCOg )
Assay Procedure .*
The incubation mixture was prepared in standard test tubes and comprised the following :
Phosphate buffer 650 p\
Ascorbate 100//I
p-NitrophenoI 100 p\
Microsomal suspension 50 p\
The sample mixture was incubated for 3 minutes at 37 °C in a shaking water bath and the 
reaction was initiated by addition of 100 pL  NADPH. Further incubation was carried out 
for 10 minutes and the reaction was terminated by the addition of ice-cold 0.6 N 
perchloric acid ( 0.5 ml ). Protein was removed by centrifugation at 2000 x g for 10 
minutes. An aliquot of the supernatant (1ml) was mixed with 0.1 ml of 10 M sodium 
hydroxide and the absorption was measured at 536 nm immediately in a Kontron 
Uvikon 860 spectrophotometer. Suitable blanks and standards (0-50 nmoles of
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nitrocatechol) were carried out through the same procedure except for the addition of 
NADPH.
2.2.5.S D im ethyln itrosam ine N -dem ethylase
N-Demethylation of dimethylnitrosamine is a reaction catalysed by the 
cytochrome P-450 drug-metabolising enzymes , in particular CYP2Elat low substrate 
concentrations, and results in the formation of formaldehyde which is estimated 
colourimetrically. The activity of dimethylnitrosamine N-demethylase was measured 
according to the method described by Holtzman et al.(1968).
Reagents :
Potassium phosphate buffer ( 50 mM ; pH 7.24 )
MgCIi ( 150 mM )
Trichloroacetic acid ( 12.5 % w/v )
Ammonium acetate ( 4M )
Nash Reagent, freshly prepared:
(4M ammonium acetate containing 4 ml / L acetylacetone)
Dimethylnitrosamine ( 60 mM in DMSO )
Assay Procedure :
Incubation mixture was prepared in test tubes and comprised the following :
Phosphate buffer 0.6 ml
MgCl2 0.1 ml
Dimethylnitrosamine 0.1 ml
Microsomal suspension (25 % w/v) 0.1 ml
The reaction mixture was pre-incubated for 3 minutes at 37 °C in a shaking waterbath 
prior to the initiation of the reaction by the addition of 0.1 ml of NADPH ( 10 mM ). 
Further incubation was carried out for 10 minutes, after which the reaction was
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terminated by the addition of ice-cold 12.5 % trichloroacetic acid ( 0.5 ml ). The tubes 
were then left on ice for 5 minutes and centrifuged for 10 minutes at 2000 g in a Beckman 
J- 6  centrifuge. The deproteinised supernatant ( 1 ml ) was then added to 1 ml freshly 
prepared Nash reagent and a further incubation was performed for 40 minutes at 37 °C in 
a shaking waterbath to allow the colour development. The tubes were removed and 
allowed to cool, after which the absorbance of the yellow colour was measured at 412 nm 
using a Kontron Uvikon 860 spectrophotometer. Suitable blanks and formaldehyde 
standards ( 0 - 1 2 0  nmoles ) were performed using the same procedure.
2.2.2.S.8 E rythrom ycin N -dem ethylase
The N-demethylation of erythromycin results in the formation of formaldehyde 
which is produced from the methyl group and subsequently estimated colourimetrically. 
This reaction appears to be predominately catalysed by the cytochrome P-450 (CYP3A ) 
isoenzyme. The method was essentially that of Wrighton et al. ( 1985 ).
Reagents :
Potassium phosphate buffer ( 50 mM ; pH 7.25 )
MgCl2 ( 150mM)
Erythromycin ( 10 mM in phosphate buffer )
NADPH ( 10 mM in 1 % w/v NaHCOs )
Formaldehyde solution ( 3 mM )
Assay Procedure :
The incubation mixture was prepared in standard test tubes as described below
Phosphate buffer 600 p\
Mg02 100 p\
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Erythromycin 100 pi\
Microsomal suspension 100 fi\
The test tube contents were incubated in a shaking water bath at 37 °C for 3 minutes. The 
reaction was then initiated by addition of NADPH ( 100 piL ) and incubation was carried 
out under the same conditions mentioned above for 10 minutes. After that, the reaction
was terminated by the addition of 12.5 % w/v ice-cold TCA ( 0.5 ml ) and the tubes kept
on ice for 5 minutes. Protein was removed by centrifugation at 2000 g for 10 minutes 
using a Beckman J-6  centrifuge. An aliquot of deproteinised supernatant ( 1 ml ) was 
added to 1 ml of freshly prepared Nash reagent ( 4 M  ammonium acetate containing 4 
ml / L acetylacetone ), mixed and incubated in a shaking waterbath at 37 °C for 40 
minutes. Following incubation, the tubes were allowed to cool and the absorption of the 
yellow colour was measured at 412 nm using a Kontron Uvikon 860 spectrophotemeter. 
Suitable blank and formaldehyde standards ( 0 - 0.3 ji moles ) were carried out through 
the same procedure except for the addition of NADPH.
2.2 5.9 Laurie acid H ydroxylase
This microsomal enzyme activity was assayed in order to investigate the 
induction of cytochrome P-450, and in particular the CYP4A subfamily. Accordingly, the 
combined co- and co-1 hydroxylations of launc acid were determined essentially as 
described by Parker and Orton ( 1980 ).
Reagents :
Tris-HCl buffer ( 50 mM ; pH 7.4 ) 
Laurie acid ( ImM in methanol )
1 ^ -L aurie  acid ( 10 jiCi / ml )
NADPH ( 40 mM in 1 % w/v NaHCO) )
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HCl ( 3N )
Assay Procedure :
The incubation mixture was prepared in Sovirel tubes ( 15 ml ) and consisted of :
Tris-HCl buffer 1.5 ml
Laurie acid 0.2 ml
14C-Lauric acid 10 //I
Microsomal suspension (25 % w/v ) 200 }i\
The tubes were incubated at 37°C for 5 minutes in a shaking waterbath. The reaction was 
initiated in the test tubes by the addition of 40 pi\ NADPH. Further incubation was 
carried out for 10 minutes at 37°C in a shaking waterbath, after which the reaction was 
terminated by the addition of 3N HCl ( 0.2 ml ). Diethyl ether (10 ml) was added and the 
tube contents were vigorously mixed and then allowed to stand for 10 minutes. Using a 
glass pipette, 7.8 ml of the organic phase was removed into clean tubes and evaporated to 
diyness under nitrogen. The residue was dissolved in methanol ( 60 pih ) and 25 //L of 
the solution was spotted onto silica gel TLC plates. The plates were developed in a 
solvent mixture composed of hexane 70: diethyl ether 28 : acetic acid 1.5. Each lane on 
the TLC plate was scanned for 5 minutes in a Berthold Linear TLC scanner. Suitable 
blanks were carried out through the same procedure but without addition of NADPH.
2.2.6 Characterisation of Phase II Enzyme Activities
2.2.6.1 GlutathioneS-transferase
The glutathione-S-transferases are a family of isoenzymes that catalyse the 
conjugation of endogenous electrophilic xenobiotics or their metabolites. Thus these 
enzymes possess an important role in the detoxication of biologically reactive 
electrophiles. The activity of glutathione-S-transferase was determined according to the
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procedure of Habig et al. (1974 ) and employing two substrates, 3,4- 
dichloronitrobenzene ( DCNB ) and l-chloro-2,4-dinitrobenzene ( CDNB ).
i) Using DCNB as substrate
Reagents :
Potassium phosphate buffer ( 0.1 M ; pH 7.5 )
DCNB ( 25 mM in ethanol )
Reduced glutathione ( 25 mM in 1.15 % w/v KCl )
Assay Procedure :
The reaction mixture was prepared in two cuvettes as follows :
Test Reference
Phosphate buffer 1.8 ml 1.9 ml
DCNB 0.1 ml 0.1 ml
Reduced glutathione 0.5 ml 0.5 ml
After establishing a base line, the reaction was commenced by the addition of 100 //I of 
the diluted cytosol ( 1 : 4 ) to the test cuvette, and the reaction was followed at 345 nm 
using a Kontron Uvikon 860 spectrophotometer. The specific activity of glutathione-S- 
transferase was calculated using the extinction coefficient of 8.5 mM'^ cm'^ for the 
nitrophenyl-glutathione conjugate.
ii) Using CDNB as substrate 
Reagents :
Potassium phosphate buffer (0.1 M ; pH 7.5 )
CDNB ( 25 mM in ethanol )
Reduced glutathione ( 5 mM in 1.15 % w/v KCl )
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Assay Procedure :
The reaction mixture was prepared in two cuvettes as follows :
Test Reference
Phosphate buffer 1.8 ml 1.9 ml
CDNB 0.1ml 0.1 ml
Reduced glutathione 0.5 ml 0.5 ml
Both sample and reference cuvettes were placed in a Kontom Uvikon 860 
spectrophotometer, and the baseline was recorded. The reaction was then initiated by the 
addition of 100 //L of the diluted cytosol ( 1 : 100 ) to the test cuvette, and the reaction 
was followed at 340 nm. The activity of glutathione-S-transferase was calculated utilising 
the extinction coefficient of 2,4-dinitrophenyl-glutathione which is 9.6 mM'^ cm~^  .
2 2.6.2 G lucuronyltransferases
The microsomal glucuronyltransferase family of enzymes functions as an 
important enzyme system associated with the metabolism and excretion of numerous 
xenobiotics. Because of their existence in many forms, the enzyme activity was 
determined using the substrates 2-aminophenol and 4-methylumbelliferone.
i) Using 2-aminophenol as substrate
The activity of glucuronyltransferase was measured by monitoring the glucuronidation of 
2-aminophenol to the corresponding glucuronide conjugate. The principle of the method 
is based on the fact that addition of an aqueous solution of sodium nitrite to a cold, 
acidified solution of aromatic amine resulted in the diazonium salt formation. The reaction 
of the generated diazonium salt with a complex aromatic amine (N-naphthylethylene
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diamine) leads to a brightly-coloured azo compound that can be detected 
spectrophotometrically. The assay was carried out according to the procedure described 
by Burchell ( 1974 ).
Reagents:
2-Aminophenol ( 1 mM )
Aniline-HCl salt ( 0.1 mM in 6  % w/v TCA )
Trichloroacetic acid buffered (20 % w/vin 0.1 M phosphate buffer pH 2.7 ) 
Trichloroacetic acid buffered ( 6  % w/v in 0.1 M phosphate buffer pH 2.7 ) 
Magnesium chloride ( 0.15 M )
Triton X-100 ( 1 % w/v )
Ascorbic acid ( 0.02 M )
Sodium nitrite (0 .1%  w/v)
Ammonium sulphamate ( 0.5 % w/v)
N-Naphthylethylene diamine ( 0.1 % w/v )
Assay Procedure :
As the cofactor requirement for glucuronyltranferase activity differs from cytochrome P- 
450 activity , the following cofactor solution was prepared :
0.1 M Tris-HCl buffer, pH 8 8 ml
M g a2 (0 .1 5 M ) 1 ml
Triton X-100 ,1  % (w/v) 0.5 ml
Ascorbic acid ( 0.02 M) 1 ml
UDP-glucuronic acid 10 mg
An aliquot (1 ml ) of the cofactor solution was mixed with 2-aminophenol ( 0.5 ml ). The 
reaction was initiated by the addition of 0.5 ml microsomal suspension, 25 % (w/v ), and 
the reaction mixture was incubated at 37 °C for 30 minutes in a shaking waterbath. 
Following incubation, the reaction was terminated by addition of ice-cold 20 % (w/v) 
buffered TCA and tubes allowed to stand on ice for 5 minutes. Protein was removed by
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centrifugation at 2000 g for 10 minutes using a Beckman J- 6  centrifuge. Freshly 
prepared sodium nitrite ( 0.5 ml ) was added to the supernatant ( 1 ml ), mixed and 
allowed to stand for 2 minutes. Ammonium sulphamate ( 0.5 ml ) was then added and the 
mixture allowed to stand for 3 minutes. This was followed by addition of N- 
naphthylethylene diamine ( 0.5 ml ), mixed well and the tubes were allowed to stand 
again at room temperature for 60 minutes in the dark. Finally, the absorbance was 
measured at 540 nm using a Kontron Uvikon 860 spectrophotometer. A substrate blank, 
made up by adding 0.5 ml water instead of 2-aminophenol, and aniline standards ( 0-80 
nmoles ) were carried out through the same procedure,
ii) Using 4-methvlumbelliferone
The rate of the glucuronidation reaction was monitored fluorimeterically by measuring the 
disappearance of 4-methylumbelliferone fluorescence upon conjugation. 
Glucuronyltransferase activity was determined by the procedure of Dutton et al. ( 1981 ).
Reagents :
Sodium phosphate buffer ( 0.1 M ; pH 7.4 at 37°C ) 
4-Methylumbelliferone ( 0.2 mM in phosphate buffer ) 
UDP-Glucuronic acid ( 80 mM in phosphate buffer )
Assay Procedure :
The incubation mixture was prepared in a fluorimeter cuvette as follows : 
Sodium phosphate buffer 2 ml
4-Methylumbelliferone 0.8 ml
Microsomal suspension (25 % w/v ) 50 pi\
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The cuvette contents were mixed and the base line was recorded using a Perkin-Elmer 
LS-5 luminescence spectrophotometer, set to an excitation wavelength of 376 nm and an 
emission wavelength of 460 nm, with excitation and emission slit widths of 10 cm and
2.5 cm respectively. The reaction was initiated following the addition of UDP-glucuronic 
acid ( 50 jiL  ) and the initial rate of the reaction was recorded. Calibration was performed 
by the addition of 25 piL of 4-methylumbelliferone ( 200 pmol / //I ) to a mixture 
comprising assay buffer and microsomal suspension.
2.2.6 3 Sulphotransferase
The cytosolic sulphotranseferase activity was determined colourimetrically using 
2-naphthol as a substrate. The principle of the method is based on the conjugation of 2- 
naphthol to form the corresponding 1-naphthyl sulphate, in the presence of a sulphate 
donor molecule such as 3 ’-phosphoadenosine 5^-phosphosulphate ( PAPS ). This was
achieved according to the procedure described by Sekura et al. ( 1981 ).
Reagents :
Sodium phosphate buffer ( 1 M ; pH 7.4 )
2-Naphthol ( 1 mM in 5 % (v/v) acetone )
PAPS ( 2 mM in 0.1 M sodium phosphate buffer )
2-Mercaptoethanol ( 0.1 M in 0.1 M sodium phosphate buffer )
Methylene blue: (250 mg in IL distilled water containing 50 g anhydrous
sodium sulphate and 10 ml Cone. H2 SO4  )
Assay Procedure :
The following incubation mixture was prepared in standard test tubes and consisted of : 
Sodium phosphate buffer 100 //I
2-Naphthol 100 /d
2-Mercaptoethanol 20 //I
PAPS 40//I
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The reaction was started by addition of cytosol ( 100 //L ). Following enzyme addition 
and incubation for 30 minutes at 37°C, the reaction was terminated with methylene 
blue solution (0.5 ml) followed by 2 ml of chloroform. After mixing, the suspension 
was centrifuged at 2000 g for 10 minutes using a Beckman J- 6  centrifuge. The 
chloroform layer was transferred to a tube containing between 50 to 100 mg of 
anhydrous sodium sulphate. The tube content was poured into a quartz cuvette and the 
absorbance was measured at 651 nm using a Kontron Uvikon 860 spectrophotometer. 
Based on the assumption that 1 //mol of 1-naphthol sulphate would yield an absorbance 
unit of 30, the enzyme activity was calculated.
2 2.6.4 E poxide hydrolase
The hydrolysis of benzopyrene 4,5-epoxide mediated by microsomal epoxide 
hydrolase to the corresponding dihydrodiol was determined fluorimetrically. The assay 
procedure was essentially that of Dansette et al. ( 1979 ).
Reagents :
T ris-H a buffer ( 0.015 M ; pH 8.7 at 37°C )
Benzo(a)pyrene-4,5-epoxide ( 2 mM in acetonitrile ) 
Benzo(a)pyrene-4,5-trans-dihydrodiol ( 2 mM in acetonitrile )
Assay Procedure :
The reaction mixture was prepared in a fluorimetric cuvette as follows : 
Tris-HCl buffer 2 ml
Microsomal suspension (25  % w/v ) 50 pi
Benzo(a)pyrene4,5-epoxide 10 pi
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The cuvette contents were mixed and the increase in fluorescence with time was 
monitored utilising a Perkin-Elmer LS-5 luminescence spectrophotermeter set at excitation 
and emission wavelengths of 310 nm and 385 nm respectively, with excitation slit width 
of 2.5 cm and emission slit width of 5 cm respectively. The fluorimeter was calibrated 
using 10 pL  aliquots of benzo(a)pyrene-4,5-dihydrodiol instead of benzo(a)pyrene4,5- 
epoxide in the incubation mixture.
2.2.7 Characterisation of Antioxidative Stress Enzyme Activities
2.2.7.1 Superoxide D ism utase
The dismutation of superoxide ( O2 ) to hydrogen peroxide ( H2Q2 ) is catalysed 
by the metalloenzyme superoxide dismutase. Thus, the superoxide is generated by 
xanthine oxidase during the conversion of hypoxanthine to xanthine and then to uric acid. 
The superoxide anion is detected by the reduction of cytochrome c, measured at 550 nm. 
Accordingly, the superoxide dismutase activity was measured by determining the extent
of inhibition of cytochrome c reduction. The method employed is that based on the
procedure of McCord et al. ( 1969 ).
Reagents :
Potassium phosphate buffer ( 50 mM ; pH 7.8 containing 0.1 mM EOT A ) 
Hypoxanthine (1.5 mM in phosphate buffer )
Xanthine Oxidase ( 25 unit / ml in phosphate buffer )
Cytochrome c ( 0.3 mM in phosphate buffer )
Superoxide Dismutase ( 10 unit / ml in phosphate buffer )
Assay Procedure :
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The cytosol was further diluted ( 1 : 10 ) with phosphate buffer and the following 
reagents were added and mixed in a spectrophotometric cuvette as described below :
Phosphate buffer / EDTA 2.69 ml
Hypoxanthine 0.1 ml
Xanthine oxidase 0.1 ml
Cytochrome c 0.1 ml
The reaction was commenced by the addition of the diluted cytosol ( 10 //L ) and 
monitored at 550 nm in a Kontron Uvikon 860 spectrophotometer. A suitable blank was 
prepared by adding 10 //L of assay buffer instead of cytosol. A superoxide dismutase 
standard curve ( 0 - 1  units ) was prepared from which the activity of the enzyme was 
calculated.
2. 2. 7.2 Glutathione Peroxidase
Glutathione peroxidase is a cytosolic enzyme involved in the metabolism of 
H2Q2. The indirect determination of the enzyme activity depends on the measurement of 
NADPH oxidation by glutathione reductase that can be monitored spectrophotometrically. 
The method uesd is essentially that of Giinzler and Flohe' ( 1985 ).
Reagents ;
Potassium phosphate buffer ( 0.1 M ; pH 7 )
GSH ( 40 mM in phosphate buffer )
Sodium azide [ NaNg ] ( 20 mM in phosphate buffer )
Glutathione reductase [ GR ] ( 40 units in phosphate buffer )
NADPH ( 2.4 mM in 1 % w/v NaHCOs )
H2Q2 ( 2 mM in distilled water )
Assay Procedure :
The cytosol was further diluted ( 1: 50 ) with phosphate buffer. The incubation mixture 
was prepared in a spectrophotometric cuvette as follows :
6 6
Phosphate buffer 500 p\
GSH 50 p\
NaNs 50 p\
H2O 100 pl
Sample 100 p\
GR 50 p\
NADPH 50 p\
The reaction was initiated by addition of 100 pL  hydrogen peroxide and the decrease in 
absorbance was measured at 340 nm in a Kontron Uvikon 860 spectrophotometer. The 
chemical reaction rate ( control ) was determined using phosphate buffer instead of the 
soluble enzyme in the incubation mixture. The enzyme activity was estimated applying the 
following equation:
Sample rate = Sample A abs. - Control A abs. xlO  ^ = nmol min ^
6.2
2.2.7.3 Catalase
The enzyme is regarded as one of the major protective enzymes against cellular 
damage caused by reactive products such as hydrogen peroxide ( H2Q2 ). The 
metabolism of H2 O2  to H2O plus O2  is therefore mediated by catalase which is primarily 
present in the soluble fraction . The activity of the enzyme was essentially assayed as 
described by Leighton et al. 1968.
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Reagents:
Imidazole-HCl buffer ( 20 mM ; pH 7 containing 1 g / L BSA )
Titanyl sulphate (2.25 g / L in IM H 2SO4 )
Substrate solution ( 2.25 ml of 1.5 % H2Q2 in 300 mis of imidazole buffer ) 
Triton X-100 ( 20 g / L in distilled water )
Assay Procedure :
The cytosol was further diluted ( 1: 100 ) with imidazole buffer. The incubation mixture 
was prepared in standard glass test tubes kept on ice and comprised :
Diluted cytosol 0.1 ml
Triton X -100(2% ) 0.1 ml
The reaction was initiated by adding substrate solution ( 2ml ), and incubation was carried 
out for 4 minutes at 0°C. After that, the reaction was terminated following the addition of 
ice-cold titanyl sulphate ( 3 ml ). Substrate blank was prepared using water instead of 
diluted cytosol, while in the case of tissue blank, the substrate solution was replaced 
with imidazole buffer. Suitable standards ( 0 - 6.62 p  moles ) of H2Q2 were carried out 
through the same procedures. Absorbance was measured at 405 nm using a Kontron 
Uvikon 860 spectrophotometer.
2.2.8 Cyanide-insensitive Palmitoyl Co-A 8-Oxidation
The oxidation of fatty acids involving the peroxisomal fatty acid oxidising system 
is catalysed by a cyanide insensitive system. The activity of the peroxisomal enzyme was 
determined utilising palmitoyl-CoA dependent NAD+ reduction as substrate. The assay 
protocol is identical to the method used by Bronfman ( 1979 ).
6 8
Reagents :
Tris-HCl buffer ( 60 mM ; pH 8.3 )
Triton X-100 ( 1 %  w/v in Tris-HCl buffer ) 
Palmitoyl CoA ( 7.5 mM in Tris-HCl buffer ) 
Coenzyme A ( 75 pM  )
FAD+(180//M )
NAD+(555//M )
Nicotinamide ( 141 mM )
Dithiothreitol ( 4.2 mM )
Potassium Cyanide ( 3 mM )
BSA [ fatty acid free ] ( 225 pg I m l)
Assay Procedure :
The following reaction mixture was prepared in 100 ml of 60 mM tris-HCl buffer and 
consists of :
Coenzyme A 5.8 mg
FAD 14.9 mg
NAD 37.0 mg
Nicotinamide 1720 mg
Dithiothreitol 64.8 mg
KCN 19.8 mg
BSA 25.5 mg
Tris-HCl buffer ( 1 m l ) was mixed with 2 ml aliquots of reaction mixture and allowed to 
stand to equilibrate at 37 °C for 5 to 10 minutes, in a shaking waterbath. Liver 
homogenate ( 25 % w/v ) was further diluted ( 1 : 1 )  with triton X-100, and placed in a 
1 ml eppendorf. After equilibration at 37 °C for 2 minutes, the homogenate samples were
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centrifuged for 5 to 10 seconds in a small centrifuge ( Micro Centaur , MSE ) to remove 
any cellular debris. Assay sample ( 40 p L  ) was then added to the equilibrated reaction 
mixture and vortexed. Thereafter, the test tube contents were divided between two 1.5 ml 
cuvettes and placed into a controlled temperature Kontron Uvikon 860 
spectrophotometer, maintained at 37°C. The reaction was started by addition of palmitoyl- 
Co A enzyme ( 20 p L )  to the test cuvette. Absorbance change with time was measured at 
340 nm and the enzyme activity was calculated from the gradient of the resulting line 
which represents NADH production utilising the molar extinction coefficient of 6.22 
mM”lcm ”l.
2.2.9 SDS-PAGE And W estern Blot Analysis of Cytochrome P-450 And 
Trifunctional Proteins
2.2.9.1 Solubilisation o f  H epatic Preparations
Hepatic 25 % ( w/v ) whole homogenate or microsomal suspension proteins were 
solubilised by the addition of 10 pL  of solubilisisation buffer ( 0.1 M phosphate buffer ; 
pH 7.4 , containing 10 % w/v sodium cholate and 2 % w/v Emulgen 911 ) for every mg 
of protein and mixed for 40 minutes at 4 °C. The samples were then stored at -20 °C until 
required.
2.2.9.2 SDS-PAGE
Separation of various hepatic preparation proteins was performed utilising 
discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis, as 
devised by Laemmli 
( 1970).
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Reagents:
Sample buffer : 1 M Tris-HCl buffer ; pH 6 .8 , containing 10 % w/v SDS,
50 % v/v glycerol, 10 % w/v bromophenol blue, 5% v/v 
2 -mercaptoethanol
Lower gel buffer : 1.5 M Tris-HCl buffer,pH 8 .8  containing 0.4 % w/v SDS )
Upper gel buffer : 0.5 M Tris-HCl buffer ; pH 6 .8  containing 0.4 % w/v SDS 
Electrode buffer : 25 mM Tris-HCl buffer ; pH 8.3 containing 192 mM
glycine and 0.1 % w/v SDS 
Acrylagel : Commercially available
f
Bis-Acrylagel : Commercially available 
Ammonium persulphate : 100 mg / ml distilled water
Assay Procedure :
A vertical slab gel apparatus was assembled using two clean and acetone-dried glass 
plates. The glass cassette was partitioned with perspex side and bottom spacers and held 
together with bull dog clips. The lower running gel was prepared as described :
Lower gel buffer 12.5 ml
Distilled water 14.28 ml
Aciylagel 16.22 ml
Bis-Aciylagel 6.76 ml
Ammonium persulphate 250//I
Polymerisation was commenced by the addition of 40 //L TEMED. The gel was then 
poured into the cassette to a height of 8  cm. To ensure a flat interface between the lower 
and upper gels, a thin layer of distilled water was added on the top of the lower gel
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surface. Once the lower gel had completely set, the water layer was removed and the 
upper stacking gel was prepared as follows :
Upper gel buffer 5 ml
Distilled water 12ml
Acrylagel 2 ml
Bis-Acrylagel 800//I
Ammonium persulphate 200//I
Similarly to the lower gel, polymerisation was started by the addition of 40 p L  of 
TEMED and the gel was poured into the cassette above the lower gel. The sample wells 
were formed by introducing a perspex comb into the upper gel. After approximately 30 
minutes, the gel had polymerised and consequently the comb was removed, after which 
the sample wells were filled with electrode buffer to maintain their integrity. The cassette 
was then placed into the electrophoresis tank. Thereafter, the solubilised samples were 
diluted with sample buffer to give a final protein concentration of 2 mg / ml. Dénaturation 
of protein was achieved by boiling for 3 minutes in a waterbath, prior to loading into the 
sample wells. Following the addition of test samples, the cassette was covered with the 
upper reservoir and clamped . Electrode buffer was placed in both the upper and lower 
reservoirs of the tank. Electrophoresis was carried out immediately at maximum voltage 
and a constant current of 20 mA using a Pharmacia EPS 500 / 400 power supply, until 
the front of the dye band entered the lower gel. Subsequently, the current was set to 40 
mA until the bromophenol blue band had migrated up to 2 cm from the lower edge of the 
lower running gel when the current was switched off. The cassette then was removed 
from the electrophoresis tank and the glass plates separated. The upper stacking gel was 
cut from the lower gel using a rubber spacer and the latter employed for Western blot 
analysis.
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2.2.9 3 Western B lo t A nalysis
Transfer of proteins from polyacrylamide gel to nitrocellulose sheets and the 
immunological characterisation of proteins were achieved using the procedure devised by 
Towbin et al. ( 1979 ).
Reagents :
Transfer buffer : 20 mM Tris, 150 mM glycine, 400 ml methanol, 2.6 L 
distilled water
Phosphate-buffered saline [PBS] :
Sodium chloride (8%w/v)
Potassium dihydrogen orthophosphate (0.2 % w/v)
Disodium hydrogen orthophosphate (2.9 % w/v)
Potassium chloride (0.2 % w/v)
Distilled water (IL)
Wash buffer :
PBS (10 % v/v)
BSA (1 % w/v)
Triton X-100 (0.2 % v/v)
Distilled water (998 ml )
Substrate buffer : 0.1 M Tris-HCl ; pH 7.5
3,3-diaminobenzidine : 0.1 g /100 ml substrate buffer
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Assay Procedure :
Following electrophoresis, the polyacrylamide gel was placed into a transfer buffer ( 50 
ml ) for 30 minutes or overnight at 4 °Q to permeate the gel and to replace the electrode 
buffer. The gel shrinks as a result of equilibration with the transfer buffer. Proteins were 
then transfered to nitrocellulose sheet using a Scotch-Brite assembly (Fig.2.1). The 
nitrocellulose sheet was laid on wetted double layer of Watman filter paper with transfer 
buffer, followed by the gel and then two sheets of filter paper. All air bubbles were 
removed by rolling with test tube and a second Scotch-Brite was strung around all layers. 
The cassette was then placed into the transfer tank with the nitrocellulose sheet facing the 
positive electrode. Proteins were transferred applying maximum current and a constant 
voltage of 60 V for 1 hour, after which the sheet was removed and placed into 50 mis of 
wash buffer and rocked for 2 hours or overnight at 4°C.
Scotchbrite
Filter Paper
Acrylamide Gel 
Nitrocellulose Sheet
 Filter Paper
Scotchbrite
FIGURE 2.1 Transfer cassette construction.
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Different primary and secondary antibodies were used depending on the type of 
proteins to be detected ( table 2.2 ). The sheet was then incubated with primary antibody, 
diluted to a final volume of 50 mis with wash buffer, for 1 hour at room temperature. 
The nitrocellulose sheet was then washed twice with wash buffer over a period of 30 
minutes. Once the washing process had been completed, the peroxidase-linked 
secondary antibody, diluted in 50 mis of wash buffer, was placed onto the nitrocellulose 
sheet for 1 hour. The sheet was subsequently washed twice with 50 mis wash buffer for 
15 minutes, before the pre-substrate wash buffer was added. The wash buffer was then 
replaced with 100 mis of pre-substrate wash buffer ( 20 ml PBS and 80 ml H2O ) and left 
for 10 minutes.
TABLE 2.2 Types of primary and secondary antibodies used in Western 
blot analysis
P-450 Family Primary Antibody Secondary Antibody
CYPIA Sheep IgG 
1:10000 dilution
Peroxidase linked donkey anti-sheep IgG 
1:2000 dilution
CYP2E Sheep IgG 
1:5000 dilution
Peroxidase linked donkey anti-sheep IgG 
1:2000 dilution
CYP4A Sheep IgG 
1:5000 dilution
Peroxidase linked donkey anti-sheep IgG 
1:2000 dilution
CYP2B Rabbit IgG 
1:2000 dilution
Peroxidase linked goat anti-rabbit IgG 
1:2000 dilution
CYP3A Rabbit IgG 
1:2000 dilution
Peroxidase linked goat anti-rabbit IgG 
1:2000 dilution
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Protein bands were developed by adding the substrate buffer ( 0 . 1  g 3,3- 
diaminobenzidine in 100 ml of 0.1 M tris-HCl buffer, pH 7.5 containing 40 p L  of 30 % 
H2Q2 ). The reaction was terminated by washing several times with distilled water after 
the bands became visible. Specific proteins were recognised by comparison with a 
prestained SDS molecular marker (SDS-7B), which consists of 7 standard proteins 
conjugated to a blue dye as shown in table 2.3.
TABLE 2.3 Prestained SDS-PAGE Molecular Weight Markers
Prestained Protein
a 2"Macroglobulin from Human Plasma 
B-Galactosidase from E. coli 
Fructose-6-phosphate Kinase from Rabbit Muscle 
Pyruvate Kinase from Chicken Muscle 
Fumarase from Porcine Heart 
Lactic Dehydrogenase from Rabbit Muscle 
Triosephosphate Isomerase from Rabbit Muscle
Molecular Weight 
180,000 
116,000
84.000
58.000
48.500
36.500 
26,600
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2.2.10 Electron-Microscope Histology Determination
Morphological examination of peroxisomal enzymes was essentially based on the 
standard operating procedure modified in the Robens institute and updated by Dr. M. 
Dobrota.
Reagents :
Glutaraldehyde 25 % solution : Commercially available 
Cacodylate buffer: Sodium cacodylate 0.2 M; pH 7.4 adjusted with dilute 
NaOH
Osmium tetroxide 4 % solution : Commercially available
Buffered glutaraldehyde :
Glutaraldehyde 25 % solution 16 ml
Distilled water 34 ml
Sodium cacodylate buffer 0.2 M , pH 7.4 50 ml
Buffered 2 % Osmic acid : Osmium solution diluted 1:1 with cacodylate buffer
Absolute ethanol : Commercially available
Propylene Oxide : Commercially available
Epon 812 : Commercially available
Storage buffer :
Sodium cacodylate 0.2 M ; pH 7.4 50 ml
Distilled water 35 ml
Formaldeyde 40% ( w/v ) 10 ml
Glutaraldehyde 25 % ( w/v ) 4 ml
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Assay Procedure :
Following animal sacrifice, liver tissue was immediately excised. A slice of 0.5 - 1 mm 
thickness was rapidly cut from the tissue using 70 % v/v ethanol-sterilised scalpel and 
immediately covered with a small volume of glutaraldehyde. Each slice was cut into 
small sections ( 0.5 mm cubes ) and this was performed on a clean plastic plate moistened 
with glutaraldehyde solution. Tissue blocks were then transferred to a 5 ml screw-capped 
glass vial and fixed in 4 % glutaraldehyde, dissolved in 0.1 M cacodylate , pH 7.4 for 1- 
4 hours or overnight. Alternatively the samples can be kept in a storage buffer indefinitely 
at room temperature if the sample cannot be processed further following primaiy 
fixation. The tissue was then washed thoroughly by decanting and resuspending in 0.1 M 
cacodylate buffer several times, over a period of 1 to 18 hours. Therafter , the tissue 
blocks were counterfixed in buffered 2 % osmic acid / 0.1 M cacodylate , pH 7.4 for 2 
hours, followed by dehydration with increasing concentrations of ethanol ( 25, 50, 75, 
96, and 100 % v/v ). The tissues were kept in each solution for 10 minutes and changed 
twice, after which they were left in a mixture of propylene oxide : absolute ethanol ( 1 : 1  
) for 2 hours over two changes. Tissue blocks were subsequently covered with a 1 : 1 
mixture of propylene oxide and epon 812 resin and left for 1 hour. Approximately 2-3 
blocks were transferred with a microspatula to the resin-filled capsule and left at room 
temperature for 4 hours before polymerisation. Resin polymerisation was achieved by 
incubation at 60 °C for 12 hours. This procedure was kindly provided as a service by the 
University of Surrey, Microstructural Studies Unit. The Epon blocks were trimmed to 
expose the tissue sample and sections of 700 °A thick (silver grey colour) were cut using 
the Reichert OMU-3 Ultramicrotome (Reichert-Jung Ltd., Slough). They were counter­
stained in 2% uranyl acetate and 4% lead citrate for 20 minutes in each case at 60°C. 
Counterstained sections were examined in the Philips 400 T electron microscope at fairly 
low magnifications quoted in the figure legends.
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2.2.11 Statistical Analysis
Statistical analysis was performed by the unpaired Student’s t-test employing 
StatWorks software program. Statement of significant statistical differences between the 
means of treated and control animals were based on P <  0.05.
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CHAPTERS
EVALUATION OF THE ANTIMUTAGENIC 
POTENTIAL OF ANTHRACENE 
IN VITRO AND EX VIVO STUDIES
8 0
3.1 INTRODUCTION
There is a growing interest in evaluating the contribution of diet in the 
development of human cancer, since the incidence of various cancers appears to be 
dependent on the life-style, including diet which is considered as an important causative 
factor ( Doll & Peto, 1981). A variety of potential mutagens and carcinogens in the diet 
have been characterised as food contaminants, as naturally-occurring substances in food 
or as being generated while food has been processed (Felton et al., 1984; Sugimura, 
1982; Anthony et al., 1990). The last group of food mutagens is of particular importance 
due to their widespread occurrence in commonly consumed food items. Heterocyclic 
aromatic amines are one of those toxicants that are produced during the cooking process 
of proteinaceous food (Kasai et al., 1980). It has been established that most heterocyclic 
amines are potent bacterial mutagens in the presence of appropriate activation system 
(Kato et al., 1983), and also induce cancers in all animal species in which they were 
tested (Ohgaki et al., 1984; Takayama et al., 1984; Sato et al., 1987; Tsuda et al., 1988 
and 1990; Hiroko et al., 1991).
It is well established that chemical carcinogenesis can be inhibited by a wide array 
of naturally-occurring compounds as well as synthetic agents. One conceivable 
mechanism through which these anticarcinogens may antagonise the effects of 
carcinogenic chemicals is by selectively inhibiting the enzyme system(s) responsible for 
their bioactivation to highly reactive intermediates which, by interacting covalently with 
DNA, express their carcinogenicity. Indeed, numerous studies conducted in in vitro 
mutagenicity systems showed that a number of naturally-occurring chemicals could 
reduce the mutagenic potential of chemical carcinogens, presumably by inhibiting their 
metabolic activation (Hartman arid Shankel, 1990). However, few investigations were 
extended to indicate that the same mechanism(s) is operative in the in vivo situation.
Previous studies with anthraflavic acid (2,6-dihydroxyanthraquinone), a naturally- 
occurring plant phenolic flavonoid, revealed that the mutagenicity of food-borne
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heterocyclic amine 2-amino-3-methylimidazo[4,5-f]quinoIine (IQ) was effectively 
decreased in vitro as a result of suppressing CYPl-mediated activation through N- 
hydroxylation (Ayrton et al., 1987; 1988a). In contrast, however, anthraflavic acid 
induced the activity of CYPl when administered to rats thus exacerbating the mutagenic 
potential of the food mutagens (Ayrton et al., 1988b). Therefore, these observations 
demonstrate that studies conducted only in in vitro systems may be misleading, and it is 
essential that they are supported by in vivo evidence.
It is also conceivable that synthetic chemicals of structurally-related compounds 
derived from natural origins can suppress the mutagenic potency of food mutagens. The 
capacity of the simple polycyclic aromatic hydrocarbon anthracene, for example, to 
exhibit a potential antimutagenic activity against the food carcinogen IQ was evaluated. 
Anthracene was selected in the present study for several reasons: (a) it is not carcinogenic 
and displays negative mutagenic response in many short-term genotoxicity tests, 
including the Ames mutagenicity assay (Soderman, 1982); (b) it is a rigid planar molecule 
and consequently likely to interact with and inhibit the CYPl family of proteins (Lewis et 
al., 1986). Considering the molecular structure and the metabolic activation by CYPl, it 
has been established that all CYPl substrates are characterised by their high degree of 
planarity (Lewis et al., 1989). Moreover, preliminaiy studies have shown that anthracene 
does not induce hepatic CYPl activity when administered to rats, inspite of its metabolism 
mediated by CYPl proteins, which are also ressponsible for the bioactivation of the food 
mutagen IQ (Ayrton et al., 1990).
3.2 MATERIALS
All chemicals. Salmonella typhimurium strain TA 98, and cofactors were 
purchased as cited in chapter 2.
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3.3 METHODS
3.3.1 Animal Treatment
Male Wistar albino rats (180-200g) were purchased from the Animal Breeding 
Unit, University of Surrey . The animals were treated with a single intraperitoneal 
injection of Aroclor 1254 (500 mg/kg) dissolved in corn oil (200 mg/ml) to achieve 
induction of the mixed-function oxidase system for general mutagenicity testing in the 
Ames test. Animals were killed on the 5th day following administration. Two 
experimental studies were undertaken. In the first one, the animals were allocated into 
three groups of 4 each. Two groups were administered a single i.p. injection of 
anthracene (20 mg/kg), dissolved in corn oil (10 mg/ml), whereas the third one serves as 
control and received the corresponding volume of corn oil. The anthracene treated rats 
were killed by cervical dislocation 2 and 24 hours following injection. In the second 
study, anthracene was administered to rats that had already been treated with Aroclor 
1254. On the 5th day following induction with Aroclor 1254, a group of 4 rats received a 
single i.p. dose of anthracene (20mg/kg), dissolved in corn oil (10 mg/ml), while a 
second group was given the equivelent volume of corn oil. All animals were killed 2 
hours following the administration of anthracene.
3.3.2 Determination of Mixed-function Oxidase Activities
The hepatic post-mitochondral supernatant (S9 fraction) and microsomal fractions 
were prepared according to the method of loannides and Parke (1975). The microsomal 
protein content was determined as described by Lowry et al. (1951) using bovin serum 
albumin as standard. Total cytochrome P-450 was assayed according to Omura and Sato 
(1964). Ethoxyresorufin O-deethylase (Burke and Mayer, 1974) and methoxyresorufm 
0-demethylase (Burke et al., 1983) activities were determined as probes for CYPl A 1 
and CYP1A2 proteins respectively.
83
3.3.3 Mutagenesis Assays
The metabolic activation of both IQ and Giu-P-1 was determined using the Ames 
mutagenicity test (Maron and Ames, 1983). The assay was carried out employing the 
Salmonella typhimurium strain TA 98 and 10 % (v/v) hepatic preparations S9 or 
isolated microsomes, as activation system derived from Aroclor 1254-induced rats. When 
microsomes were employed, the activation system was supplemented with glucose-6- 
phosphate dehydrogenase (1 unit/plate). In the studies concerned with the possible direct 
interaction between anthracene and IQ-reactive metabolite, a different protocol was used. 
The mutagen , bacteria and activation system were pre-incubated in a shaking waterbath at 
37“C for 20 minutes and metabolism was terminated by addition of 0.9 mM menadione 
(100 ;d/plate). Anthracene was then added to the mixture and a second 20 minutes pre­
incubation was carried out prior to plating out the mixture. All test compounds and 
menadione were dissolved in 100//I dimethylsulphoxide (DMSO).
3.4 RESULTS
3.4.1 Effect of Anthracene on IQ-induced Mutagenesis In vitro
Hepatic 89 preparations from Aroclor 1254-induced rats efficiently converted IQ 
to mutagens. Incorporation of anthracene into the activation system caused a significant 
concentration-dependent decrease in the mutagenicity of IQ, even at concentrations as 
low as 5x10’^ M (Figure 1). When the 89 fraction was substituted with isolated 
microsomes, the mutagenic response elicited by IQ was less pronounced. In order to 
investigate the possible role of soluble fraction in the increased IQ mutagenic response by 
89 preparations, a separate experiment was adopted to study the mutagenicity of IQ using 
cytosolic fraction as a source of activation enzyme system. However, cytosol did not 
increase the activation of IQ (results not shown). Once again anthracene caused a potent 
and concentration-dependent inhibition in mutagenic response but the effect appeared to 
be less marked when compared with the studies utilising 89 fraction as activation system 
(Figure 2). At the concentrations employed, anthracene was neither mutagenic nor toxic 
(data not shown).
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Figure 3.1 Inhibitory effect o f anthracene on IQ mutagenesis. The food mutagen was incorporated 
into the hepatic S9 mix activation system derived from Aroclor 1254-induced rats in the absence and 
presence of anthracene at concentration levels of 5x10"^ M, 5x10'^ M, 5x10'^ M and 5x10^ M. The 
mutagenicity assay was carried out using S.typhimurium TA98 and employing 10 % (v/v) activation 
system. The spontaneous reversion rate of 18 ± 6 has already been subtracted. Results are presented as 
mean ± SD of triplicates.
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Figure 3.2 Inhibitory effect of anthracene on IQ mutagenesis. The food mutagen was incorporated into 
the hepatic microsomal activation system derived from Aroclor 1254-induced rats in the absence and 
presence of anthracene at concentration levels o f 5x10'^ M, 5x10"^ M, 5x10'^ M and 5x10'^ M. The 
mutagenicity assay was carried out using S. typhimurium TA98 and employing 10 % (v/v) 
activation system supplemented with glucose-6-phosphate dehydrogenase (1 unit/plate). The spontaneous 
reversion rate of 13 has already been subtracted. Results are presented as mean ± SD of triplicates.
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3.4.2 Influence of A nthracene Incorporation on Monooxygenase System 
The effect of anthracene on hepatic ethoxyresorafin O-deethylase activity in rats 
pretreated with Aroclor 1254 is shown in Figure 3. Anthracene gave rise to a 
concentration dependent inhibition of the 0-deethylation of ethoxyresorafin, and 
diminished by more than 50 % when anthracene was incorporated at a final concentration 
of 5x10-5 M.
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Figure 3 .3  In vitro inhibition of ethoxyresorufm O-deethylase by anthracene. Ethoxyresorufin (0.35 
mM) was incubated with Aroclor 1254-induced rat hepatic microsomes in the absence and presence of 
anthracene (0.5 to 500 pM ). Results are presented as mean ± S.E.M for three animals.
Furthermore, the incorporation of anthracene into the hepatic microsomal 
activation system, derived from Aroclor 1254-treated animals, resulted in an inhibition of 
the metabolic activation of the promutagen Glu-P-1 (Table 1). Inhibition of mutagenicity 
was not significantly affected when NADPH-generating system replaced by NADPH in 
the presence of anthracene at concentration level of 5x10"^ M, indicating that anthracene
8 6
does not influence the production of NADPH (data not shown). On the other hand, when 
microsomal activation of IQ was terminated by the addition of menadione into the 
incubation system, incorporation of anthracene (5x10"^ M) markedly decreased 
mutagenic response by 60 % aproximately (Table 2).
Table 3.1 Inhibition of Glu-P-1 m utagenicity by anthracene
Glu-P-1 Cone, 
(/fg/plate)
Anthracene Cone. 
> M )
Mutagenic response 
(Histidine revertants/plate)
14±7
1 1980 ± 189
1 0.5 1964 ±106
1 5 1138 ±108
1 50 220 ± 8
1 500 176 ±12
The test was carried out using Salmonella typhimurium strain TA98 and employing 10 % 
(v/v) hepatic microsomal activation system derived from Aroclor 1254-treated rats, 
supplemented with glucose-6-phosphate dehydrogenase (1 unit/plate), results are 
presented as mean ± SD for triplicates.
Table 3.2 Evaluation of the interaction of anthracene with mutagenic 
species derived from  IQ
Additions to activation Mutagenic response
system (Histidine revertants/plate)
Buffer 2406 ±25
Anthracene (500//M) 894 ±47
Hepatic microsomes from Aroclor 1254-treated rats (10 % ^/v) were preincubated with IQ 
(40 ng) and Salmonella typhimurium TA98 for 20 minutes at 37°C in a shaking 
waterbath. Following termination by the addition of 900 pM  menadione (100 p\), a 
further preincubation for 20 minutes was carried out after addition of buffer or 
anthracene. The spontaneous reversion rate of 25±2 has already been substracted. Results 
are presented as mean ± SD for triplicates.
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3.4.3 Modulation of Microsomal Mixed-function Oxidase Activity by 
Anthracene: E x vivo studies
Administration of anthracene to rats had no effect on total cytochrome P450 as 
well as microsomal protein, either 2 or 24 hours after injection. However, small but 
significant increases were observed in the O-deethylation of ethoxyresorufin and O- 
demethylation of methoxyresorufin 24 hours after administration. In contrast, there was 
no significant increase in the O-deethylation of ethoxyresorufin 2 hours following 
administration as shown in Table 3, but the 0-demethylation of methoxyresorufin was 
significantly elevated.
Table 3.3 Effect of anthracene administration on rat hepatic microsomal 
mixed-function oxidases
Parameter Control Anthracene
(2h)
Anthracene
(24h)
Ethoxyresomfin O-deethylase 
(pmol / min per mg protein)
36±8 51± 12 63± 14*
Methoxyresorufin O-demethylase 
(pmol / min per mg protein)
24±7 52± 14* 70± 20*
Total cytochrome P450 
(nmol / mg protein)
0.43± 0.07 0.51 ±0.04 0.36±0.10
Microsomal protein 
(m g /g liver)
17.1±5.3 22.1±5.4 16.5±2.5
All assays were carried out employing hepatic microsomal preparations derived from 
anthracene-treated rats and untreated animals. Treated rats were administered a single i.p. 
dose (20 mg /kg), dissolved in com oil (10 mg / ml), and were killed 2 or 24h after 
administration, while the control animals received the corresponding volume of com oil. 
Results are presented as mean± SD of four animals.
*Significantly different from control group, P< 0.05.
8 8
In a separate study anthracene was administered to rats induced by pretreatment with 
Aroclor 1254. Anthracene did not modulate cytochrome P450 activity when animals were 
killed 2 hours after administration (Table 4).
Table 3.4 Effect of anthracene on the hepatic mixed-function oxidase 
system in rats pretreated with Aroclor 1254
Parameter Aroclor 1254 Aroclor 1254 
+
Anthracene
Ethoxyresomfin Odeethylase 
(nmol / min per mg protein)
7.9±1.7 5.9± 1.2
Methoxyresomfm O-demethylase 
(nmol / min per mg protein)
1.6± 0.6 0.9± 0.3
Total cytochrome P450 
(nmol / mg protein)
1.24± 0.25 1.13± 0.13
Microsomal protein 
(mg / g liver)
19.7± 8.7 30.3± 3.3
Rats received a single intraperitoneal administration of Aroclor 1254 (500 mg / kg). On 
the 5th day following administration, animals were also pretreated with a single 
intraperitoneal administration of either anthracene (20 mg/kg) or the corresponding 
volume of com oil, and were killed 2h after administration. Results are presented as 
mean± SD for four animals.
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3.4.5 Effect of Anthracene Administration on the Metabolic Activation of
IQ by Rat Hepatic Microsomal Preparations
Pretreatment of rats with anthracene had no effect on the activation of IQ to 
mutagens, 2 hours after administration, whether S9 or isolated microsomes served as the 
activation system (Figure 4 & 5). However, both S9 and microsomes derived from rats 
treated with the same dose of anthracene, but killed 24 hours after administration were 
more efficient, at high IQ concentration only, than untreated animals in converting IQ to 
its reactive species (Figure 4 & 5). Conversely, the mutagenicity of IQ was not effectively 
modulated by anthracene when administered to Aroclor 1254-pretreated animals, 2 hours 
before sacrifice (Figure 6 & 7).
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Figure 3.4 Metabolic activation of IQ by hepatic postmitochondrial preparations from anthracene- 
treated rats. The mutagenicity assay was carried out using S.typhimurium  strain TA98 and 10 % (v/v) 
activation systems derived from control ( □  ) and anthracene-treated rats, killed 2h (♦ )  or 24h ( ■  ) after 
administration. The spontaneous reversion rates of 19±3 (control), 24±3 (anthracene-treated 2h), 17db5 
(anthracene-treated 24h) have already been subtracted. Results are presented as mean ± SD of triplicates.
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Figure 3.5 Metabolic activation of IQ by hepatic microsomes from anthracene-treated rats. The 
mutagenicity assay was carried out using S.typhimurium strain TA98 and employing 10 % (v/v) 
activation systems derived from control ( D ) and anthracene-treated rats, killed 2h (♦ )  or 24h ( ■  ) after 
administration and supplemented with glucose-6-phosphate dehydrogenase (1 unit/plate). The spontaneous 
reversion rates of 20±5 (control), 17±4 (anthracene-treated 2h), 14+5 (anthracene-treated 24h) have already 
subtracted. Results are presented as mean ± SD of triplicates.
3 000-1
«
&
I 2000  -
I*  1000 -  
I .
X
5020 30 4 00 10
IQ Conc. ( ng / plate )
Figure 3.6  Effect of anthracene on the Aroclor 1254-induced mutagenicity of IQ. The mutagenicity 
assay was performed using S.typhimurium strain TA98 and employing 10 % (v/v) hepatic 89 fractions as 
activation systems derived from rats treated with Aroclor 1254 alone (D ) and Aroclor 1254 + anthracene 
(♦ ). The spontaneous reversion rates of I5±l and 17±2 in the Aroclor 1254 only and Aroclor 
1254+anthracene-treated animals respectively, have already been subtracted.
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Figure 3.7 Metabolic activation of IQ by hepatic microsomal activation systems derived from rats 
treated with Aroclor 1254 alone (□ ) and Aroclor 1254+anthracene (❖). The mutagenicity assay was carried 
out using S.typhiniurium strain TA98 and employing 10 % (v/v) activation systems supplemented with 
glucose-6-phosphate dehydrogenase ( 1 unit /  plate). The spontaneous reversion rates of 15±4 and 12±1 in 
the Aroclor 1254 alone and Aroclor 1254+anthracene treated animals respectively, have already been 
subtracted. Results are presented as mean±SD of triplicates.
3.5 DISCUSSION
It has been demonstrated clearly that dietary factors play an important role in the 
modulation of human cancer. It is therefore conceivable that the activity of cytochrome 
P450, the essential enzyme system involved in the metabolic activation of most 
environmental carcinogens, might be affected by dietary components. The overall 
anticarcinogenic action of a chemical appears to be attributed to its ability to inhibit the 
bioactivation of procarcinogens which are metabolised by cytochrome P450 proteins.
Of the various cytochrome P450 families, the CYPl family is perhaps the most 
closely associated with chemical carcinogenesis (loannides and Parke, 1990). It catalyses, 
both in human and animals, the metabolic activation of planar chemical carcinogens 
(Parke et al., 1991), such as polycyclic aromatic hydrocarbons and the heterocyclic amine 
food carcinogens, two of the most widespread classes of chemical carcinogens to which
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humans are continuously and involuntarily exposed; such exposure is unlikely to be 
curtailed significantly in the foreseeable future. In the light of these findings, it is 
necessaiy to focus the attention towards the identification of possible antimutagens and 
anticarcinogens or evaluating naturally-occurring compounds for such activity in order to 
design chemicals that may selectively inhibit the CYPl family and consequently the 
bioactivation of such carcinogens, thus directing the metabolism towards alternative 
routes leading to the formation of inactive molecules. Anthracene is a possible candidate 
for such a role. It is a planar molecule and therefore likely to inhibit competitively the 
CYPl family, the substrates of which are invariably essentially planar (Lewis et al., 
1986; 1987). It is neither a carcinogen nor a mutagen in a variety of systems (Soderman, 
1982). Experimental evidence revealed that anthracene is metabolised by the CYPl family 
to form an arene oxide which is then readily converted to the dihydrodiol by the enzyme 
epoxide hydrolase (Van Bladeren et al., 1985). Finally, preliminary studies have shown 
that anthracene is not an inducer of the CYPl family (Ayrton et al., 1990). In fact, 
anthracene was used successfully as an anti carcinogen in animal studies as early as 1946 
where it inhibited the carcinogenicity of polycyclic aromatic hydrocarbons such as 
benzo(a)pyrene in the mouse skin model (Crabtree, 1946).
In the present study, in vitro mutagenicity assay showed that anthracene caused a 
marked decrease in the mutagenicity of the CYPl-activated food promutagen IQ, whether 
S9 or microsomes were used, indicating that the microsomal metabolism (presumably N- 
hydroxylation), rather than the further metabolism of the microsomal metabolites by 
cytosol (Abu-Shakra et al., 1986) is inhibited. It is well-known that the activity of 
CYPl A 1 is specifically characterised by the O-deethylation of ethoxyresorufin 
(Guengerich et al., 1982; Philipson et al., 1984), and it is therefore possible that 
anthracene incorporation in vitro would adversely affect the enzyme activity leading to a 
decrease in the bioactivation of this mutagen. Supporting this conclusion is the finding 
that addition of anthracene at concentration level of 50 jiM  led to more than 50 % 
inhibition in the ethoxyresorufin O-deethylase activity. IQ requires metabolism catalysed
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primarily by CYP1A2 (Kato et al., 1983; Abu-Shakra et al., 1986; Battula et al., 1991; 
Kitada et al., 1990) in order to generate N-hydroxy-IQ which can directly interact with 
DNA to form an adduct (Okamoto et al., 1981; Snyderwine et al., 1988) and it appears 
likely that the inhibition of the metabolic activation of IQ by anthracene incorporation 
might be due to suppressed CYP1A2 activity. This speculation, therefore, was 
investigated by monotoring the Glu-P-1 mutagenicity. The activation of Glu-P-1 to 
mutagens is exclusively catalysed by the CYP1A2 isoform (Yamazoe et al., 1984). 
Indeed, the mutagenic potential of Glu-P-1 was markedly decreased (91%) when 
anthracene was incorporated, at concentration level of 500 piM, into the hepatic 
microsomal activation system. Moreover, anthracene appears also to act through another 
mechanism involving neutralisation of the mutagenic intermediates of IQ, presumably the 
N-hydroxy derivative, by direct interaction. This is inferred from the study where 
anthracene retained some of its antimutagenic activity even when microsomal metabolism 
was terminated by the presence of menadione. All the above in vitro findings indicate that 
anthracene has a good potential as a possible anticarcinogen.
In vivo studies have been subsequently undertaken in order to establish whether 
anthracene could exert its antimutagenic effects under such conditions. Initially it was 
considered necessary to confirm that, at the doses employed in the present study, 
anthracene did not modulate the hepatic microsomal CYPl levels. Animals treated with 
anthracene were killed 2 hours following administration, as high concentrations of the 
hydrocarbon are expected to be in the liver, or 24 hours after administration where CYPl 
induction by chemicals is clearly manifested (Phillipson et al., 1984). The activity of 
CYPl was monitored by the O-dealkylations of ethoxy- and methoxy-resorufin which are 
used to probe the A1 and A2 proteins respectively (Namkung et al., 1988). Increases in 
both activities were observed 24 hours after anthracene administration and only in the 
activity of methoxyresorufin O-demethylase 2 hours following administration, but these 
were minimal when compared with other polycyclic aromatic hydrocarbons, indicating 
that anthracene is a weak inducer of CYPl family. It was consequently not surprising that
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the mutagenicity of IQ was not modulated markedly when the microsomal activation 
system was isolated from animals that received a single injection of anthracene and were 
killed 2 hours afterwards. S9 fraction was also used in this study to avoid washing away 
any anthracene that might be present in the liver, but again no effect was evident. When 
hepatic preparations from rats killed 24 hours after administration were used in the 
activation system, there was à modest increase in IQ mutagenicity compatible with 
CYP1A2 induction although this effect was seen only at the highest concentration of the 
promutagen used. These studies illustrate that in vivo anthracene lacks the ability to inhibit 
CYPl and other constitutive forms of cytochrome P450 that might contribute to the 
activation of IQ. As in the in vitro studies, in order to ensure a good mutagenic response, 
it was considered pertinent to investigate whether anthracene could inhibit CYPl activity 
in animals pretreated with Aroclor 1254, where CYPl proteins comprise a major fraction 
of the total hepatic cytochrome P450 concentration. However, even under these 
conditions anthracene failed to inhibit significantly CYPl activity as well as the 
mutagenicity of IQ.
While the metabolism of anthracene to arene 1,2-oxide is selectively catalysed by 
the CYPl family, especially the A1 isoenzyme, anthracene administration to rats did not 
effectively influence the bioactivation of IQ to genotoxic species. It appears that, at the 
doses studied, the concentrations of anthracene achieved in the liver, even 2 hours after 
administration, are not suficient to inhibit CYPl activity. Generally potent inhibitors of 
cytochrome P450 activity can also function as potent inducers of the same proteins 
activity (Phillipson et al., 1982; loannides et al., 1985). The fact that anthracene was a 
poor CYPl inducer lends support to the lack of inhibition . On the basis of the described 
studies anthracene is unlikely to be a useful anticarcinogen. It should be emphasised, 
however, that these results are in contrast to the reported anticarcinogenic effect of 
antharcene against benzo(a)yrene (Crabtree, 1946). Thus, this discrepancy might be 
explained by anthracene-treatment protocol and to the CYPl isoform involved in the 
metabolism of anthracene and the test carcinogen.
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3.6 CONCLUSION
In vitro studies clearly demonstrated the antimutagenic potential of anthracene 
against the food mutagen IQ. Anthracene acts in two ways, first by inhibiting its CYPl A- 
mediated metabolic activation of IQ and secondly by interacting directly with IQ-reactive 
intermediate leading to their inactivation. However, treatment with anthracene, even after 
induction with Aroclor 1254 to achieve higher CYPl activity, did not significantly 
influence the ability of hepatic preparations to bioactivate IQ to mutagenic forms. In 
accordance to these observations, it can be concluded that anthracene does not suppress 
the mutagenic activity of IQ ex vivo and thus it is unlikely to be an inhibitor of the 
CYP1A2 activity. Finally what clearly these studies emphasise is that in vitro assays, 
employing short-term test study as the Ames assay, can be very misleading. It is essential 
that studies are conducted ex vivo or in vivo to demonstrate that the in vitro mechanism 
responsible for antimutagenicity are also operative in vivo .
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CHAPTER 4
EVALUATION OF THE ANTIMUTAGENIC
POTENTIAL 
OF AQUEOUS GREEN TEA EXTRACTS
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4.1 INTRODUCTION
Since dietary factors play a substantial role in the incidence of human cancer and 
chemically-induced cancer in animal models, there is a rapidly increasing interest in the 
identification of possible antimutagenic and anticarcinogenic compounds that might be 
present in the human diet Epidemiological evidence has revealed that increased 
consumption of green and yellow vegetables is of several protective factors associated 
with lower risk for human cancer incidence (Doll et a t, 1981). In fact, chemical 
mutagenesis and carcinogenesis can be inhibited by a large number of naturally-occurring 
compounds of plant origin (Wattenberg, 1983; 1985). One of these dietary components 
are phenolic compounds (Brown, 1980). Many of these phenolics are minor constituents 
of some of the commonly consumed vegetables, fruits, spices, and of beverages such as 
coffee and tea (Ames, 1983; Ramel et a t, 1986; Ito et al., 1989). Moreover, 
experimental studies revealed the protective effect of dietary phenolic compounds against 
chemical mutagenesis (San and Chan, 1987). The same authors demonstrated that 
mutagenicity induced by several carcinogens was inhibited by phenolics including gallic 
acid, caffeic acid, chlorogenic acid, ferulic acid, and ellagic acid. Moreover, formation of 
endogenous nitrosamines was impaired following administration of polyphenolic 
compounds in man (Hans et a t, 1984).
Green tea {Camellia sinensis ) is one of the most extensive consumed beverages 
particulary in parts of Asia. Over the last few years, many studies have shown an 
inhibitory action of green tea extracts and of its constituents on carcinogenesis and 
mutagenesis induced by several chemical carcinogenes. Green tea polyphenols, for 
example, displayed a strong scavenging effect towards the generated carcinogenic reactive 
intermediates of polycyclic aromatic hydrocarbons such as 3-methylcholanthrene, 7,12- 
dimethylbenz[a]anthracene and of the ultimate carcinogen of benzo(a)pyrene, namely the 
7,8-diol-9,10-epoxide (Khan et al., 1988). Cheng and his colleagues (1986) reported 
that mutagenicity induced by 4-nitroqunoline-N-oxide, 2-amino-3-4-dimethylimidazo[4-
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5-fJquinoline, and cigarette smoke condensate was inhibited by green tea catechins. 
Similarly, water extracts of green tea, as well as its phenolic fraction, were also effective 
antimutagens against aromatic amines, benzo(a)pyrene and methanol extracts of coal tar 
pitch (Wang et al., 1989). Recent studies have shown that green tea extracts decreased 
mutagenesis and carcinogenesis caused by nitrosamines, such as 
nitrosomethylbenzylamine (Han and Xu, 1990), diethylnitrosamine (Wang et al., 1992a), 
and 4-(methylnitrosamino)-l-(3-pyridyl)-l-l butanone (Xu et al., 1992; Wang et al., 
1992a). Green tea polyphenols can also function as scavengers of reactive oxygen species 
and this property may contribute towards their protective effect (Yuting et al., 1990). 
Components of tea such as (-)epigallocatechin gallate (EGCG), the principal flavanol in 
green tea, strongly suppressed mutagenicity caused by many mutagens in different 
bacterial species (Kada et al., 1985). EGCG was also effective against the direct-acting 
carcinogen N-ethyl-I^nitro-nitrosoguanidine (Fujita et al., 1989). Green tea extracts as 
well as EGCG were also considered as protective defence against carcinogenesis induced 
by UV light (Conney et al., 1992).
The protective effect of green tea against chemically-induced mutagenesis, at the 
level of initiation, could be attributed either to inhibition of the bioactivation process or 
more facilitating deactivation of the reactive intermediates (Spamins et al., 1982; Wang et 
al., 1989). Alternatively, green tea could influence the post-initiation action phase by 
suppressing cell proliferation (Wang et al., 1992b; Lea et al., 1993) which may be a 
function of the antioxidant properties of green tea (Ruch etal., 1989; Xu et al., 1992).
As green tea is a dietaiy constituent, it was considered pertinent in the present 
study to evaluate its antimutagenic activity towards food mutagens which are likely to be 
consumed simultaneously with tea. Therefore, the antimutagenic potential of green tea 
was evaluated against the heterocyclic amine food carcinogens and the polycyclic aromatic 
hydrocarbons, two major groups of dietary carcinogens that are generated during 
cooking, and nitroso compounds that are food contaminants. The studies were also
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extended to investigate aromatic amines, a principal group of occupational carcinogens. 
Whether the antimutagenic activity of tea is due to its ability to inhibit the metabolic 
activation of carcinogens and/ or direct interaction of tea components with the genotoxic 
intermediates of chemical carcinogens has not been established and this constitutes the 
main objective of the present study.
4.2 MATERIALS
Green tea (Gunpowder brand) was bought locally from Whittard Shop, 
Guildford, Surrey, UK and stored at 4 °C in a sealed bag. Aqueous extracts were 
prepared by brewing the green tea leaves ( 10 g) in freshly boiled water ( 400 ml ) for 10 
minutes followed by filtration to obtain a 2.5 % (w/v) tea infusion.
4.3 METHODS
4.3.1 Animal T reatm ent
Male Wistar albino rats (150-180g) were purchased from the Animal Breeding 
^ n it. University of Surrey. Induction of the CYPl family was achieved by administration
of a single intraperitoneal dose of Aroclor 1254 (500mg/ kg), the animals being killed on 
the 5th day following administration. For CYP2E induction, the animals received single 
daily intragastric doses of isoniazid (100 mg/ kg) for three days and were killed 24 hours 
after the last administration.
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4.3.2 Enzyme Assays
Hepatic S9 fraction and its constituents microsomes and cytosol were prepared as 
previously described (Chapter 2). The cytosol was recentrifuged at 105,000 x g for Ih to 
remove any contaminating microsomes. Total cytochrome P450 levels and protein 
contents were determined as described in chapter 2 similarly. The activity of NADPH- 
cytochrome c reductase and the O-dealkylations of ethoxyresorufin (Burke and Mayer, 
1974), pentoxyresorufm (Lubet et al., 1985), and methoxyresorufin (Burke et al., 1985) 
were carried out as described in chapter 2.
4.3.3 Evaluation of M utagenicity
The mutagenic potential was determined in the Ames test according to the method 
of Maron and Ames (1983) described in detail in chapter 2. The S.typhimurium strains 
TA 97, TA98, TA1530, TA 100 were utilised in the presence of either Aroclor 1254- or 
isoniazid-induced hepatic 89 fraction as activation system. In the experiments where 
isolated microsomes were used, the activation system was supplemented with glucose 6- 
phosphate dehydrogenase (1 unit /plate). In order to investigate whether green tea 
interacted with the electrophilic metabolites of the premutagens, a mixture of the bacteria, 
promutagen and the activation system were preincubated for 20 minutes at 37 °C in a 
shaking waterbath (1st preincubation). Menadione (900 piM) was added (100/^1) to 
terminate microsomal metabolism, and the green tea extracts were added to the activation 
system and a further 20 minutes preincubation was carried out (2nd preincubation). Top 
agar was then added (2 ml ), and the mixture was immediately plated onto minimal agar 
plates, which were incubated for 48 hours at 37 °C.
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4.4 RESULTS
4.4.1 Inhibition of Chemical Mutagenicity by Green Tea Extracts
Green tea aqueous extracts, prepared in the same fashion as consumed by humans
i.e 2.5 % (w/v) infusion caused a veiy marked and concentration-dependent decrease in 
the Aroclor 1254-induced S9-mediated activation of the heterocyclic amines IQ and Glu- 
P-1, so that virtually no mutagenic response was detectable when 200 piL aliquots of the 
tea extract were incorporated into the activation system (Figure 1). The metabolic 
activation of 2-aminofluorene and 2-aminoanthracene was also inhibited, but the effect of 
green tea extracts is much more effective in suppressing the bioactivation of 2- 
aminoflorene (Figure 2). 2-Aminoanthracene was more mutagenic when activated by 
Aroclor-induced cytosol than isolated microsomes, but the incorporation of green tea 
extracts into the activation system could markedly inhibit the mutagenicity of this aromatic 
amine in both systems (Figure 3). Mutagenesis induced by two cyclic nitrosamines, 
namely nitrosopyrrolidine and nitrosopiperidine was also significantly inhibited, 
following the addition of aqueous tea extracts into the activation system containing 
isoniazid-induced rat hepatic S9 preparations (Figure 4). Green tea extracts were also 
effective in reducing the mutagenic response resulting from the polycyclic aromatic 
hydrocarbons benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene, the effect being more 
pronounced with the former compound (Figure 5). Finally , aqueous green tea extracts 
suppressed the mutagenicity of the direct-acting mutagens 9-aminoaciidine and MNNG, 
but the effect was not as marked as compared to the indirect-acting mutagens. Aqueous 
extracts of green tea was more efficient in inhibiting MNNG-induced mutagenicity than 
that mediated by 9-aminoacridine (Figure 6).
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Figure 4.1 Inhibition of the mutagenicity of heterocyclic amine f(X)d-borne carcinogens by green tea 
extracts. Mutagenicity assay was carried out using S.typhimurium  TA 98 and employing 10 % 
(v/v) hepatic S9 preparation from Aroclor 1254-treated rats as activation systems and IQ (lOng) or Glu- 
P-1 (lOOng) as promutagens. The spontaneous reversion rate of 35±4 has already been subtracted. 
Results are presented as mean±SD of triplicates.
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Figure 4 .2  Inhibitory effect of green tea aqueous extracts on aromatic amine-induced mutagenicity. 
The assay was carried out using s.typhimurium  strains TA 98 (2-aminofluorene) and TA 100 (2- 
aminoanthracene) at concentration level of 5 //g/plate and 10 % (v/v) hepatic preparations derived from 
Aroclor 1245-pretreated rats as activation system. The spontaneous reversion rates of 17±4 and 109±9 for 
TA 98 and TA 100 respectively have already been subtracted. Results are presented as mean±SD of 
triplicates.
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Figure 4.3 Inhibition of the microsome- and cytosol-mediated mutagenicity of 2-aminoanthracene 
by green tea aqueous extracts. The mutagenicity assay was carried out using S.typhimurium  
strain TA 100, 2-aminoanthracene (5 pg) and 10 % (v/v) microsomal or cytosolic activation 
systems derived from Aroclor 1254-treated rats. When microsomes were utilised, the activation 
system was supplemented with glucose-6-phosphate dehydrogenase (1 unit / plate). The spontan­
eous reversion rate of 107±5 has already been subtracted. Results are presented as m ean ± S D  
of triplicates.
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Figure 4.4 Inhibitory effect of green tea aqueous extracts of nitrosamine-induced mutagenicity. 
The mutagenicity assay was carried out using S.typhimurium strain TA 1530, the nitrosamine 
(4mg) and 25 % (v/v) hepatic S9 preparations from isoniazid-treated rats as activation systems. 
The spontaneous reversion rate of 6±2 has already been substracted. Results are presented as 
mean ± SD of triplicates.
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Figure 4.5 Inhibition of polcyclic aromatic hydrocarbon-induced mutagenicity by green tea 
aqueous extracts. The study was carried out using S.typhimurium  strain TA 100 int he Ames 
test employing 10 % (v/v) hepatic S9 preparations from rats treated with Aroclor 1254 as 
activation systems and the promutagen (25 ;/g). The spontaneous reversion rate of 103±13 
has already been subtracted. Results are presented as mean ± SD of triplicates.
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Figure 4.6 Inhibition of the mutagenicity of direct-acting mutagens by green tea aqueous 
extracts. The study was performed using S. typhimurium TAIOO (MNNG) and TA97 
(9-aminoacridine) and MNNG (1 pg) or 9-aminoacridine (50 pg). The spontaneous rever­
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subtracted. Results are presented as mean±SD of triplicates.
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4.4.2 Inhibition of Cytochrome P450 Enzyme Activity by Green Tea
Aqueous extracts of tea inhibited the NADPH-dependent reduction of cytochrome 
c in Aroclor 1254-induced rat hepatic microsomes (Figure 7). Consequently, the activity 
of mixed-fuction oxidase system was suppressed, showing a significant inhibition in the 
O-dealkylations of methoxyresorufin (MROD)and ethoxyresorufin (EROD) (Figure 8).
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F igure 4.7 Inhibitory effect o f green tea aqueous extracts on the activity of cytochrome c 
reductase. Green tea was incubated with Aroclor 1254-induced microsomal suspension 
(25% w/v) and cytochrome c (0.1 mM). Results are presented as mean ± SEM for three 
rats. *P< 0.05 , **?< 0.01.
Similarly the 0-depentylation of pentoxyresorufin (PROD) was inhibited significantly 
following an initial increase in the activity (Figure 9). It is pertinent to point out at this 
stage that green tea extracts, at the concentrations used, neither fluorescence nor influence 
the fluorescence of resorufm which is the product of the dealkylation reactions (results not 
shown).
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Figure 4.8 Influence of green tea aqueous extract on hepatic mixed-function oxidase 
activity. Green tea was incubated with isolated microsomes from Aroclor 1254-treated 
rats and ethoxyresorufin (0.53 mM) or methoxyresorufin (1 mM). Results are presented 
as mean ± SEM for three animals. *P<0.05, **P<0.01, ***P<0.001.
110
PROD ACTIVITY
<uWro
It•a o)
6  I
O
C  CL
I ' i
s i
o
Q.
/ - T
10 25 50 100
Green Tea Extract ( pL )
Figure 4.9 Inhibition of hepatic mixed-function oxidase activity by green tea aqueous 
extracts. The study was carried out employing isolated microsomes from Aroclor 
1254-treated rats and pentoxyresorufin (ImM). Results are presented as mean± SEM 
for three animals. *P<0.05, **P<0.01.
4.4.3 Direct Interaction of Green Tea Extracts with Reactive
Intermediates of Carcinogens
It was desirable to investigate the possible interaction of tea components with the 
reactive, electrophilic intermediates of the various promutagens studied, and to achieve 
this objective the following experimental protocol was adopted. Bacteria, promutagen and 
the activation system were mixed and incubated for 20 min at 37 °C. Green tea extracts 
were added after termination of the microsomal activation by menadione addition, and a 
further preincubation was carried out. In some incubations menadione was added during 
the first incubation in order to ensure the effectiveness of menadione in inhibiting the 
microsomal metabolism of the various promutagens. Under such conditions, menadione 
completely abolished or very markedly suppressed the mutagenic response (Table I). 
Following microsomal enzyme inactivation, incorporation of green tea extracts decreased 
the mutagenic response in all cases but the effect was modest (Table 1). The mutagenic 
potential of aromatic amines , in the presence of Aroclor 1254-induced hepatic cytosolic 
activation system, was also inhibited by green tea extracts following the addition of 
menadione (Table 2).
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It is worth to point out that menadione could not totally inhibit the cytosolic activation of 
2-aminofluorene and especially of 2-aminoanthracene.
4.5 DISCUSSION
Since the realisation that dietary constituents play an important role in cancer 
prevention, the identification of such possible antimutagenic and anticarcinogenic 
chemicals has become a subject of an increasing interest Epidemiological evidence lends 
support to the hypothesis that naturally-occurring plant compounds in fruit and vegetables 
may be responsible for the antimutagenic and anticarcinogenic activities. Furthermore, 
experimental studies in animal models indicated that chemical mutagenesis and 
carcinogenesis may be inhibited by various naturally-occurring chemicals including 
polyphenolic compounds (Okuda et al., 1984; San and Chan, 1987; Tanaka et al., 1993). 
The manipulation of dietaiy intake, therefore, may play a vital role in the developing of 
new strategies for protection against the unavoidable daily exposure to environmental 
carcinogens.
Aqueous extracts of green tea, prepared at the concentration used for human 
consumption, displayed a veiy potent antimutagenic effect against an array of chemical 
carcinogens, including food-home carcinogens such as heterocyclic amines (IQ,Glu- 
P-1), polycyclic aromatic hydrocarbons (benzo(a)pyrene and 7,12- 
dimethylbenz(a)anthracene) and nitrosamines (nitrosopiperidine and nitrosopyrrolidine), 
as well as against occupational carcinogens (2-aminoanthracene and 2-aminofluorene). 
The antimutagenic effect of green tea extracts was extremely potent, the inhibitoiy effect 
being clearly evident at concentrations as low as 100 //1/plate. In consistent with the 
present results, Wang et al.(1989) found that aqueous extracts of green tea and its 
component polyphenols inhibited the reverse mutation induced by benzo(a)pyrene, 
aflatoxin Bj and 2-aminofluorene in Salmonella typhimurium TAIOO. Thus this 
antimutagenic activity of green tea extract has been associated with catechin derivatives.
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such as epigallocatechingallate (Kada, 1985). These results demonstrate that the 
mutagenicity of chemical carcinogens in the Ames test can be influenced by dietary 
compounds such as green tea polyphenols. In addition,these studies raise the possibility 
that green tea may exert its anticarcinogenic effect, at least partly, by acting at the initiation 
stage, presenting the interactions between the mutagen and DNA. Moreover, these studies 
indicate that green tea may also be an effective anticarcinogen against the heterocyclic 
amine and polycyclic aromatic hydrocarbon carcinogens, to which humans are exposed 
virtually for their entire life.
A number of possible mechanisms may account for the antimutagenic effect of 
green tea extracts. One feasible mechanism of action is that green tea components may 
interact with the enzyme systems catalysing the metabolic activation of the various 
promutagens, impeding the production of genotoxic intermediates. The polycyclic 
aromatic hydrocarbons and heterocyclic amines, being essentially planar molecules, are 
selectively activated by the subfamily A of the cytochrome P450 family 1 (CYPl), which 
comprises two proteins namely A1 and A2 (loannides and Parke, 1990; Overvik and 
Gustaffson, 1990). The function of these two proteins was therefore monitored by using 
the O-dealkylations of ethoxyresorufin and methoxyresorufin since they are diagnostic 
probes for CYPlA1 and CYP1A2 respectively (Phillipson et al., 1984; Namkung et al., 
1988). In vitro administration of green tea extracts into the incubation system gave rise to 
significant inhibition of these activities demonstrating that green tea components can 
inhibit CYPl A activity, and this may represent one of the mechanisms of their 
antimutagenic action. On the other hand, nitrosamines such as nitrosopyrrolidine and 
nitrosopiperidine are activated by alternative subfamilies of cytochrome P450, namely 
CYP2E and CYP2B (Yang et al., 1985; Ayrton et al., 1987; McCoy et al., 1979). 
Recently, the role of CYP2E in the metabolism of nitrosamines such as nitrosopyrrolidine 
has been confirmed using cDNA expressed human cytochrome P450s (Flammang et al., 
1993). The activation of these two nitrosamines in the Ames test was achieved using 
hepatic preparations from rats treated with isoniazid, a potent inducer of CYP2E1
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(Thomas et al., 1987). CYP2B activity was determined by the 0-dealkylation of 
pentoxyresorufin, an extensively used probe for this activity (Lubet et al., 1985). 
Addition of aqueous green tea extracts to hepatic microsomes from Aroclor 1254-treated 
rats also inhibited this activity, albeit to lesser extent when compared to methoxy- and 
ethoxy resorufin, indicating that green tea constituent(s) can also suppress this activity 
and may be a factor in their antimutagenic effect against the nitrosamines. While the best 
chemical probe for CYP2E1 activity is the oxidation of p-nitrophenol to nitrocatechol 
(Koop et al, 1989), monitored spectrophotometrically, the inhibitory effect of green tea 
could not be investigated as tea components interfered with the assay, presumably 
because of their high phenolic content (results not shown). Similar difficulties were 
encountered when the N-demethylation of dimethylnitrosamine, a substrate also 
associated with the CYP2E subfamily (Holtzman et al., 1969)was studied (results not 
shown). Therefore, the effect of green tea extracts on CYP2E activity could not be 
evaluated.
The S9-mediated activation of the two aromatic amines 2-aminofluorene and 2- 
aminoanthracene is catalysed by at least two enzyme systems, one microsomal and the 
other residing in cytosol (Ayrton et al, 1992; Leist et al, 1992). Thus, studies were 
conducted using activation systems containing Aroclor 1254-induced hepatic microsomal 
and cytosolic preparations in order to establish whether either or both enzyme systems are 
modulated by green tea extracts. A marked decrease in the metabolic activation of 2- 
aminoanthracene was observed when both cytosol or microsomes were employed as 
activation system, indicating that green tea components are capable of inhibiting both 
enzyme systems.
As tea contains high levels of catechins, which have previously been shown to 
inhibit the NADPH-dependent reduction of cytochrome P450 (Steele et al., 1985), it was 
important to investigate the effect of green tea extracts on this enzyme. Indeed, addition of 
green tea aqueous extracts significantly inhibited NADPH-cytochrome c reductase activity
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indicating that tea components, presumably catechins, interfere in some way with the 
electron transport system and possibly serve as electron acceptors impairing the flow of 
electrons away from NADPH to cytochrome P450. Similarly, Wang et al. (1988) have 
reported that the addition of green tea polyphenols resulted in a significant inhibition in 
microsomal monooxygenase activities and NADPH-cytochrome c reductase activity. Thus 
inhibition of cytochrome P450 activity by green tea extracts may be partly attributed to 
interference with the electron flow to cytochrome P450. As green tea extracts caused 
differential effects on the metabolism of the various substrates , it may be inferred that this 
is not the only site of action of green tea extracts.
Another possible mechanism whereby green tea extracts exert their antimutagenic 
effect is through interaction of tea components with the genotoxic reactive intermediates of 
mutagens, leading to their neutralisation. Such a mechanism has already been invoked to 
partly explain the antimutagenic effects of the plant polyphenol ellagic acid and flavonoids 
(Huang et al, 1993; Sayer et al, 1982). In the present study, incorporation of green tea 
extracts into the incubation mixture, following termination of microsomal metabolism, 
caused a substantial inhibition in the mutagenicity of all mutagens studied. In the case of 
the two aromatic amines 2-aminofluorene and 2-aminoanthracene, such inhibition was 
also seen when the cytosolic fraction served as the activation system. Overall the 
inhibition of the mutagenic effect of the promutagens by green tea was clearly more potent 
when the aqueous extracts were incorporated into the activation system at the start of the 
experiment, before termination of microsomal metabolism, rather than after metabolism 
termination. Finally, the ability of green tea aqueous extracts to function as a nucleophile 
is supported by the observations that tea extracts suppressed the mutagenicity of the 
direct-acting mutagens MNNG and 9-aminoacridine. However, the antimutagenic 
response was not as pronounced as with the indirect-acting promutagens.
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4.6 CONCLUSION
On the basis of the present results, it appears that green tea extracts can antagonise 
effectively the in vitro mutagenicity of various structurally diverse promutagens employed 
in the study, including many food-borne mutagens, by decreasing their cytochrome P450- 
mediated activation . The data also indicate that the antimutagenic activity of green tea, to 
lesser extent, is attributed to the direct interaction of the reactive carcinogen-metabolite 
with nucleophiles present in green tea and thus preventing their interaction with DNA. 
Whether these in vitro mechanisms are also operative in vivo is discussed in chapter 7.
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CHAPTER 5
COMPARATIVE STUDY OF THE ANTIMUTAGENIC 
POTENTIAL OF OF GREEN , BLACK AND 
DECAFFEINATED TEAS
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5.1 INTRODUCTION
Tea is one of the most commonly consumed beverages worldwide aside from 
water. Considering the commercial production of tea, two major types are recognised, 
green tea and black tea. Green tea constitutes about 20 % of the estimated 2.5 million 
metric tons of dried tea manufactured, consumed primarily in Asian countries and North 
Africa. However the vast majority of tea is black comprising 80 % of the total, and is 
more popular and considered as the major beverage in the Middle East countries and in the 
Western Nations (Wang et al., 1992).
Green tea is made generally by steaming and drying fresh tea leaves at elevated 
temperatures. Its composition is similar to that of fresh tea leaves with regard to the 
principal components, so that up to 30 % of the dry weight is composed of polyphenols 
(flavonoids), most of which are flavan-3-ols, and usually known as catechins (Wang et 
al., 1988). Black tea manufacture, however, comprises the enzymic fermentation of the 
tea leaves leading to the formation of theaflavins, thearubigins, and other oligomers 
(Wang et al., 1992).
Clearly the cancer chemopreventive effects of different varieties of tea and its 
polyphenols have been shown in various animal models invoking a diversified class of 
chemical carcinogens as well as ultraviolet radiation. Laboratory studies indicated the 
inhibitory action of green tea and its polyphenol extract on mutagenesis in a number of 
bacterial strains (Kada et al., 1985; Mukhtar et al., 1992). Continuous administration of 
the green tea polyphenol fraction or epigallocatechin-3-gallate (EGCG) exerted 
antimutagenic activity against benzo(a)pyrene, aflatoxin B i, 2-aminofluorene, 4- 
aminobiphenyl or benzo(a)pyrene diol-epoxide in Salmonella typhimurium strains TA 98 
and TA 100 (Wang et al., 1989b). Aqueous extracts of green tea, however, showed 
substantial anticarcinogenesis effects in animal bioassay systems (Wang et al., 1989). 
Indeed green tea polyphenolic fraction as well as EGCG have displayed protective effects 
against benzo(a)pyrene and nitrosodiethylamine-induced forestomach and lung
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tumorigenesis when administered orally (Katiyar et al., 1993). Topical application of 
green tea extracts, or its major constituent EGCG, also resulted in a significant inhibition 
in the carcinogen-induced tumour initiation and promotion (Conney et al., 1992). 
Similarly, green tea polyphenols protect against 12-O-tetradecanoyl-phenol-13- 
acetate(TPA)-induced tumour promotion in dimethylbenz(a)anthracene-initiated skin 
(Wang et al., 1989). Oral feeding of green tea polyphenols in drinking water also 
afforded marked protection against skin photocarcinogenesis caused by ultraviolet-B- 
radiation (Mukhtar et al., 1992). Studies also showed that the intensity of red colour and 
areas of lesions produced by ultraviolet light on mice skin were inhibited in a dose- 
dependent manner by the adminstration of green tea extracts (Wang et al., 1992). 
Similarly, the same workers reported that tea infusion inhibited the formation of UV- 
induced skin tumours and increased spleen size (Wang et al., 1992).
It is obvious that most of the available evidence on the anticarcinogenic potential 
of tea has been referred to green tea extracts and its components, especially EGCG. In 
contrast, only few investigators utilised black tea infusion in studying the 
anticarcinogenesis activity of tea. It has been demonstrated that oral administration of 
black tea extracts decreased nitrosamine-induced carcinogenesis such as N- 
nitrosodiethylamine (NDEA)-induced forestomach and lung tumorigenesis and 4- 
(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone (NNK)-induced lung tumorigenesis, but to 
a lesser extent when compared with green tea extract (Wang et al., 1992; Xu et al., 1992). 
On the other hand, the awareness that caffeine may cause cancer and is a cardiovascular 
risk factor aroused the trends towards "healthy lifestyles" and therefore leads to the 
increasing consumption of decaffeinated beverages including decaffeinated tea. 
Dcaffeinated black tea extracts were less effective than decaffeinated green tea, when 
administered in the post-initiation period, in suppressing tumour formation and 
multiplicity in mice (Wang et al., 1992). However treatment with black tea extracts, 
which contained much lower amount of catechins than green tea, during the carcinogen 
exposure was just as efficient as green tea infusion in inhibiting tumorigenesis (Wang et
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al., 1992). These results indicate that the inhibitory action was not due to caffeine. In 
contrast to this observation, caffeine treatment caused a slight and significant reduction in 
lung tumour multiplicity in mice, possibly because its adverse effect on body weight gain 
(Xu et al., 1992). Thus the present study was conducted to assess whether green, black 
and decaffeinated tea extracts exert any antimutagenic response and to compare the effect 
of the three types of tea extracts on the metabolic activation of selected mutagens, 
encountered in the diet and likely to be consumed simultaneously with tea. The 
mechanisms whereby tea elicits its protective activity were also elucidated.
5.2 MATERIALS
Green tea (Gunpowder brand), black tea (Keemun brand), and decaffeinated tea 
(Ceylon brand) were purchased locally from Wittard Shop, Guildford, Surrey, UK and 
stored at
4 °C in a sealed bag. The 2.5 % tea infusion was prepared by soaking 10 g of the tea 
leaves in freshly boiled distilled water (400 ml ) for 10 minutes and then filtered into a 
pre-warmed thermos flask so that tea extracts can be used hot, as cooling facilitates 
caffeine interaction with polyphenols.
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5.3 METHODS
5.3.1 Pretreatment of Animals
Male Wistar albino rats (150 -180 g) were obtained from the Animal Breeding 
Unit, University of Surrey. The animals were pretreated with a single intraperitoneal 
injection of Aroclor 1254 (500 mg/kg), dissolved in com oil (200 mg/ml), and killed on 
the 5th day following administration in order to induce the hepatic microsomal enzymes, 
the CYPl family. Induction of the CYP2E subfamily was achieved by single daily doses 
of isoniazid (100 mg/kg), dissolved in saline water (0.9 % w/v) administered 
intragastrically for three days, and were sacrificed 24 hours after the last administration.
5.3.2 Enzyme Assays
Preparation of liver fractions were performed as previously illustrated in chapter
2. The microsomal protein contents and total cytochromes P450 levels were determined 
according to the procedures described in chapter 2. The activities of ethoxyresorufin O- 
deethylase (Burke and Mayer, 1974), methoxyresorufin O-dmethylase (Burke et al. 
,1983) and the O-dealkylation of pentoxyresomfin (Lubet et al.,1985) were evaluated as 
previously described in chapter 2. The measurement of NADPH-cytochrome c reductase 
activity was assayed using the method described in chapter 2.
5.3.3 Mutagenicity Studies
The mutagenic activity was determined in the Ames test as illustrated essentially 
by Maron and Ames (1983) using Salmonella typhimurium TA 97, TA 98, TA 100, TA 
102, TA 104 and TA 1530 as the indicator strains. In mutagenesis experiments utilising 
hepatic microsomes, the activation system was supplemented with glucose-6-phosphate 
dehydrogenase (lunit /plate). A slight modification was introduced to the Ames test in 
investigating the possibility of direct interaction of tea components with mutagen-derived 
reactive intermediates. In this case, that the activation system, promutagen and bacteria
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were preincubated for 20 minutes at 37 °C in a shaking waterbath. Promutagen 
metabolism was terminated by the addition of 100 //I menadione (900 pM). A  further 20 
minute preincubation was carried out following the addition of the tea extracts. Top agar 
(2ml), maintained at 45 °C, was then added and the mixture was poured out onto minimal 
agar plates. Following 48 hours incubation at 37 ®C, bacterial revertant colonies were 
counted.
5.4 RESULTS
5.4.1 Mutagenicity of Tea Extracts
Neither of green tea nor black tea aqueous extracts displayed mutagenic response 
in Salmonella typhimurium strains TA 97, TA 98, TA 102 and TA 104. However, there 
was a slight increase in the number of histidine revertant colonies both in the absence and 
presence of an activation system derived from the liver of Aroclor 1254-induced rats, 
when TA 97 was employed as the tester strain (Table 5.1). However, no double number 
of the spontaneous reversion rate was observed. Increasing green tea extract 
concentration, however, did not influence the frequency of produced revertants, whether 
the activation system was added or not in TA 98 strain but a toxic effect was evident in the 
absence of an activation system (Table 5.2). Similar results were also obtained with black 
tea extracts (Table 5.2).
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TABLE 5.1 Mutagenicity of aqueous green tea and black
tea extracts in S.typhimurium TA97
Preincubation Mixture
Mutagenic Response 
(Histidine revertants/plate)
without 89 with 89
Spontaneous reversion rate 125 ± 13 109 ±8
2-Aminoanthracene
(5//g/plate)
- 2211 ±176
9-Aminoacridine
(50//g/plate)
1526 ±200 -
Green Tea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
165 ± 9  
181 ±10 
182±9 
189 ±14
183 ±3  
201 ± 9  
210 ± 2  
230 ± 12
Black T ea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
175 ± 17 
178 ± 17 
223 ±47 
180 ±50
165 ±23 
176±5 
249 ±55 
283 ±36
The test was carried out using Salmonella typhimurium TA 97 strain and 
employing 10% (v/v) hepatic S9 fraction derived from rats pretreated with 
Aroclor 1254 as activation system. Numbers of histidine revertants are 
presented as mean ± SD of triplicates.
In mutagenicity experiments where TA 104 was employed as the indicator strain, 
incorporation of aqueous extract of green tea caused a slight concentration-dependent 
inhibitory effect on the number of histidine revertants in the absence of an activation 
system (Table 5.3). A slight increase was observed, however, in the presence of an 
activation system. On the other hand, black tea extracts showed minimal inhibition in the 
frequency of histidine revertants in TA 104 in the absence of an activation system (Table
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5.3), Supplementation of an activation system did not affect significantly the tea response, 
regardless the type of indicator strains.
TABLE 5.2 Evaluation of the mutagenic potential of aqueous green and 
black tea extracts in S.typhimurium TA98 and TAIOO
Mutagenic Response 
(Histidine revertants/plate)
Preincubation Mixture TA 98 TA 100
without S9 with S9 without S9 with S9
Spontaneous reversion rate 1 4 ± 2 15 ±3 95 ± 2 114±6
2-Aminoanthracene
(5;/g/plate)
- 1132 ±98 - 1094 ±134
2-Nitrofluorene
(2//g/plate)
485 ±49 - — —
MNNG*
(l//g/plate)
- - 296 ± 24 -
Green Tea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
1 7 ± 2
9 ± 4
7 ± 2
5 ± 1
23 ± 2  
25 ±1 
23 ± 2  
23 ±5
94 ± 10  
109 ± 12  
97± 11  
99± 11
9 0 ± 7  
76 ± 16  
73 ± 7  
69 ±11
Black Tea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
17± 5  
8 ± 2  
9 ± 4  
5 ± 3
30 ±12 
2 4 ± 2  
2 0 ± 5  
2 6 ± 8
95 ± 6  
9 2 ± 3  
9 9 ± 5  
68 ± 30
104±7 
95 ± 8  
9 4 ± 6  
78 ±19
Mutagenicity studies were performed using an activation system containing 10 % 
(v/v) hepatic S9 fraction derived from Aroclor 1254-induced rats and utilising 
Salmonella typhimurium TA98 and TAIOO as the indicator strains. Number of 
histidine revertants is presented as mean ± SD for triplicates.
*MNNG: Methyl N'-nitro-nitrosoguanidine
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TABLE 5.3 Mutagenicity of aqueous green and black tea extracts
in S.typhimurium TA102 and TA104
Mutagenic Response 
(Histidine revertants/plate)
Preincubation Mixture TA 102 TA 104
without S9 with S9 without S9 with S9
Spontaneous reversion rate 265 ± 36 343 ±22 375 ±48 475 ± 10
2-Aminoanthracene
(5//g/plate)
- 2021 ± 135 - 1729 ±273
Nitroquinoline N-oxide 
(5//g/plate)
5824 ±333 - 5057 ±735 -
Green Tea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
232 ± 2  
250± 32 
263 ± 15 
284 ±26
440 ±19 
439 ±47 
394 ±13 
368 ±28
280 ±25 
271 ±22 
236 ±28 
226 ±41
649 ± 66 
641 ± 56 
774 ± 4 2  
779 ± 27
Black Tea Extracts
0.25 ml 
0.50 ml 
0.75 ml 
1.00 ml
253 ±24  
253 ± 14 
255 ± 14 
231 ±21
368 ± 12 
364±7 
325 ± 8  
317 ±21
285 ±24 
247 ±35 
266 ±22 
263 ± 18
7 41± 185 
549 ± 12 
501 ± 9 4  
308 ± 57
Mutagenic potency was determined in the absence and presence of a hepatic activation 
system (10 % v/v) derived from Aroclor 1254-induced rats and using Salmonella 
typhimurium TA 102 and TA104 as indicator strains. The results are expressed as mean 
± SD for triplicates.
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5.4.2 Antimutagenic Activity of Aqueous Tea Extracts
Aqueous extract of green tea as well as black and decaffeinated teas exerted 
effective antimutagenic potency against all mutagens studied. The Aroclor 1254-induced 
S9-mediated activation of Glu-P-1 was significantly inhibited by the three types of tea 
extracts in a concentration-dependent fashion. Green tea extracts caused marked decrease 
in mutagenicity even when incorporated at low concentrations (50 //1/plate), whereas all 
tea extracts gave rise to a 100 % inhibition at the higher concentrations (Figure 5.1).
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Figure 5.1 Inhibition of the S9-mediated mutagenicity of the food mutagen Glu-P-1 by green tea (0 ), 
black tea ( ♦  ) and decaffeinated black tea (o) aqueous extracts. The mutagenicity assay was carried out 
using S.typhimurium strain TA98, Glu-P-1 (0.1//g/plate) and 10 % (v/v) hepatic preparations from 
Aroclor 1254-induced rats as activation system. The spontaneous reversion rate of 23±2 has not been 
subtracted. Results are presented as mean±SD of triplicates.
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Both green and black tea extracts together with decaffeinated black tea infusions showed 
protective effects towards benzo(a)pyrene-induced mutagenesis (Figure 5.2). Clearly 
these tea extracts reduced mutagenicity by 50 % at the lowest concentration studied (50 
//1/plate). Consequently the activation of benzo(a)pyrene was completely inhibited at the 
higher concentrations.
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Figure 5.2 Inhibitory effect of green tea (D ), black tea (♦ ) , and decaffeinated black tea (o) aqueous 
extracts on the mutogenicity of benzO(a)pyrene. The study was carried out using S.typhimurium  strain 
TAIOO, benzo(a)pyrene (25 /fg/plate) and 10 % (v/v) hepatic 89 fraction derived from Aroclor 1254-treated 
rats as activation system. The spontaneous reversion rate of 121±17 has not been subtracted. Results are 
expressed as mean±SD of triplicates.
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The mutagenic response of nitrospyrrolidine, a promutagen activated by isoniazid-induced 
hepatic S9 preparations, was significantly suppressed by the three types of tea extracts 
(Figure 5.3). The inhibitory effect was slightly higher with green tea and black tea than 
with decaffeinated tea, even though the latter produced 4-fold decrease in the 
mutagenicity.
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Figure 5.3 Inhibition of the mutagenicity of nitrosopyrrolidine by aqueous extracts of green tea (D  ) ,  
black tea (♦ ), and decaffeinated black tea (o). The mutagenicity study was performed using S.typhimurium  
strain TA 1530, the nitrosamine (4 mg/plate) and 25 % (v/v) hepatic 89 fraction from isoniazid-treated rats 
as activation system in the Ames test. The spontaneous reversion rate of 16±5 has not been subtracted. 
Results are presented as mean±SD of triplicates.
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Similarly the metabolic activation of the aromatic amine 2-aminoanthracene was also 
inhibited in the presence of tea extracts, especially with the extract of black tea (Figure
5.4). However, the inhibition efficiency at low tea extract concentration was not as 
marked as that described with the food mutagens (Figures 5.1- 5.3).
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Figure 5.4 Inhibitory effect o f aqueous extracts of green tea (D ), black tea (♦ ) , and decaffeinated black 
tea (o) on the metabolic activation of 2-aminoanthracene. Mutagenesis studies were carried out using 
S.typhimurium  strmn TAIOO, the aromatic amine (5 pg  / plate) and activation system containing 10 % 
hepatic 89 fraction derived from Aroclor 1254-induced rats. The spontaneous reversion rate o f 129±13 has 
not been subtracted. Results are presented as mean±SD of triplicates.
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The decrease in 9-aminoacridine-induced mutagenicity by the addition of black tea and 
decaffeinated tea was slightly greater than that observed with green tea although all the 
three tea infusions produced almost 100 % inhibition at the highest concentrations (Figure
5.5).
1500
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1200100060 0 8 0 0200 4 0 00
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F igure 5.5 Inhibition of the mutagenicity of direct-acting carcinogen 9-aminoacridine by green tea (D  ) ,  
black tea (♦ ) , and decaffeinated black tea (o) aqueous extracts. The study was carried out using 
S.typhimurium  strain TA97 and 9-aminoacridine (50 / plate). The spontaneous reversion rate of
161±9 has not been subtracted. Results are presented as mean±SD of triplicates.
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5.4.3 Inhibition of Cytochrome P450 Enzyme Activities by Tea Extracts
Figure 5.6 shows the effects of the three different tea extracts on the NADPH- 
dependent reduction of cytochrome c. AJI three types of tea extracts gave rise to a marked 
decrease in the NADPH cytochrome reductase activity. Similarly, all three tea infusions 
inhibited the O-dealkylations of ethoxyresorufin and methoxyresorufin, mediated by 
Aroclor 1254-induced rat hepatic microsomes (Figure 5.7). Both ethoxyresorufin O- 
deethylase and methoxyresorufin O-demethylase activities were decreased in a very 
similar pattern by tea extracts where black tea infusion was consistently the most and the 
decaffeinated tea the least effective enzyme inhibitors. To a lesser extent, the O- 
depentylation of pentoxyresorufin was also reduced by the three different tea types 
although this was not statistically significant (Figure 5.7).
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Figure 5.6 Inhibitory effect of 2.5 % (w/v) aqueous tea extracts on the activity of cytochrome c 
reductase. Tea extracts (50 pi\) were incubated with isolated microsomes from Aroclor 1254-treated rats and 
cytochrome c (0.1 mM). Results are presented as mean±SEM for three animals.
♦♦♦Statistically different from control, P < 0.001
GTE = Green tea extracts
BTE = Black tea extracts
DTE = Decaffeinated black tea extracts
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Figure 5.7 Inhibitory effect of 2.5 % (w/v) aqueous tea extracts on hepatic monooxygenase activities. 
Tea extracts ( 50 /<L) were incubated with isolated microsomes from Aroclor 1254-induced rats and 
ethoxyresorufin (0.53 mM), methoxyresorufin (ImM) or pentoxyresorufin (1 mM). Results are presented 
as mean ±  SEM for 3 animals.
GTE = Green tea extracts
BTE = Black tea extracts
DTE = Decaffeinated black tea extracts
*P < 0.05, **P <  0.01, ***P < 0.001
5.4.4 Direct Interaction of Tea extracts with the Reactive
Intermediates of Carcinogens
Incorporation of the aqueous tea extracts in mutagenesis test system, following 
termination of the microsomal activation of the promutagens by menadione, resulted in a 
moderate concentration-dependent inhibition in the carcinogen-mediated mutagenicity. It 
is important to point out that the microsomal activation of the test promutagens to their 
active metabolites was markedly inhibited or completely abolished by menadione. In all 
cases, the mutagenic response was markedly suppressed at the highest concentration of 
green tea extracts (Table 5.4). Black tea and decaffeinated tea extracts, at low 
concentrations, were more effective inhibitors of the mutagenicity of benzo(a)pyrene 
compared with the green tea (Table 5.5 & 5.6). Effective decrease in mutagenicity was 
clearly evident, at the highest concentration level of both black tea infusion or 
decaffeinated black tea extract, in the case of Glu-P-1 and nitrosopyrrolidine.
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5.5 DISCUSSION
Many studies from several laboratories around the world demonstrated that 
different varieties of tea and its constituents can afford protection against a diversity of 
chemical carcinogens in various experimental animal models (Conney et al., 1992; 
Katiyar et al., 1993). Consistent with this fact, most of these studies have provided 
substantial evidence of antimutagenic properties for green tea extracts and its major 
components (Wang et al., 1989; Katiyar et al., 1993). However, there was relatively less 
effort devoted to the study of black tea as a possible anticarcinogen although its inhibitory 
action on some carcinogen-induced tumorigenesis has been reported (Wang et al., 1992). 
An initial study was undertaken to establish whether tea extracts themselves exhibited 
mutagenicity in the Ames test Certainly this possibility can be ruled out since none of the 
tea infusions showed mutagenicity in the present study either with or without S9 
activation system in several Salmonella typhimurium strains detecting base-pair and 
frameshift mutagens.
Studies undertaken to evaluate antimutagenic potential have shown that both green 
and black tea infusions were similarly functioned as potent inhibitors of mutagenesis 
induced by different classes of chemical carcinogens. Black tea has been reported to be as 
effective as green tea in inhibiting tumorigenesis when administered to mice during the 
carcinogen treatment period, despite the catechin content being much lower than that of 
green tea (Wang et al., 1992). It may be inferred from these studies that catechins do not 
play a major role in the antimutagenic potential of tea. As the number of health-conscious 
people has increased over recent years, there has been a growing trend towards the 
consumption of caffeine-free beverages. Thus, it was interesting to investigate the effects 
of decaffeinated tea on mutagenesis. Indeed, decaffeinated tea extracts produced effective 
inhibition in the metabolism of all carcinogens used with a similar profile to that of green 
tea. In agreement with previous studies (Wang et al., 1992; Xu et al., 1992), the potential 
protective effect of tea extracts was not correlated with caffeine, although it is considered 
as a major tea component, and has been shown to inhibit chemical mutagenesis (Alldrick
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and Rowland, 1988). It may be also inferred that caffeine, at least partly, plays a small 
role but does not considerably influence the antimutagenicity action of tea extracts. 
Caffeine being an excellent substrate of CYP1A2 (Tassaneeyakul et al., 1994; Ayalogu et 
al., 1995), would be expected to act particularly on carcinogens whose activation is 
mediated by this isoform.
While the metabolic activation of many environmental chemical carcinogens is 
initially catalysed by the cytochrome P450-dependent monooxygenase system (loannides 
et al., 1992), the CYPIA subfamily of proteins, namely A1 and A2, are by far the most 
enzyme system associated with the activation of planar carcinogens such as polycyclic 
aromatic hydrocarbons, heterocyclic and aromatic amines and other genotoxins (loannides 
and Parke, 1990; Overvik and Gustaffson, 1990). Inhibition of mutagenicity by tea 
extracts in vitro in the Ames test suggest that tea components may cause direct 
suppression of these enzymes. Competitive inhibition of P-450-mediated activation of 
carcinogens is a feasible mechanism that may be responsible for the antimutagenic 
activity of tea. So, the ability of tea infusions to modulate CYPl isoenzymes was 
investigated. In vitro administration of the three different tea extracts decreased 
significantly ethoxyresorufin-O-deethylase activity, a specific activity probe for CYPIA 1 
(Phillipson et al., 1984) which involved in the activation of benzo(a)pyrene and 2- 
aminoanthracene respectively. Among the tea extracts, black tea was extremely potent in 
inhibiting EROD activity. Tea extracts also produced a similar decrease in the O- 
demethyladon of methoxyresorufin, a reaction specifically catalysed by CYP1A2 
(Namkung et al., 1988; Yamazoe et al., 1984). Accordingly these results demonstrate the 
effectiveness of tea constituents in suppressing the catalytic activity of CYPl enzymes and 
could be therefore one of the responsible mechanisms for their antimutagenic potency.
However the activation of the promutagen nitrosopyrrolidine to its reactive 
intermediates is catalysed by specific isoenzymes of the cytochrome P-450 superfamily, 
namely CYP2E and CYP2B respectively (Yang et al., 1985; Ayrton et al., 1987; McCoy
1 4 0
et al., 1979). It is conceivable that the low activity of these two enzymes is associated 
with reduced nitrosopyrrolidine mutagenicity. Thus aqueous extracts of various teas 
showed a modest inhibitory effect on the CYP2B-mediated O-dealkylation of 
pentoxyresorufin. Interestingly, black tea infusion appears also to possess higher 
suppressive effect on CYP2B activity. It was not possible to investigate the effect of the 
three tea extracts on CYP2E activity because of tea polyphenols interference with the 
assay substrates studied (p-nitrophenol, aniline and dimethylnitrosamine). It may be 
concluded from these studies that caffeine has no major contribution in the antimutagenic 
effect of tea through inhibition of mutagen bioactivation.
The decreased cytochrome P-450 activities caused by the three tea extracts is 
probably associated with the low activity of NADPH-cytochrome c reductase. This 
possibility is supported by the fact that catechins, constitutive tea components, inhibited 
the NADPH-dependent reduction of cytochrome P450 (Steele et al., 1985). As reported 
here, in vitro administration of all three tea extracts resulted in a marked inhibition in the 
enzyme activity, demonstrating that tea constituents, presumably catechins, act as electron 
acceptors and adversely affect the electron transfer. Thus the inhibitory action of tea 
extracts on the cytochrome P-450 activity may be, at least partly attributed to their 
interference with the electron flow to cytochrome P-450, resulting in a decrease in 
oxidative function. It can be also suggested that the exhibited inhibitory effects of tea 
extracts against the various promutagens metabolic activation is not the only mechanism 
mediated in their protective action.
It is also conceivable that direct interaction of the genotoxic reactive forms of 
mutagens with tea constituents might be a possible alternative mechanism responsible for 
their antimutagenic activity. This hypothesis has been implicated to explain the inhibitory 
potential of the plant polyphenol ellagic acid and other flavonoids against benzo(a)pyrene- 
diol-epoxide-induced mutagenicity (Sayer et al., 1982; Huang et al., 1983). Aqueous 
extracts of green, black and decaffeinated tea, as expected, decreased the mutagenicity of
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various mutagens such as Glu-P-1, benzo(a)pyrene and nitrosopyrrolidine, when 
incorporated after metaboism termination. Obviously, the observed inhibition was due to 
the direct interaction between tea components and the reactive metabolite(s) of these 
carcinogens. These electrophiles are subsequently prevented from interacting with the 
nucleophilic sites on the DNA macromolecule. Moreover, the effectiveness of tea 
constituents as potent nucleophiles is documented by the fact that all three tea extracts 
suppressed the mutagenic response of the direct-acting mutagen 9-aminoacridine. As the 
three tea infusions have all been shown to effect their antimutagenic potential in a similar 
way and to the same extent, the different types of tea may act through the same 
mechanisms.
5.6 CONCLUSION
The results of the present study indicate that aqueous extracts of black tea and 
decaffeinated black tea as well as green tea showed no mutagenic activity in the Ames 
Salmonella test. The experimental results also demonstrate the effectiveness of black tea 
and decaffeinated tea as potent inhibitors of the in vitro mutagenicity of various 
promutagens including dietary related carcinogens. Further, these observations suggested 
that the antimutagenic properties may be due to at least with two mechanisms, inhibition 
of the cytochrome P-450-dependent metabolism of carcinogens and / or direct interaction 
of the generated reactive metabolites of mutagens with tea constituents. Additional 
studies, however, are required to isolate and characterise further biological active 
compounds from tease as antimutagenic agents, because of the increasing interest in tea 
polyphenols and their proposed use in therapeutic preparations. It would be also advisable 
to evaluate the antimutagenic activity of tea extracts in vivo to ensure that the in vitro 
mechanisms are operative. On the basis of the findings reported here, black tea and 
decaffeinated black tea should also prove to be effective anticarcinogens.
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CHAPTER 6
ANTIMUTAGENIC POTENTIAL
OF
GREEN TEA FRACTIONS
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6.1 INTRODUCTION
Tea is one of the commonly consumed beverages that contain a large number of 
polyphenolic compounds (Balentine, 1992). Green tea leaves contain various phenolic 
catechins including the flavanols (-)-epigallocatechin gallate (EGCG), (-)-epicatechin 
gallate (EGG), (-)-epigallocatechin (EGG) and (-)-epicatechin (EC). These catechin 
derivatives represent up to 30 % of the dry leaf weight (Graham, 1992). It has been 
recently reported that two of the main green tea polyphenols, EGCG and EGC displayed 
the strongest protection against lipid peroxidation among tea catechins, and they were 
more effective than the standard antioxidants a-tocopherol and propyl gallate (Osawa, 
1992). Another study indicated that these catechins not only diminished the free radical 
chain reaction of cell membrane lipids, but also inhibited mutagenicity and DNA 
damaging activity (Osawa, 1992). Consequently, these polyphenols were found to 
suppress DNA single-strand cleavage induced by N-hydroxy-2-aminonaphthaIene 
(Osawa, 1992). Furthermore, it was reported further that catechin gallates clearly 
inhibited the mutagenicity of N-hydroxy-2-aminonaphthalene in the Salmonella 
typhimurium strain TA 104. EGCG also exhibited marked antimutagenic activity against 
the carcinogenic food mutagens Trp-1, Trp-2 and benzo(a)pyrene-diol epoxide (Okuda et 
al., 1984). Finally, EGCG effectively decreased mutagenicity of benzo(a)pyrene and 
aflatoxin Bi in several bacterial species (Kada, 1985; Wang et al., 1989) and more 
recently decreased the mutagenicity of two typical carcinogenic heterocyclic amines IQ 
and PhIP (Weisburger, 1994).
Several experimental studies have demonstrated the suppressive effects of green 
tea components on carcinogenesis in various animal models. Green tea polyphenol 
fractions, particularly EGCG, have been shown to be protective against skin tumour 
induction by polycyclic aromatic hydrocarbons in mice (Wang et al., 1989). Many studies 
have recently indicated the inhibitory effect of EGCG on tumorigenesis induced by 
teleocidine and 7,12-dimethylbenz(a)anthracene in mouse skin (Laskin et al., 1992). As 
reviewed by Chung et al.(1992), oral administration of EGCG also remarkably inhibited
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the duodenal cancer induced by N-ethyl-N-nitro-N-nitrosoguanidine in rats. In a further 
study, EGCG inhibited the binding of topically applied polycyclic aromatic hydrocarbons 
such as benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to epidermal DNA in mouse 
skin (Katiyar et al., 1992). Moreover, EGCG displayed a protective effect against 4- 
(methylnitrosamino)-l-(3-pyridyl)-l-butanone(NNK)-induced lung tumourigenesis in 
mice (Chung et al., 1992).
It is now widely recognised that green tea polyphenols could exert their preventive 
activities through different mechanisms of actions. Inhibitory effects of tea polyphenols 
against chemically-induced mutagenesis and/ or carcinogenesis might be related to their 
ability to modify the metabolic pathways of mutagens, presumably by inhibiting the 
enzymes involved in the bioactivation of promutagens and / or enhancing the detoxication 
pathways. It has been revealed that tea catechins decrease hepatic cytochrome P-450 and 
NADPH-cytochrome c reductase activities (Wang et al., 1987). This inhibition may be 
related to the interaction of green tea catechins with the active site of cytochromes P-450 
(Wang et al., 1989), and subsequently reduce its catalytic activity in a concentration 
responsive-manner, as previously demonstrated in chapter 4. In addition, catechin 
derivatives of green tea inactivate the ultimate carcinogens, of which benzo(a)pyrene-diol 
epoxide is one of these carcinogenic electrophiles, and this mechanism may be attributable 
to their protection against a wide array of mutagens and/or carcinogens (Wang et al., 
1989). In view of the proposed marked suppressive effects of green tea polyphenols 
against carcinogenesis, it would be of great importance to fractionate the aqueous extracts 
of green tea in order to identify and characterise further protective components other than 
EGCG. The present study has been carried out to evaluate the inhibitoiy action of tea 
fractions on the bioactivation of selected food mutagens and direct-acting mutagens, and 
to elucidate the possible mechanisms underlying their antimutagenicity.
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6.2 MATERIALS
Ethyl hexanoate and propyl acetate were purchased from Sigma Chemical 
Company, Poole, Dorset, U.K. All other chemicals, cofactors, as well as Salmonella 
typhimurium strains TA 1530, TA 97, TA 98, TA 100 were obtained as previously cited 
in chapter 2.
Green tea (Gunpowder brand) was purchased locally from a specialist tea 
merchant (Wittard Shop, Guildford, Surrey, U.K.). Green tea leaves (10 g) were 
infused in a thermos flask with 400 ml of freshly boiled distilled water. The flask was 
then inverted every 30 seconds for 10 minutes, followed by filtration to obtain a 2.5 % tea 
infusion. Following cooling to approximately 60°C, decaffeination was achieved by 
extracting the tea liquor three times with equal volumes of chloroform (300 ml ). 
Fractionation of the decaffeinated green tea infusion was performed as illustrated in 
Figure 6.1. All isolated fractions were stored at -20°C until required.
6.3 METHODS
6.3.1 Animals Pretreatment
Male Wistar albino rats (150-180 g) were obtained from the Experimental Biology 
Unit, University of Surrey. Induction of CYPl family was achieved by a single 
intraperitoneal injection of Aroclor 1254 (500 mg/kg). The animals were killed on the 5th 
day following administration. In the case of CYP2E subfamily induction, the animals 
were treated with a single daily intragastric doses of isoniazid (100 mg/kg) for three days. 
The isoniazid-induced rats were sacrificed 24 hours after the last administration.
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Green Tea Aqeous Extracts 
(for HPLC see Fig. 6.2)
Extraction with chloroform  (3 x 300 mis)
Decaffeinated Green Tea Extract (100 mis)
(for HPLC see Fig. 6.3)I
Extraction with ethyl hexanoate (4 x 50 mis)
Aqueous Phase 
Fraction A 
(for HPLC see Fig. 6.4)
Solvent Phase
Dried in a rotary evaporator and the 
residue was resuspended in a few ml 
of water |
Extraction with propyl acetate ( 4 x 4 0  mis) Extraction with propyl acetate ( 4 x 4 0  mis)
Aqueous Phase 
(HPLC not shown) Solvent Phase
Aqueous Phase 
Fraction B Solvent Phase
(for HPLC see Fig. 6.5)
Dried in a rotary vacuum evaporator 
and the residue was resuspended in a 
few mis of water
Fraction C 
(for HPLC see Fig. 6.6)
Dried in a rotary vacuum evaporator 
and the residue was resuspended in a 
few mis of water
Fraction D 
(for HPLC see Fig. 6.7)
Figure 6.1 Fractionation of green tea.
147
6.3.2 Total Solids Determination and HPLC Analysis
Total solids (non volatile constituents) were determined by freeze-drying a portion 
(1ml ) of the whole green tea extracts or the different isolated fractions. The actual amount 
of the total solids was calculated using the weight-difference method. Chromatographic 
analysis were performed using a Spectra Physics P4000 liquid chromatograph equipped 
with Hichrom Hypersil 3//m ODS-3040 HPLC column (10 x 0.46 cm, i.d.) connected to 
a Spectra Physics P4000 gradient pump, and coupled to a Spectra Physics AS3000 
autosampler. Aliquots of the sample (50 pi) were injected into the analytical column, 
after which elution was carried out employing a mobile phase containing 0.5 % acetic acid 
(A) and 0.5 % acetic acid in 30 % acetonitrile (B). Gradients of 100 % solvent A to 100 
% solvent B over a convex gradient for 25 minutes were used at a flow rate of 1 ml / min, 
and the effluent was monitored at 280 nm using Spectra Physics forward Optical 
Scanning UV detector. Processing of the collected data was performed on IBM PS/2 
computer utilising Spectra Focus software.
6.3.3 Evaluation of Mlutagen&city
Mutagenic potential was assessed using the Ames test (Maron and Ames, 1983) 
described in detail in chapter 2. Various S.typhimurium strains including TA 1530, TA 
97, TA 98, and TAIOO were employed in the presence of either Aroclor 1254- or 
isoniazid-induced hepatic S9 fraction as activation systems. In the studies where isolated 
microsomes were used, the activation system was supplemented with glucose-6- 
phosphate dehydrogenase (1 unit / plate). In order to investigate the possible direct 
interaction between green tea or its fractions and the electrophilic metabolites of the 
promutagens, a mixture of the bacteria, promutagen and the activation system were 
preincubated for 20 minutes at 31°C in a shaking waterbath (1st preincubation). After 
that, the carcinogen metabolism was terminated by the addition of (100 p\) menadione 
(900 pM) and either green tea extracts or its fractions were added to the activation 
system. Following a further 20 minutes preincubation (2nd preincubation), top agar was 
added (2 ml) to the mixture and the entire liquid was immediately poured onto minimal
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agar plates. Histidine-revertant colonies were counted after a 48-hours incubation at 37°C
6.3.4 Enzyme Assays
The various hepatic fractions were prepared as previously described in chapter 2, 
except that the cytosolic fraction which was recentrifuged at 105,000 x g for Ih to 
eliminate any microsomal contamination. Total cytochrome P-450 and protein contents 
were determined as described earlier in chapter 2 similarly. The activity of NADPH- 
cytochrome c reductase (William and Kamin, 1962) and the O-dealkylations of 
ethoxyresorufin (Burke and Mayer, 1974), pentoxyresorufin (Lubet et a!., 1985), and 
methoxyresorufin (Burke et al., 1985) were determined as illustrated previously in 
chapter 2.
6.4 RESULTS
6.4.1 Composition and Characterisation of Green Tea Fractions
The amount of total solids present in the 2.5 % aqueous green tea extract was 
found to be 7.43 mg/ml, where 39.8 % of the extract dry matter are tea polyphenols 
(Table 6.1). The highest portion of this polyphenolic content was, however, present in 
fraction C and represented about 21% of the dry weight of tea infusion (Table 6.1). 
HPLC analysis showed that aqueous extracts of green tea, prepared at a drinking strength 
similar to that consumed by humans, contains gallic acid (GA), caffeine, (-)-epicatechin 
(EC), EGC, EGCG, as well as ECG and, that among these epicatechin derivatives, 
EGCG was the major tea component (Figure 6.2). Identification of these materials was 
achieved by comparing the HPLC chromatogram obtained from green tea liquor analysis 
with that of the authentic compounds (results not shown). The decaffeinated green tea 
infusion contained the same chemical constituents present in the original tea extract, 
except for caffeine (Figure 6.3).
TABLE 6.1 The relative total solids content of aqueous green tea 
(2.5 % w/v) and its polyphenolic fractions
Tea Constituent Total Solids 
(mg / ml)
% of Total Solids
Green tea extract 7.43 ±0.02 100
Fraction A 2.96 ± 0.01 39.8
Fraction B 1.09 ± 0.02 14.7
Fraction C 1.56 ±0.03 21
Fraction D 1.26 ± 0.01 17
Results are presented as mean ± SD of triplicates, where the total solids percentage was measured 
in comparison to dry weight of whole tea extract solids.
As indicated in Figure 6.4, fraction A ( ethyl hexanoate aqueous extract ) is 
composed of gallic acid and tea catechins including EC, EGC, EGCG, and ECG in 
addition to the, most likely, condensed tannins peaks I and II (Clifford, 1993). 
Chromatography analysis also indicated that the most abundant compounds detected in 
fraction B (ethyl hexanoate and propyl acetate aqueous extract) were gallic acid, EGC, 
ECG and possibly flavonol glycosides (peaks I and II) as shown in Figure 6.5. EGCG 
was the most abundant tea component detected in the propyl acetate extract of ethyl 
hexanoate aqueous layer (Fraction C). This fraction also contains EC and EGC as minor 
constituents (Figure 6.6). Finally, fraction D contains a high amounts of EGCG and ECG 
as well as a very small amounts of EC and, most likely, condensed tannins (peaks I and 
II) as demonstrated in Figure 6.7.
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6.4.2 Inhibition of Chemical Mutagenicity by Green Tea Polyphenolic
Fractions
As expected, aqueous green tea infusion and its polyphenolic fractions inhibited 
the mutagenicity action of all mutagens employed in the present study, though the degree 
of inhibition varied between individual fractions (Table 6.2). The results showed that the 
mutagenic activity of Glu-P-1 was significantly decreased by all tea fractions; whole tea 
extract and fraction A were the least effective . In addition to the whole tea extract, green 
tea polyphenol fractions also caused effective inhibition in the metabolic activation of 
benzo(a)pyrene. The mutagenic response of benzo(a)pyrene was markedly suppressed 
by fraction C. The mutagenicity of nitrosopyrrolidine was considerably reduced by tea 
liquor or fraction A, but to a lesser extent when compared to other fractions. However, 
there was no significant difference between the inhibitory actions of aqueous green tea 
extracts and that of fraction A against the 2-aminoanthracene mutagenesis. Of the various 
fractions isolated, fraction B showed the lowest antimutagenic effects towards 
benz(a)pyrene, 2-aminoanthracene and nitrosopyrrolidine. The results also demonstrated 
that tea extracts and all fractions antagonised the mutagenicity of the direct-acting mutagen 
9-aminoacridine, fractions C and D being the most effective.
6.4.3 Inhibition of Hepatic Microsomal Enzyme Activities by Green
Tea Polyphenolic Fractions
Incorporation of aqueous extract of green tea and its polyphenol fractions resulted 
in a significant inhibition in the NADPH-cytochrome c reductase activity (Figure 6.8). 
Consequently, all fractions isolated from green tea extracts significantly suppressed the O- 
deethyladon of ethoxyresorufin, fraction A being by far the most potent next to green tea 
infusion (Figure 6.9). A similar pronounced inhibition was also obtained in the O- 
demethylation of methoxyresorufin, where the inhibitory effect was almost comparable 
between fractions B, C, and D (Figure 6.10). Both green tea liquor and fraction A were 
markedly more efficient than other fractions in reducing the activity of pentoxyresorufin 
O-depentylase (Figure 6.11).
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Figure 6.8 Inhibitory effect of various green tea extract fractions on the activity 
of NADPH-cytochrome c reductase. The enzyme activity was determined using 
Aroclor 1254-induced rats microsomal suspension (25 % w/v) and cytochrome c 
(0.1 mM) in the presence of 50 pil o f each 2,5 % aqueous green tea infusion (GTE) 
and green tea fractions (A—D) and in the absence of added tea (control). Results are 
presented as the mean ± SEM of triplicates. * P <  0,01, ** P <  0.001
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Figure 6.9 Inhibition of hepatic mixed-function oxidase activity (ethoxyresorufin O- 
deethylase) by aqueous green tea extract fractions. The reaction mixture contained 25 % 
(w/v) microsomal suspension derived from Aroclor 1254-induced rats and ethosyresorufm 
(0.53 mM) were preincubated without tea extract (control) and with 50 of either 2.5 % 
green tea infusion (GTE) or isolated green tea fractions (A-D). Results are presented as 
mean ± SEM of triplicates.
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Figure 6.10 Inhibitory effect of aqueous green tea extract fractions on the activity of 
methoxyresorufin 0-demethylase. The assay was carried out in the presence of 50 }i\ of 
green tea liquor (2.5 % w/v) and isolated green tea fractions (A-D) or in the absence of 
added tea extract (control) employing microsomal suspension (25 % w/v) pretreated with 
Aroclor 1254-induced rats and ethoxyresorufin (1 mM). Results are presented as mean ± 
SEM of triplicates. *P< 0.001, **P< 0.0001
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Figure 6.11 Inhibitory effect of aqueous green tea extract fractions on the activity of  
pentoxyresorufin O-depentylase. The test was performed using hepatic Aroclor 1254- 
induced microsomes and pentoxyresorufin (1 inM) in the presence of 50 fi\ o f green tea 
extract (GTE) and isolated green tea fractions (A-D) or in the absence of added tea extract 
(control). Results are presented as mean ± SEM of triplicates. * P< 0.05
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6.4.4 Direct Interaction of Green Tea Polyphenol Fractions with Reactive 
Intermediates of Fromutagens
Incorporation of tea polyphenol extracts into mutagenicity assay mixture, 
following metabolism termination by the addition of menadione, caused a marked 
decrease in the metabolism-mediated mutagenic response of promutagens. An almost 
complete suppression in the activation of promutagens to their highly reactive metabolite 
was evident when menadione was added during the first incubation (results not shown). 
Fraction A caused a very marked inhibition in the mutagenic response of 
nitrosopyrrolidine (Table 6.3). Fraction B, however, exerted only a moderate suppressive 
effect on the mutagenicity of Glu-P-1, benzo(a)pyrene and nitrosopyrrolidine (Table 6.3). 
In contrast, fraction C showed the highest inhibitory action against the mutagenesis 
induced by Glu-P-1 and benzo(a)pyrene (Table 6.3). Fraction D also decreased the 
mutagenicity of the above mutagens, although the degree of inhibition tended to be lower 
than that observed with fraction C. The mutagenicity of the aromatic amine 2- 
aminoanthracene was also inhibited by all green tea phenolic fractions and the tea infusion 
(Table 6.4). A similar, but less pronounced, inhibition in the mutagenicity action of 2- 
aminoanthracene was obtained when activated by Aroclor 1254-induced cytosol than 
isolated microsomes served as the activation system. The mutagenic potential of the 2- 
aminoanthracene was effectively inhibited by fraction C in both activation systems (Table 
6.4).
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6.5 DISCUSSION
It has become clear that tea is a source of valuable components, mainly 
polyphenols, acting as potential antimutagenic agents (Wang et al., 1989). The present 
study confirms that aqueous extracts of green tea leaves were rich in flavanols commonly 
recognised as epicatechin derivatives, specifically EGCG. This is in agreement with 
earlier findings (Mukhtar et al., 1992) which revealed that EGCG is usually by far the 
most prevalent flavanol component.
Several studies have suggested that the antimutagenic activity of green tea extracts 
was primarily due to epicatechin derivatives ( Kada, 1985; Wang et al., 1989). 
Accordingly, it was desirable to investigate the possible antimutagenic actions of various 
tea polyphenols extracts, so that the active compounds responsible for the inhibitory effect 
other than EGCG can be identified. As reported in the present study, green tea liquor or 
the various tea extract fractions markedly decreased the in vitro S9-mediated mutagenicity 
of Glu-P-1, benzo(a)pyrene, nitrosopyrrolidine, showing different degrees of inhibition. 
This variation in the inhibitory effect may be related to either the amounts of total solids or 
the difference in the antimutagenic potency of polyphenol compounds that dominate each 
fraction. In agreement to previous studies (Lunder, 1992), the most abundant flavanol in 
tea was EGCG, with EGC, EC and ECG being present in much lower amounts. Of the 
four tea fractions prepared, fraction A and C were the richest in flavanol content 
However, in contrast, fraction B had the lowest content of epicatechins, but was rich in 
theogallic acid. Indeed, fraction C (EGCG-rich fraction) and fraction D exerted the 
highest inhibitory actions on the mutagenicity of Glu-P-1 and benzo(a)pyrene, although 
the total solids concentration was less than that of fraction A. It appears likely that the 
antimutagenic effects of fraction C was due to the EGCG component rather than the total 
solids amount. With this respect, EGCG demonstrated a powerful inhibiting action 
towards the mutagenicity of two typical carcinogenic heterocyclic amines IQ and PhIP 
(Weisberger, 1994). Since fractions A and C contained similar amounts of EGCG clearly
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(its flavanol cannot be the principal tea component antagonising the mutagenicity of 
benzo(a)pyrene and Glu-P-1, and inspection of the HPLC chromatograms of fraction C 
and D clearly shows that no other flavanol is common to these fractions. Furthermore, all 
fractions suppressed the mutagenicity of 2-aminoanthracene to the same extent from 
which it may be inferred that none of the flavanols determined or gallic acid and theogallic 
acid are responsible for the antimutagenic effect of green tea. Fraction B, despite having 
the lowest content of flavanols, was the most effective antimutagen against 
nitrosopyrrolidine. Moreover, all tea polyphenol fractions isolated from green tea extracts 
inhibited the direct mutagenic activity of 9-aminoacridine indicating that they also contain 
nucleophiles that can neutralise 9-aminoacridine. However fraction D showed slightly 
higher inhibitory effect on 9-aminoacridine mutagenicity but the difference was marginal. 
Previous results revealed that EGCG possessed a suppressive effect on the direct-acting 
mutagenicity of the activated forms of food-derived carcinogens N-OH-Glu-P-1 and N- 
OH-Trp-P-2 (Hayatsu et al., 1992). It is likely that the strong antimutagenic activity of 
green tea is due particularly to its high EGCG content. Overall, these studies may 
suggest that the flavanols are not the major antimutagenic components present in green 
tea.
It is widely accepted that the mutagenic effect of different environmental chemicals 
is associated with their metabolic activation initiated by cytochrome P-450 enzymes, 
among which one of the most important is the cytochrome P-4501 family (loannides and 
Parke, 1993). It is important to point out that CYPl family is the principal catalyst of the 
activation of polycyclic aromatic hydrocarbons, aromatic and heterocyclic amines 
(loannides and Parke, 1990; Overvik and Gustaffson, 1990). The major cytochrome 
P4501 isoforms catalysing the bioactivation of benzo(a)pyrene and Glu-P-1 are 
CYPlAl and CYP1A2 respectively (Yamazo et al., 1984; Battula et al., 1987). While the 
biactivation of 2-aminoanthracene is more complex as it involves, in addition to the 
CYPIA subfamily (Norman et al., 1979), cytosolic enzymes system(s) (Ayrton et al., 
1992; Marczylo and loannides 1994). It is likely, therefore, that the observed inhibitory
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actions of green tea extract as well as tea epicatechin derivatives on chemical mutagenesis 
may resulted from their ability to diminish the cytochrome P-450-dependent 
monooxygenases catalysing the metabolic activation of the employed promutagens. Such 
mechanism appears to be consistent with the present study which showed that, when 
added into the incubation system in vitro, phenolic fractions A, B, C and D extracted from 
green tea infusion inhibited the dealkylations of both ethoxyresorufin and 
methoxyresorufin, two reactions catalysed selectively by the cytochrome P4501A1 and 
A2 proteins respectively (Phillipson et al., 1984; Namkung et al., 1988). Next to tea 
infusion, fraction A displayed a very marked inhibition towards these activities when 
compared to other fractions. The activity of ethoxyresorufin O-deethylase was also 
effectively inhibited by fraction C and, to a lesser extent, by fractions B and D 
demonstrating that EGCG is the most likely tea component inhibiting CYPIA 1 
isoenzyme. However, in contrast, fractions B, C and D decreased to similar extent the 
methoxyresorufin O-demethylation. Since the antimuategenic effects of green tea extracts 
and fraction A towards Glu-P-1 are the same, caffeine is unlikely to contribute extensively 
to the antimutagenic potential of green tea by virtue of being a CYP1A2 substrate 
(Tassaneeyakul et al., 1994; Ayalogu et al., 1995). Another aspect for the variation in the 
inhibitoiy action of green tea fractions is that flavanols play no major role in inhibiting the 
cytochrome P450 isoforms involved in the carcinogens bioactivation, thus explaining the 
lack of correlation between antimutagenic potential of the tea fractions and flavanol 
content.
On the other hand, the major catalysts of the bioactivation of nitrosamines are 
CYP2E1, activating preferentially small-sized molecules, and CYP2B more active in the 
bioactivation of larger molecules (Yang et al., 1985; Kokkinakis et al., 1985; Flammang 
et al., 1993; Bellec et al., 1996). For this reason it was considered essential to investigate 
the effects of each individual tea fractions on the catalytic activities of these two 
cytochrome P-450 (CYP) isoforms. In this respect, the selective dealkylation of 
pentoxyresorufin was used as a marker activity for CYP2B enzyme . Fraction A showed
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a significant inhibitory action and is almost as potent as aqueous green tea liquor in 
suppressing pentoxyresorufin dealkylation. However, no marked inhibition was evident 
in the CYP2B-mediated O-dealkylation of pentoxyresorufin when fractions B, C and D 
were incorporated into the incubation mixture. It may be concluded that CYP2B activity is 
not inhibited by EGCG, gallic acid and ECG are not responsible for the inhibition seen by 
the green tea infusion. However, inhibition studies on CYP2E1 activity could not be 
performed because of the interference of tea components with the spectrophotometric 
assays of the selective substrates p-nitrophenol, aniline and dimethylnitrosamine and, 
therefore, it was not possible to evaluate the suppressive potential of green tea isolated 
fractions on CYP2E activity.
It is conceivable that inhibition of cytochrome P-450-dependent monooxygenase 
activities may be due to modulation of NADPH-cytochrome c reductase activity, which in 
turn could adversely affect the electron flow from NADPH to cytochrome P-450. Such an 
assumption is supported by the fact that green tea aqueous extracts as well as tea 
polyphenols fractions inhibited markedly the NADPH-dependent cytochrome c reductase 
activity. However, fraction C (EGCG-rich fraction) was the most potent inhibitor of 
NADPH-cytochrome c reductase showing that the effectiveness of green tea infusion in 
suppressing this enzyme may be related to the inhibitory action of EGCG. Wang et al. 
(1987) implicated that inhibition of cytochrome c reductase was associated with catechins 
ability to undergo reversible redox transformation resulting in the formation of quinones 
which presumably act as electron acceptors. Thus the impairment of electron transport 
from NADPH to the cytochrome P450 protein may also contribute to the inhibitory 
potential of tea polyphenols on cytochrome P450 mixed-function oxidase activities. On 
the other hand, the difference in inhibition potency of catechin derivatives has been 
suggested to be dependent on substitution at the 2,3-position of 5,7-dihydroxy- 
benzoflavan and the numbers of hydroxyl groups present in these substituents (Wang et 
al., 1987). He also reported that these phenolic groups may bind through a hydrogen
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bond to the catalytic sites of cytochrome P-450 such as the ketoimide group and the 
inhibition of the observed enzyme activities may be partly due to such interactions.
The formation of highly reactive electrophilic forms, the ultimate mutagens , is 
responsible for the initiating events in the carcinogenic process (Ames, 1983; Timbrell, 
1991). Scavenging these electrophilic reactants would be a possible mechanism by which 
green tea components exert their antimutagenic and andcarcinogenic activity. This 
possibility is supported by the observation that incorporation of polyphenolic fractions, 
extracted from green tea, into the mutagenicity system, following termination of the 
microsomal metabolism, gave rise to a marked decrease in the mutagenicity of all 
mutagens studied. The most marked inhibitory effect was related to fraction C (EGCG- 
rich fraction) and fraction A. The latter tea extract fraction was more effective against 
nitrosopyrrolidine mutagenesis. The observed inhibition is therefore consistent with the 
constitutive epicatechin derivatives EGCG and to a lesser extent with other tea 
polyphenols being capable of scavenging the microsomes-generated reactive metabolite(s) 
of promutagens.
As 2-aminoanthracene was reported to be metabolically activated by cytosolic 
enzymes (Ayrton et al., 1992), the possibility that tea constituents could react directly 
with cytosol-mediated reactive intermediate(s) of 2-aminoanthracene was also 
investigated. In fact, green tea aqueous extracts and its phenolic fractions inhibited the 
mutagenic response of 2-aminoanthracene after terminating cytosolic metabolism by the 
addition of menadione . However, the inhibition efficiency of tea extract and its extracted 
fractions was considerably lower when compared to microsomes-mediated activation. 
Such an observation suggests that menadione was more effective in abolishing 
microsomal enzymes rather than cytosolic enzyme systems. It is unlikely that this is due 
to the formation of different reactive intermediates by the two subcellular fractions. These 
results also raise the possibility that tea polphenols, in particular EGCG, possess the
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ability to trap the reactive metabolites produced from both cytosolic and microsomal 
activation of 2-aminoanthracene.
6.6 CONCLUSION
In summary, the results of the present study support the view that traditionally 
prepared green tea liquor is rich in epicatechin derivatives, more specifically EGCG. The 
results also demonstrate the ability of isolated green tea fractions to reduce the in vitro 
mutagenesis of several promutagens, such as Glu-P-1, benzo(a)pyrene, 
nitrosopyrrolidine and 2-aminoanthracene as well as 9-aminoacridine. Fraction C 
(EGCG-rich fraction) was the most potent inhibitor of the mutagenicity of all 
promutagens except nitrosopyrrolidine, for which fraction A was the most potent. Green 
tea polyphenols present in the isolated fractions appear to exert their antimutagenic effect 
by inhibiting cytochrome P-450-mediated activation of promutagens, at least partly, 
through impairing the electron transfer to these enzymes and by interacting with 
microsomal cytochrome P-450 enzymes, primarily the CYPIA and CYP2B subfamilies. 
In the case of nitrosopyrrolidine, a CYP2E1 substrate (Yang et al., 1985; Ayrton et al., 
1987), the mutagenic effect of tea and its various fractions was more pronounced when 
they were present during microsomal metabolism that when added after its incubation, 
indicating that CYP2E1 metabolism is likely to be inhibited although direct inhibition of 
this activity was not demonstrated. Furthermore, this study shows that the capacity of 
green tea polyphenols in inhibiting mutagenesis is also related to their ability to scavenge 
the reactive species of chemical carcinogens resulting from microsomal and, in the case 
of 2-aminoanthracene, also cytosolic metabolism. Collectively, the strong trapping 
potential was related to EGCG contents although contribution by other tea components 
cannot be ruled out. Finally, the present study illustrates that different tea components 
may be the predominant antimutagenic compounds for various promutagens.
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CHAPTER 7
SELECTIVE INDUCTION OF RAT HEPATIC 
XENOBIOTIC METABOLISING ENZYMES AND 
PEROXISOMAL PROLIFERATION 
BY GREEN TEA
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7.1 INTRODUCTION
A number of extensive epidemiological studies and strong experimental evidence 
in numerous animal models have established a substantial role for dietary constituents in 
the aetiology of many human diseases, including cancer and cardiovascular disease. Diet 
may modulate the incidence of cancer through the presence of several chemicals with 
carcinogenic potential, such as heterocyclic aromatic amines (Sugimura et al., 1993), or 
through containing chemicals that can function as precursors for the synthesis of other 
types of carcinogens (Walker, 1990). In addition to these carcinogens and mutagens, 
human diet contains many naturally-occurring compounds capable of counteracting the 
potency of chemical carcinogens (Wattenberg, 1993). Such dietary components may 
function through modifying the enzyme systems involved in the activation and 
deactivation of chemical carcinogens (loannides et al., 1993). However, many studies 
concerned with the importance of nutrition in chemical carcinogenesis have been limited 
essentially to the role of macronutrients, such as protein and lipids, and micronutrients 
like vitamins and minerals (Ames, 1983; Alldrick et al., 1987). Relatively little attention 
has been directed towards the study of the effects of anutrients on xenobiotic-metabolising 
enzyme systems.
Green tea is one of the most extensively consumed beverages in some countries, 
and it is conceivable that water extractable constituents of green tea may modulate the 
xenobiotic-metabolising enzyme systems. One of the most impressive findings is that 
green tea can effectively antagonise the carcinogenicity of several dietary carcinogens, 
including nitrosamines (Wang et al., 1992; Xu et al., 1992) and polycyclic aromatic 
hydrocarbons (Khan et al., 1988). As previously shown in chapter 4, and in agreement 
with the results of Wang et al. (1989), green tea aqueous extract caused marked inhibition 
in vitro of the mutagenicity of many structurally diverse chemicals, including dietary 
carcinogens such as heterocyclic aromatic amines, polycyclic aromatic hydrocarbons and 
nitrosamines. This decrease in mutagenic response was primarily due to inhibition of the 
cytochrome P450-dependent mixed-function oxidases, the most prominent enzyme
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system involved in the metabolic activation of chemical carcinogens. An additional 
conceivable mechanism of action of green tea is enhanced deactivation of carcinogens by 
phase II conjugation reactions with endogenous substrates, or through detoxicating the 
reactive intermediates and thereby preventing them from interacting with DNA. It was 
therefore of great importance to extend the in vitro studies to the in vivo situation and 
establish whether exposure of rats to green tea, prepared at concentrations similar to those 
consumed by humans, perturbed the cytochrome P-450 mixed-function oxidase system in 
the liver. The present study was also undertaken in order to address the effect of green tea 
on phase II enzymes system, and the consequences of such modification in these different 
enzymes on the bioactivation of dietary carcinogens.
7.2 MATERIALS
Peroxidase-linked donkey anti-sheep IgG and all chemicals, reagents and 
cofactors as well as the Salmonella typhimurium strains were obtained as cited in chapter 
2. Antibodies to rat CYPlAl, recognising both CYPlAl and CYP1A2 proteins were 
previously prepared and characterised by Rodrgues et al. (1987). Antibodies to rat 
CYP4A1 and to the trans-2-enoyl CoA hydratase trifunctional protein (as indicator of 
peroxisomal proliferation) were kindly provided by Professor G.G.Gibson (University of 
Surrey, Guildford, Surrey, UK) and Dr. D.L.Cinti (Department of Pharmacology, 
University of Connecticut Health Centre, Farmington, CT, USA) respectively.
Green tea leaves (Gunpowder type) were bought locally and stored at 4 °C in a 
sealed bag. Aqueous green tea extracts (2.5 % w/v) were prepared as previously 
described in chapter 4.
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7.3 METHODS
7.3.1 Animals pretreatment
Male Wistar albino rats (150-180 g) were purchased from the Experimental 
Biology Unit, University of Surrey. Thereafter, the rats were maintained on green tea 
aqueous extracts (2.5 % w/v) for four weeks as the sole source of fluid. The animals 
were then killed by decapitation and hepatic post-mitochondrial supernatant, microsomal 
and cytosolic fractions (25 % w/v) were prepared as previously described by loannides 
and Parke (1975), with the exception that the cytosol was recentrifuged at 105 000 g for 1 
hour to remove any microsomal contamination.
7.3.2 Enzyme assays
The protein levels of the hepatic preparations S9 fraction, microsomes and cytosol 
were measured by the Lowiy procedure (1951), using bovin serum albumin as a 
standard. Total microsomal P450 content was quantified according to the method of 
Omura and sato (1964). The determination of NADPH-cytochrome c reductase activity 
was performed as described by Williams and Kamin (1962). The following enzyme 
assays were carried out using isolated microsomes: ethoxyresomfin O-deethylase (Burke 
and Mayer, 1974), methoxyresorufin O-demethylase (Burke and Mayer, 1983), 
pentoxyresorufin O-depentylase (Lubet et al., 1985), p-nitrophenol hydroxylase (Koop et 
al., 1989), erythromycin N-demethylase (Wrighton et al., 1985), lauric acid hydroxylase, 
measuring both 11-and 12-hydroxylation metabolites (Parker and Orton, 1980), epoxide 
hydroxylase using benzo(a)pyrene-4,5-oxide as substrate (Dansette et al., 1979) and 
UDP-glucuronosyltransferase employing 2-aminophenol (Burchell, 1974) and 4- 
methylumbelliferone (Dutton et al., 1981) as representative substrates for different 
glucuronosyltransferases. In addition to these microsomal assays, the following enzyme 
activities was performed on the cytosolic fraction: glutathione S-transferase using CDNB 
and DCNB as substrates (Habig et al., 1974), sulphotransferase using 2-naphthol as 
substrate(Sekura et al., 1981), catalase (Leighton et al., 1968), superoxide dismutase 
(McCord and Fridovich, 1969) and glutathione peroxidase (Giinzler and Flohè, 1985). 
Finally, the CN-insensitive palmitoyl CoA oxidation was determined utilising the whole
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liver homogenate (Bronfman et al., 1979). All these assays are described in detail in 
chapter 2.
7.3.3 Mutagenicity assays
The effect of green tea treatment on the activation of model mutagens was 
determined using the Ames Salmonella test (Maron and Ames, 1983), except that a 
preincubation step of 30 minutes was introduced. The activation system contained 10 % 
(v/v) of the appropriate hepatic fraction (25 % w/v), supplemented with glucose 6- 
phosphate dehydrogenase (1 unit/plate) in the experiments where isolated microsomes 
were used. All mutagens were dissolved in DMSO so that the final concentration 
never exceeded 
100 fi\ per incubation.
7.3.4 Immunoblotmg studies
Immunoblot analysis of electrophoretically resolved microsomal proteins on 
sodium dodecyl sulphate polyacrylamide gels was performed using antibodies to rat 
CYPlAl and CYP4A1 according to the method of Laemmli (1970) and then 
electrotransferred to nitrocellulose sheets by the general procedure of Towbin et al. (1979) 
as described in chapter 2. Immunological determination of the trans-2-enoyl CoA 
hydratase trifunctional protein was similarly carried out following resolution of the 
solubilised homogenate proteins as described by Ayrton et al. (1991).
7.4 RESULTS
7.4.1 Effect of green tea treatment on some rat hepatic parameters
Administration of 2.5 % green tea infusion as the sole source of drinking fluid for 
four weeks did not affect the animal body weight gain (results not shown). The same 
treatment showed no significant differences in liver weight, whole homogenate, 
microsomal and cytosolic protein levels, NADPH-cytochrome c reductase activity as well
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as total cytochrome P450 content (Table 7.1). However, a significant increase was 
observed in palmitoyl CoA oxidation determined in liver homogenate (Table 7.1).
TABLE 7.1 Effect of green tea administration on some rat hepatic 
parameters
Parameter Control Green tea
Liver weight/body weight xKX) 4.3 ± 0.2 4.6 ±0.1
NADPH-cytochrome c reductase 
( nmol/min per mg protein )
75 ±5 7 1 ± 6
Total cytochrome P450 
( nmol/mg protein )
0.38 ±0.04 0.51 ± 0.06
Palmitoyl CoA oxidation 
( nmol NADH/min per mg protein )
2.1 ±0 .2 5.0 ±0.8*
Microsomal protein 
( mg/g liver )
19.7 ± 3.0 26.8 ± 2.6
Cytosolic protein 
( mg/g liver )
58.3 ±4.1 62.6 ± 3.7
Whole homogenate protein 
( mg/ g liver )
181 ± 10 189 ± 12
Rats were treated with freshly prepared aqueous green tea extracts (2.5 % w/v) as their 
sole drinking fluid for four weeks. Results are presented as mean ± SEM for five 
animals. *P <  0.01
7.4.2 Modification of cytochrome P450-dependent activities by green tea
As shown in Table 7.2, treatment of rats with green tea infusion gave rise to 
statistically significant increases in the O-dealkylations of methoxyresorufin and 
pentoxyresorufin. Similarly, the O-deethyladon of ethoxyresorufin was also increased by 
green tea extracts administration but this increase did not attain statistical significance. A 
marked increase was also seen in lauric acid hydroxylation, whereas the activity of
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erythromycin N-demethylase was significantly inhibited (Table 7.2). In contrast, the same 
treatment had no influence on the hydroxylation of p-nitrophenol (Table 7.2).
TABLE 7.2 Effect of green tea administration on rat hepatic mixed- 
function oxidase activities
Parameter Control Green tea
Ethoxyresorufin O-deethylase 
( pmol/min per mg protein )
11.2 ±3.1 23.7 ±5 .0
Methoxyresorufin O-demethylase 
( pmol/min per mg protein )
14.2 ± 2.5 40.1 ± 5.3**
Pentoxyresorufin O-depentylase 
( pmol/min per mg protein )
2.5 ± 0.5 4.7 ± 0.8*
p-nitrophenol hydroxylase 
( nmol/min per mg protein )
0.87 ±0.10 0.77 ± 0.15
Erythromycin N-demethylase 
( nmol/min per mg protein )
2.46 ± 0.28 1.37 ± 0.20*
Lauric acid hydroxylase 
( nmol/min per mg protein )
1.24 ±0.18 1.87 ±0.17*
Rats were maintained on freshly prepared aqueous green tea extracts (2.5 % w/v) as their 
sole drinking liquid for four weeks. Results are presented as mean ± SEM for five 
animals. * P <  0.05 , **P <  0.01
7.4.3 Immunoblot analysis of P450 forms and peroxisomal enzymes
Western blot analysis were carried out to ascertain whether the observed increases 
in enzyme activities was accompanied by an elevation of specific enzyme apoprotein 
levels. Hepatic microsomes from green tea-treated rats probed with polyclonal antibodies 
to rat CYPlAl, also recognising CYP1A2, and CYP4A1 showed increased apoprotein 
levels of CYP1A2 and CYP4A1 (Figure 7.1). Neither control (water-treated) nor green 
tea-treated animals displayed a band corresponding to the apoprotein level of CYPlAl, 
following probing with the antibody against CYPlAl (Figure 7.1 A).
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Figure 7.1 Immunoblot analysis of hepatic solubilised microsomes from control and 
green tea-treated rats employing antibodies to CYPlAl and CYP4A1. Microsomal 
proteins (20 pg) were resolved by electrophoresis in a 10 % (w/v) SDS-polyacrylamide 
gel and transferred electophoretically to nitrocellulose. (A) The immunoblot was 
performed with sheep anti-CYPlAl (diluted 1: 10 000) followed by peroxidase-linked 
donkey anti-sheep IgG (diluted 1: 2(X)0). (B) The immunoblot was carried out with 
sheep anti-CYP4Al (diluted 1: 16(X)) followed by peroxidase-linked donkey anti-sheep 
IgG (diluted 1: 2000) and both blots were visualised using 3,3'-diaminobenzidine. 
Control (C); green tea (GT); Aroclor 1254 (Ar) and clofibrate (CL) were used as positive 
controls.
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Immunoblot analysis of solubilised homogenates probed with antibodies to the trans- 2- 
enoyl CoA hydratase trifunctional protein showed that administration of green tea aqueous 
extracts to rats gave rise to an increase in the level of this protein (Figure 7.2).
GT C GT C IT  C GT
Figure 7.2 Immunblot analysis of hepatic solubilised homogenates from control and 
green tea-treated rats using antibodies to the trans-2-enoy[ CoA hydratase trifunctional 
protein. Homogenates proteins (80 pg) were resolved by electrophoresis in a 3 % (w/v) 
SDS-polyacrylamide gel and transferred electrophoretically to nitrocellulose. The 
immunoblot was carried out with rabbit anti sera to the trans-2-enoy\ CoA hydratase 
trifunctional protein (diluted 1: 1000) followed by peroxidase-linked anti-rabbit IgG 
(diluted 1: 2(XX)) and visualised with 3,3'-diaminobenzidine. Control (C); green tea (GT); 
clofibrate (CL) was used as positive control. The molecular weight markers were: (1) 
triosephosphate isomerase (26 600), (2) lactate dehydrogenase (36 500), (3) fumarase (48 
500), (4) pyruvate kinase (58 000), (5) fructose 6-phosphate kinase (84 500), (6) (3- 
galactosidase (116 000), (7) a 2-macroglobulin (180 000).
178
7.4.4 Effect of green tea treatment on hepatic conjugation and antioxidant
enzyme activities
The effect of green tea administration on hepatic phase II conjugating enzymes is 
illustrated in Table 7.3. GlutationeS-transferase activity, as determined using CDNB and 
DCNB substrates, was not significantly modulated following treatment with green tea 
extracts. Similarly, there was no significant change in the activity of sulphotransferase 
monitored using 2-naphthol as the accepting substrate. However, exposure of rats to tea 
aqueous extracts resulted in a doubling increase in the activity of glucuronyltransferase 
only when measured in the presence of 2-aminophenol as the accepting substrate. No 
such effect was seen when 4-methylumbelliferone served as the substrate (Table 7.3). 
Treatment with green tea did not influence the activity of epoxide hydroxylase utilising 
benzo(a)pyrene-4,5-oxide as the substrate (Table 7.3). Finally, the same treatment also 
failed to modulate the antioxidant enzyme systems catalase, glutathione peroxidase and 
superoxide dismutase activities (Table 7.4).
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TABLE 7.3 Effect of green 
enzyme activities
tea treatm ent on ra t hepatic conjugation
Parameter Control Green tea
Glutathione S-transferase^ 
O^mol/min per mg protein)
0.48 ± 0.04 0.56 ± 0.03
Glutathione S-transferase^ 
(nmol/min per mg protein)
77.7 ± 5.6 89.7 ± 3.2
Glucuronosyl transferase^ 
(pmol/min per mg protein)
6.9 ± 1.0 15.5 ± 3.5*
Glucuronosyl transferase^ 
(nmol/min per mg protein)
2.9 ± 0.7 2.3 ±0 .2
Sulphotransferase® 
(nmol/min per mg protein)
0.55 ±0.10 0.34 ± 0.04
Epoxide hydrolase^ 
(nmol/min per mg protein)
1.77 ±0.28 2.32 ± 0.40
Rats were treated with freshly prepared aqueous green tea extracts (2.5 % w/v) as their 
sole drinking liquid for four weeks. Results are presented as mean ± SEM for five 
animals. The various enzyme activities was determined using the following accepting 
substrates: ^ D N B , ^DCNB, ^2-aminophenol, ^4-methylumbelliferone, ^2-naphthol, 
and ^benzo(a)pyrene-4,5-oxide. *p<  0.05
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TABLE 7.4 Effect of green tea administration on ra t hepatic antioxidant
enzymes
Parameter Control Green tea
Catalase
(//mol/min per mg protein)
80.5 ± 3.3 86.7 ± 3.0
Glutathione peroxidase 
(nmol/min per mg protein)
348 ±40 420 ±58
Superoxide dismutase 
(units/min per mg protein)
37.6 ± 1.3 42.9 ± 6.2
Rats were maintained on freshly prepared aqueous green tea extracts (2.5 % w/v) as their 
sole drinking fluid for four weeks. Results are presented as mean ± SEM for five 
animals.
7.4.5 Modulation of the mutagenicity of model carcinogens by green tea
Hepatic S9 and microsomal preparations from green tea-treated rats were much 
more effective than controls in activating the carcinogen IQ to mutagenic intermediates in 
the Ames test (Figure 7.3). The mutagenic response of 2-aminoanthracene was also 
enhanced markedly following treatment with green tea in the presence of an activation 
system derived from S9 fraction or its components, microsomes and cytosol (Figure 7.4). 
Green tea-treated hepatic S9 fraction, however, appeared to be less effective in converting 
nitrosopyrrolidine to mutagenic metabolites than control preparations (Figure7.5). 
However, no difference between the tea-treated activation system and that of control could 
be discerned when isolated microsomes served as the activation system (Figure 7.5).
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Figure 7.3 Metabolic activation of IQ by hepatic preparations from control and green tea- 
treated rats. The mutagenicity assay was carried out employing Salmonella typhimurium 
strain TA 98 and 10% (v/v) activation systems. The activation system was supplemented with 
glucose 6-phosphate dehydrogenase (1 unit/plate) when isolated microsomes were utilised. 
Bacteria, promutagen and the activation system were preincubated for 30 min at 37 ®C in a 
shaking waterbath. Each point represents the mean ± SD for three determinations. The 
spontaneous reversion rate of 19 ± 5 has already been subtracted.
Control ( □); Green tea-treated ( ■  ).
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Figure 7.4 Metabolic activation of 2-aminoanthracene by hepatic preparations from 
control and green tea treated rats. The mutagenicity assay was carried out employing 
Salmonella typhimurium strain TA 100 and 10 % (v/v) activation systems. When 
isolated microsomes were utilised, the activation system was supplemented with 
glucose 6-phosphate dehydrogenase (1 unit / plate). Results are presented as mean 
± SD of triplicates. The spontaneous reversion rate of 103 ± 7 has already been 
subtracted. Control (D); Green tea-treated ( ■  ).
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Figure 7.5 Metabolic activation of N-nitrosopyrrolidine by control and green tea-treated 
hepatic preparations. The assay was carried out using the Salmonella t yphimurium strain 
TA 1530 and employing 25 % (v/v) activation systems. The activation system was 
supplemented with glucose 6-phosphate dehydrogenase (1 unit/plate) when microsomes 
were used. The promutagen was preincubated with bacteria and the activation system in 
a shaking waterbath for 30 min at 37°C . The spontaneous revereion rate of 8±2 has 
already been subtracted. Each point represents the mean ± SD for three experiments. 
Control (D); Green tea- treated ( ■ ) .
7.5 DISCUSSION
According to many epidemiological and experimental studies in a variety of animal 
models, several dietary constituents have been shown to modulate the process of 
carcinogenesis and prevent genotoxicity. This modulatory effect of diet can be confined to 
changes in the enzyme systems activities that catalyse the metabolic activation or 
deactivation of chemical carcinogens. Green tea is one of the most consumed beverages 
that exhibits antimutagenic action against a number of promutagens, including food 
carcinogens (Chapter 4), and to suppress the carcinogenicity of chemical carcinogens 
such as polycyclic aromatic hydrocarbons and nitrosamines (Wang et al., 1992; Katiyar et 
al., 1993). Such in vitro inhibition in mutagenic response was initially assigned to a 
decrease in cytochrome P450-mediated mixed-function oxidase activity and may also 
contribute to the anticarcinogenic potential of green tea. However, in vitro findings may 
not always be successfully extrapolated to the in vivo situation. Many inhibitors of 
cytochrome P450 proteins when administered in vivo induce the enzyme systems that 
they inhibit in vitro, such as ellipticines (Phillipson et al., 1982), methylenedioxyphenyl 
compounds (loannides et al., 1985) and anthraflavic acid (Ayrton et al., 1988).
The present investigation was therefore concerned with the effect of green tea 
administration on hepatic xenobiotic-metabolising cytochrome P450 isoforms. 
Subsequent changes in the activities and levels of individual cytochrome P450 families /
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subfamilies were monitored by the use of diagnostic probes and immunologically utilising 
polyclonal antibodies. In the present study, treatment with green tea did not influence the 
animal growth as exemplified by body weight gain and no untoward effect was evident. 
Pretreatment with green tea increased significantly the 0-demethylation of 
methoxyresorufin, which is specific probe of CYP1A2 activity (Burke and Mayer, 1983), 
and this was confirmed by the immunoblot analysis where an increase in the CYP1A2 
apoprotein levels was evident. Similarly, administration of green tea caused a marked 
increase, albeit less pronounced, in the O-depentylation of pentoxyresorufin which is 
selectively catalysed by CYP2B (Lubet et al., 1985). However, inducers of CYPl to a 
lesser extent also stimulate CYP2B activity (Lubet et al., 1985) and is likely no actual 
induction of CYP2B had occurred following the ingestion of green tea although this 
cannot be ruled out. The same treatment also stimulated lauric acid hydroxylase, an 
indicator of CYP4A1 activity, and this effect was paralleled by an increase in the CYP4A1 
apoprotein levels as determined by immunoblot analysis. The hydroxylation of p- 
nitrophenol, which is catalysed by CYP2E (Koop et al., 1989), was unaffected by this 
treatment In contrast, it was observed that the N-demethyladon of erythromycin, a 
chemical probe used to monitor CYP3A activity (Wrighton et at, 1985), was inhibited by 
the treatment with green tea. In view of these results, it appears that induction of CYPIA 
and CYP4A proteins has occurred, at least to some extent, at the expense of those of the 
CYP3A subfamily hence the total cytochrome P450 levels were unaffected by green tea 
extracts treatment
Peroxisome proliferation is generally related to an adaptive cellular response to 
acute changes in lipid metabolism resulting from an influx of lipid into the liver following 
the exposure to hypolipidemic compounds and certain phthalate-ester plasticizers (Moody 
et a t, 1992). Proliferation of peroxisomes has been linked, at least in rodents, to the 
induction and promotion of hepatic tumours through epigenetic mechanisms (Nilsson et 
a t, 1991; Rao and Reddy, 1991). The potential role of hepatic peroxisome proliferative 
activity is believed to be associated with increased production of active oxygen species
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due to imbalanced production of peroxisomal enzymes such as catalase; it has been 
proposed that these reactive oxygen species cause indirect DNA damage with subsequent 
tumour formation, as evidenced by the appearance of 8-hydroxydeoxyguansine (Reddy 
and Rao, 1989). However, there is increasing evidence that proliferation of peroxisomes 
occurs consistently with induction of a specific cytochrome P450 subfamily, namely 
CYP4A protein (Bacher and Gibson, 1989; Sharma et al., 1989). Accordingly, it was 
considered pertinent to investigate whether the increase in CYP4A activity is accompanied 
by an increase in the peroxisomal enzyme activity following the treatment with green tea 
extracts. Indeed, treatment of rats with green tea infusion enhanced the CN-insensitive 
palmitoyl CoA activity, a marker enzyme for peroxisomes, and this effect was supported 
by immunological analysis where an increase in the levels of the trans-2-tnoy\ CoA 
hydratase trifunctional protein in rats exposed to green tea extracts.
Since the induction of CYPl family is highly associated with the activation of 
chemical carcinogens (loannides and Parke, 1990), it is conceivable that green tea may 
enhance the CYPl-mediated activation of chemical carcinogens. This hypothesis has been 
evaluated by investigating the mutagenicity of the food carcinogen IQ, whose activation is 
catalysed predominantly by CYP1A2 (Kato et al., 1983; Abu-Shakra et al., 1986). Two 
types of hepatic preparations were employed in the Ames mutagenicity assay, post- 
mitochondrial supernatant (89) and isolated microsomes. The latter system reflects the 
effect of tea on microsomal enzyme system, whereas 89 fraction was also used to ensure 
that any tea component present in the hepatocyte was not eliminated during the isolation of 
microsomes. In fact, hepatic preparations from green tea treated-rats, whether 89 or 
microsomes, markedly enhanced the activation of IQ in accord to the observed increase in 
CYP1A2 levels. A third hepatic preparation, namely cytosolic fraction was used in 
evaluating the effect of green tea on the mutagenicity of 2-aminoanthracene since this 
promutagen has been found to be also activated by a cytosolic oxidase distinct from that 
of microsomal enzyme systems (Ayrton et al., 1992). Green tea extracts enhanced the 
mutagenic response of 2-aminoanthracene catalysed by all three hepatic preparations.
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However, the mutagenicity of nitrosopyrrolidine, a nitrosamine selectively activated by 
CYP2E, was not influenced by tea treatment, consistent with the lack of effect of green 
tea on CYP2E activity. Interestingly, when hepatic S9 was used, an inhibitory effect was 
clearly evident. This may be explained by the fact that tea constituents may selectively 
impair the activity of CYP2E or scavenge the reactive intermediate(s) of this carcinogen.
It is possible that green tea extracts may possess anticarcinogenic potential by 
directing the metabolism of the chemical carcinogens in such a way as to favour their 
detoxication. Therefore, the present study was also undertaken to establish whether the 
increase in mixed-function oxidase activities and carcinogen activation is compensated by 
similar changes in the detoxication enzymes. In this respect, glutathione conjugation is 
probably the most effective metabolic pathway for eliminating reactive intermediates, a 
process being catalysed by glutathioneS-transferases. Such mechanism of action, 
however, appears unlikely since the activity of glutathion S-transferase, measured using 
CDNB and DCNB substrates, was unaffected by the treatment with tea extracts. It is 
worthwhile to point out that this result is in agreement with the work of Sohn et al. 
(1994). However, the possibility that a minor form of glutathione S-transferase, which is 
not monitored by these two substrates, has been modulated can not be excluded. In 
contrast to the present study, the activity of glutathione S-transferase was significantly 
enhanced by water extract of green tea administration in mice (Katiyar et al., 1993). The 
same treatment with tea also failed to modulate sulphotransferase conjugation and 
microsomal epoxide hydrolase activity in rat liver. On the other hand, pretreatment of rats 
with aqueous green tea extracts enhanced markedly microsomal 2-aminophenol 
glucuronidation activity while there was no observable increase in the activity towards 4- 
methylumbelliferone substrates. This dramatic difference in substrate glucuronidation 
activity is likely to reflect the fact that UDP-glucuronosyl transferase exists in a multiple 
forms susceptible to differential regulation by various inducers (Tephly and Burchell, 
1990). It is therefore reasonable to infer that the effect of green tea reflects differential 
induction of this enzyme isoforms. The increased glucuronidation capacity, however.
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may contribute to the anticarcinogenic activity of green tea by facilitating the deactivation 
of the parent chemical and/ or produced metabolites which may serve as precursors for the 
ultimate carcinogens, such as phenols and dihydrodiols of polycyclic aromatic 
hydrocarbons. Alternatively, green tea might exert its anticarcinogenic potential by 
stimulating the enzyme systems that deactivate reactive oxygen species. However, this 
possible mechanism of action appears to be unlikely in view of the present findings where 
treatment of rats with tea failed to influence glutathione peroxidase, catalase and 
superoxide dismutase activities, the principal antioxidant enzyme systems.
7.6 CONCLUSION
In summary, the present study has demonstrated that treatment of rats with green 
tea aqueous extracts, at concentrations consumed by humans, caused a selective increase 
in hepatic cytochrome P450 proteins such as CYP4A and CYPIA, the latter P450 
subfamily being closely associated with the bioactivation of chemical carcinogens 
(loannides and Parke, 1990). The results also indicated that exposure to green tea 
infusion stimulated the proliferation of hepatic peroxisomes. These findings appear to be 
very far from the reported anticarcinogenic potential of green tea, particularly against 
carcinogens that are activated by the CYP1A2 protein, such as the food carcinogens. 
However, the anticarcinogenic activity of green tea extracts was demonstrated against 
nitrosamines which are not substrates of the CYPl family. Thus, the mutagenicity of 
nitrosopyrrolidine, when activated by S9 preparations but not microsomes, was decreased 
as a result of green tea consumption. It may be inferred that the component(s) of the tea 
present in the soluble fraction of the liver inhibit the formation and/ or scavenge the 
reactive intermediates of nitrosopyrrolidine. Green tea extracts had no influence on the 
antioxidant enzyme systems and thus excluding this mechanism. In contrast, the activity 
of UDP-glucuronosyl transferase, using 2-aminophenol as the substrate was selectively 
enhanced by treatment with green tea extracts and this inducing effect of specific 
conjugating enzymes may contribute to its anticarcinogenicity properties.
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CHAPTER 8
A COMPARISON OF THE EFFECTS OF GREEN TEA 
,BLACK TEA AND DECAFFEINATED BLACK TEA 
ON HEPATIC DRUG-METABOLISING ENZYMES 
AND PEROXISOMAL PROLIFERATION
IN RATS : Dose-Response studies
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8.1 INTRODUCTION
It is now well established that a variety of naturally occurring plant phenols, 
including tea polyphenols, can modulate the carcinogenic process. A number o^studies 
have shown that green tea aqueous extracts or EGCG, the major green tea polyphenolic 
constituents, can effectively counteract the carcinogenic effects of chemical carcinogens 
such as polycyclic aromatic hydrocarbons and nitrosocompounds in several animal 
models (Khan et al., 1988; Fujita et al., 1989; Chen, 1992; Wang et al., 1992; Hirose et 
al., 1993; Katiyar et al., 1993). However, few studies have dealt with the 
anticarcinogenic activity of black tea and decaffeinated black tea extracts (Wang et al., 
1994). Experimental evidence strongly indicates that administration of black tea aqueous 
extract has a marked inhibitory effect on UVB-induced skin carcinogenesis in DMBA- 
initiated SKH-1 mice, and this effect was comparable to that observed by green tea 
extracts. UVB-induced carcinogenesis was also markedly inhibited by oral administration 
of decaffeinated black tea or decaffeinated green tea, but these tea infusions were slightly 
less effective than the regular teas. A substantial decrease in tumour multiplicity was also 
reported following treatment with both black and green tea extracts (Wang et al., 1992). 
As previously demonstrated, aqueous extracts of green tea, black tea, and decaffeinated 
black tea displayed a suppressive effect against the in vitro genotoxicity of dietaiy 
carcinogens such as nitrosamines, heterocyclic amines, and polycyclic aromatic 
hydrocarbons indicating that tea components are able to modulate the initiation stage of 
chemical carcinogenesis.
It has been documented that the carcinogenicity of a chemical depends largely on 
the balance between its detoxication and metabolic activation. The effectiveness of tea 
extracts inhibitoiy action, therefore, may reside in the ability of tea components to alter the 
activity of enzymes involved in the metabolism of carcinogens. Previous studies showed 
that green tea and black tea aqueous extracts express their antimutagenic effect by 
inhibiting the cytochrome P450-dependent bioactivation of chemical carcinogens.
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Moreover, the anticarcinogenicity of these two tea aqeous extracts was also attributed to 
the enhancement of detoxication phase II enzyme activities, in particular UDP- 
glucuronosyl transferase (Sohn et al., 1994).
In contrast to the above findings, the oral administration of green tea liquor 
increased the mutagenic response of two typical carcinogens IQ and 2-aminoanthracene 
(Chapter 7). This observation implicates that green tea could induce the activities of 
different isoforms of cytochrome P450 participating in the metabolism of procarcinogens, 
both activation and detoxication. Administration of green tea extracts to rats also displayed 
an appreciable increase in the proliferation of peroxisomal enzymes system as previously 
reported in chapter 7. This study was therefore undertaken in an attempt to evaluate the 
effects of black tea aqueous extracts treatment on various enzymes associated with 
hepatic metabolism of xenobiotics and the consequences of such modulation on the 
metabolic activation of model carcinogens. The comparative effects of black tea, green 
tea, and decaffeinated black tea were also investigated in this regard.
8.2 MATERIALS
All chemicals, cofactors, primary antibodies to rat cytochrome P450 (CYPIA, 
CYP2E1, CYP4A1) as well as the peroxisomal trifunctional protein, secondary 
antibodies, and the Salmonella typhimurium strains were obtained as previously 
mentioned in chapter 2.
Tea samples (black tea, green tea, decaffeinated black tea) were purchased locally 
from a specialist tea merchant and stored at 4 °C in a sealed bag. Tea infusions (2.5 % 
w/v) were prepared according to the procedure described earlier in chapter 4.
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8.3 METHODS
8.3.1 Treatment of animals
Male Wistar albino rats (150-180 g) were purchased from the Experimental Unit, 
University of Surrey and were randomly allocated into four groups of five animals each. 
The control group received water and the three experimental groups received aqueous 
extracts (2.5 % w/v) of green tea, black tea or decaffeinated black tea for four weeks as 
the sole source of drinking fluid throughout the entire study; all animals were then killed 
by cervical dislocation.
8.3.2 Enzyme assays
Hepatic fractions were prepared and their protein levels were determined as 
described earlier in chapter 2. The following determinations were performed on the 
homogenate: p-oxidation of palmitoyl CoA; and on the microsomal fraction: total 
cytochrome P450 content, 0-deethylation of ethoxyresorufin, 0-demethylation of 
methoxyresorufin, O-depentylation of pentoxyresorufin, p-nitrophenol hydroxylation, N- 
demethylation of erythromycin, NADPH-dependent reduction of cytochrome c, the 
combined 11-and 12-hydroxylations of lauric acid, UDP-glucuronosyl transferase using 
2-aminophenol and 4-methylumbelliferone as substrates, and epoxide hydrolase, while 
the activities of glutathione S-transferase, employing CDNB and DCNB as substrates, 
sulphotransferase, glutathione peroxidase, catalase, and superoxide dismutase were 
assayed on the cytosolic fraction. All these assays are described in chapter 2.
8.3.3 Immunological analysis
Hepatic microsomal proteins as well as homogenate proteins (2 mg/ml) from 
control and tea-treated rats were solubilised in O.IM phosphate buffer pH 7.4 (containing 
emulgen 10 % v/v and cholate 2% v/v) as previously described (section 2.2.9.1). 
Proteins were resolved by electrophoresis on SDS-polyacrylamide gels and transferred 
electrophoretically onto nitrocellulose sheets according to the method described previously 
(sections 2.2.9.2 and 2.2.9.3). The separated proteins were identified by probing the
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nitrocellulose sheets with antibodies to CYP1A2, CYP2E1, CYP4A1 and peroxisomal 
trifunctional protein employing the immunoperoxidase staining technique as previously 
described (section 2.2.93).
8.3.4 Morphological examination
After the animals had been sacrificed, the livers were rapidly excised and cut into 
small pieces. The slices were then preserved in a storage fixative buffer prior to 
processing for electron microscopy examination as previously described (section 2.2.10). 
Morphometric analysis was performed on ultrathin sections of aldehyde-fixed and Epon- 
embedded liver tissue from control and tea-treated rats according to the procedure 
discussed earlier (section 2.2.10).
8.3.5 Mutagenicity studies
The effect of tea pretreatment on the metabolic activation of model mutagens was 
assessed using the Ames mutagenicity test employing TA 98, TA 100, and TA 1530 as 
the indicator Salmonella typhimurium strains as essentially described by Maron and Ames 
(1983). The test mutagen, bacteria, and activation systems (10 % v/v), unless otherwise 
indicated, were preincubated for 30 minutes at 37 °C in a shaking waterbath. In 
experiments where isolated microsomes served as the activation systems, they were 
supplemented with glucose-6-phosphate dehydrogenase (1 unit/plate). All test mutagens 
were dissolved in a maximum volume of 1(X) p\ DMSO.
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8.4 RESULTS
8.4.1 Effect of different doses of green tea as well as black tea and 
decaffeinated black tea on body weight and some rat hepatic parameters
As expected, administration of 2.5 % green tea infusion as the sole source of 
drinking fluid for 4 weeks did not affect the animal body weight gain (results not shown). 
Under the same conditions, exposure of rats to green tea extracts at higher concentration 
levels (7.5 % w/v) also had no remarkable effect on the animal growth rate. No visible 
signs of hepatotoxicity were observed following treatment with aqueous green tea extracts 
even at the highest dose level (results not shown). At the various concentrations 
employed, green tea extracts did not alter liver weight, microsomal or total hepatic protein 
levels, total cytochrome P450 content and NADPH-cytochrome c reductase activity (Table 
8.1). Treatment with aqueous extract of green tea, at the two higher concentrations only, 
gave rise to a modest but significant decrease in the cytosolic protein levels (Table 8.1). 
However, the same treatment caused a marked increase in the palmitoyl CoA oxidation 
but the effect appeared not to be dose-dependent (Table 8.1). Histological examination 
showed a considerable increase in the number of hepatic peroxisomes as a results of green 
tea administration which once again was not dose-dependent compared with control 
animals (Figures 8.1-8.3).
Pretreatment with 2.5 % black tea infusion or decaffeinated black tea infusion did 
not influence the animal growth measured by body weight gain (results not shown). 
There was no overt histopathological changes observed in the liver of rats treated with 
black tea or decaffeinated black tea infusions. Administration of tea displayed no 
significant differences in liver weight, total cytochrome P450 content and NADPH- 
cytochrome c reductase activity (Table 8.2). Similarly, the total microsomal and cytosolic 
hepatic protein levels were not significantly modulated following treatment with black tea, 
green tea and decaffeinated black tea extracts (Table 8.2). These tea extracts however 
caused a statistically significant increase in the CN-insesitive palmitoyl CoA oxidation
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(Table 8.2). Electron microscopic examination indicated an increased number of 
peroxisomes in rat hepatocytes by both tea treatments (Figures 8.4 and 8.5).
8.4.2 Modification of cytochrome P450-dependent activities by increasing 
doses of green tea
Treatment of rats with green tea extract enhanced the O-dealkylations of 
ethoxyresorufin and methoxyresorufin but this increase was statistically significant only
at the highest doses (Table 8.3). All three tea concentrations gave rise to statistically 
significant increases in the O-dealkylation of pentoxyresorufin (Table 8.3). Furthermore, 
a significant decrease in the hydroxylation of p-nitrophenol was observed only following 
treatment with 5 % green tea infusion (Table 8.3).
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Figure 8.1 Electron micrograph of control rat liver. A 700-angstrom-thick section of Epon-embedded 
tissue was counterstained with uranyl acetate as well as lead citrate and examined in a Philips 400 T  
electron microscope. Nucleus (N), glycogen (Gly), rough endoplasmic reticulum (RER), mitochondria 
(M), and peroxisomes are very few in number showing typical granular matrix with uricase crystalloid 
core. Note that the lysosomes (L) and Golgi apparatus (Gol) are located close to the bile canaliculus (B). 
Magnification x 8000.
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Figure 8.2 Electron micrograph of liver from a rat treated with aqueous green tea extracts (2.5 % w/v) 
as their sole source of drinking fluid for 4 weeks. A 700-angstrom-thick section of Epon-embedded tissue 
was counterstained with uranyl acetate as well as lead citrate and examined in a Philips -MX) f  electron 
microscope. Nucleus (N), glycogen (Gly), rough endoplasmic reticulum (RER), mitochondria (M), and 
peroxisomes (P) are few in number showing typical granular matrix with uricase crystalloid core. Note 
that the lysosomes (L) and golgi apparatus (Gol) are located close to the bile canaliculus (B). 
Magnification x 4600.
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Figure 8.3 Electron micrograph of liver from a rat treated with aqueous green tea extracts (5 % w/v) as 
their sole source of drinking fluid for 4 weeks. A 700-angstrom-thick section of Epon-embedded tissue 
was counterstained with uranyl acetate as well as lead citrate and examined in a Philips -400 T electron 
microscope. Glycogen (Gly), mitochondria (M), rough endoplasmic reticulum (RER), golgi apparatus 
(Gol), lysosomes (L), and bile canaliculus (B). Note the presence of few peroxisomes (P) showing typical 
granular matrix with uricase crystalloid core. Magnification x 4600.
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Figure 8.4 Electron micrograph of liver from a rat treated with aqueous black tea extracts (2.5 % w/v) 
as their sole source of drinking fluid for 4 weeks. A 700-angstrom-thick section of Epon-embedded tissue 
was counterstained with uranyl acetate as well as lead citrate and examined in a Philips 400 T electron 
microscope. Nucleus (N), rough endoplasmic reticulum (RER), mitochondria (M). Note the presence of 
numerous peroxisomes (P) showing a slight matrix densities but some of them lack typical uricase 
crystalloid core. Magnification x 3600.
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Figure 8.5 Electron micrograph of liver from a rat treated with aqueous decaffeinated black tea (2.5 % 
w/v) as their sole source of drinking fluid for 4 weeks. A 700-angstrom-thick section of Epon-embedded 
tissue was counterstained with uranyl acetate as well as lead citrate and examined in a Philips 400 T 
electron microscope. Nucleus (N), glycogen (Gly), rough endoplasmic reticulum (RER), mitochondria 
(M). Note the presence of several peroxisomes (P) showing typical matrix with uricase crystalloid core. 
Magnification x 2800.
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Administration of 5 % green tea aqueous also decreased significantly the N-demethylation 
of erythromycin, although at the other two concentrations no statistically significant 
changes were evident (Table 8.3). A modest increase was however observed in lauric acid 
hydroxylase activity by the treatment with 2.5 % and 7.5 % green tea infusion (Table 
8.3).
Exposure of rats to black tea extracts at a concentration of 2.5 % (w/v) resulted in 
a significant increases in the O-demethylation of methoxyresorufin and lauric acid 
hydroxylation; an increase was also observed in the O-depentylation of pentoxyresorufin 
which was not statistically significant (Table 8.4). The black tea administration however 
caused a marked inhibition in the hydroxylation of p-nitrophenol (Table 8.4). 
Administration of 2.5 % decaffeinated black tea also had an inhibitoiy effect on the 
hydroxylation of p-nitrophenol but this did not attain statistical significance (Table 8.4). 
Similarly, the same treatment with decaffeinated tea decreased the O-dealkylations of 
ethoxyresorufin, methoxyresorufin and pentoxyresorufin but no statistical significance 
was attained (Table 8.4). No significant effect was seen in lauric acid hydroxylase, 
whereas erythromycin N-demethylase activity was inhibited following treatment with 
decaffeinated black tea infusion (Table 8.4).
8.4.3 Immunological analysis of cytochrome P450 and peroxisomal 
p ro te ins
Immunoblot analysis of solubilised microsomes using polyclonal antibodies 
against CYPlAl, also recognising (ZYP1A2, revealed increases in the apoprotein levels 
of CYP1A2 (Figure 8.6 A). When antibodies to CYP4A1 were employed, all treatment 
with green tea resulted in enhanced CYP4A1 apoprotein levels (Figure 8.6 B). With both 
antibodies, highest induction occurred at the highest dose of green tea.
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Figure 8.6 Immunoblot analysis of solubilised hepatic microsomes derived from control and green tea- 
treated rats using anti-CY PlA l and anti-CYP4Al polyclonal antibodies. Microsomal proteins (20 jig) 
were resolved by electrophoresis in a 10 % (vv/v) SDS-polacrylamide gel and transferred electrophoretically 
to nitrocellulose. (A) The immunoblot was carried out using sheep anti-CY PlA l (diluted 1: 10 000) 
followed by peroxidase-linked donkey anti-sheep IgG (diluted 1: 2000). (B) The immunoblot was 
performed with sheep anti-CYP4Al (diluted 1: 1600) followed by peroxidase-linked donkey anti-sheep IgG 
(diluted 1: 2000) and both blots were visualised with 3,3 -diaminobenzidine. Control (C); 2.5 % green tea 
(G); 5 % green tea (T); 7.5 % green tea (E); Aroclor 1254 (Ar) and clofibrate (CL) were used as positive 
controls.
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Neither control nor green tea-treated animals, at the three concentrations used, displayed 
a band corresponding to CYPlAl when blotted nitocellulose sheet probed with antibodies 
against CYPIAI. A small decrease in CYP2E1 apoprotein level was observed following 
treatment with 5 % (w/v) green tea extract (Figure 8,7). Immunological determination 
employing antibodies against homogenate trans-2-Qnoy\ CoA hydratase trifunctional 
protein showed that administration of aqueous green tea extracts to rats, at the various 
concentrations used, increased the levels of this protein (Figure 8.8).
IS
Figure 8 .7  Immunoblot analysis of solubilised hepatic microsomes from control and green tea-treated 
rats employing anti-CYP2El polyclonal antibodies. Microsomal proteins (100 jxg) were resolved by 
electrophoresis in a 10 % (w/v) SDS-polyacrylamide gel and transferred electrophoretically to 
nitrocellulose. The immunoblot was performed with sheep anti-CYP2EI (diluted 1: 5000) followed by 
peroxidase-linked donkey anti-sheep IgG (diluted I: 2000) and visualised with 3,3 -diaminobenzidine. 
Control (C); 2.5 % green tea (G); 5 % green tea (T); 7.5 % green tea (E); isoniazid (IS) was used as 
positive control.
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Figure 8.8 Immunoblot analysis of solubilised hepatic homogenates from control and green tea-treated 
rats using antibodies to the peroxisomal trifunctional protein. Homogenate proteins (80 pig) were resolved 
by electrophoresis in a 3 % (w/v) SDS-polyacrylamide gel and transferred electrophoretically to
nitrocellulose. The immunoblot was carried out with rabbit antisera to the trans-2-&noy\ CoA hydratase
trifunctional protein (diluted I: 1000) followed by peroxidase-linked anti-rabbit IgG (diluted 1; 2000) and 
visualised with 3 ,3 -diaminobenzidine. Control (C); 2.5 % green tea (G); 5 % green tea (T); 7.5 % green 
tea (E); clofibrate (CL) was used as positive control. The molecular weight markers were: (1)
triosephosphate isomerase (26 600), (2) lactate dehydrogenase (36 500), (3) fumarase (48 500), (4)
pyruvate kinase (58 000), (5) fructose 6-phosphate kinase (84 500), (6) (3-galactosidase (116 000), (7) a 2 -  
maeroglobulin (180 000).
Pretreatment with black tea extracts increased CYP1A2 apoprotein level whereas such 
increase was not evident following treatement with decaffeinated black tea extract (Figure 
8.9A). The apoprotein level of CYP4A1 was enhanced by all three tea treatments (Figure 
8.9B). However, all three tea types appeared to decrease the level of CYP2E1 apoprotein 
as shown in Figure 8.10. Finally, probing of solubilised homogenates with antibodies to 
the trans-l-Qnoy\ CoA hydratase trifunctional protein showed that aqueous tea extracts 
administration gave rise to an increase in this protein levels, with black tea infusion being 
clearly the most effective (Figure 8.11).
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Figure 8.9 Immunoblot analysis of solubilised hepatic microsomes from tea-treated rats using 
antibodies to CYPIA I and CYP4AI. Microsomal proteins (20 pig) from control and green , black, 
decaffeinated black tea-treated rats were resolved by electrophoresis in a 10 % (w/v) SDS-polyacrylamide 
gel and transferred electrophoretically to nitrocellulose. (A) The immunoblot was performed with sheep 
anti-CY PlA l (diluted 1: 10 000) followed by peroxidase-linked donkey anti-sheep IgG (diluted I: 2000). 
(B) The immunoblot was carried out with sheep anti-CYP4Al (diluted I; 1600) followed by peroxidase- 
linked donkey anti-sheep IgG (diluted 1: 2000) and both blots were visualised with 3 ,3 -diaminobenzidine. 
Control (C); green tea (G); black tea (B); decaffeinated black tea (D); Aroclor 1254 (Ar) and clofibrate (CL) 
were used as positive controls.
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Figure 8.10 Immunoblot analysis of solubilised hepatic microsomes from tea-treated rats using anti- 
CYP2E1 polyclonal antibodies. Microsomal proteins (100 pig) from control and green, black, 
decaffeinated black tea-treated rats were resolved by electrophoresis in a 10 % (w/v) SDS-polyacrylamide 
gel and transferred electrophoretically to nitrocellulose. The immunoblot was carried out with sheep anti- 
CYP2E1 (diluted 1: 5000) followed by peroxidase-linked donkey anti-sheep IgG (diluted 1: 2000) and 
visualised with 3,3"-diaminobenzidine. Control (C); green tea (G); black tea (B); decaffeinated black tea 
(D); isoniazid (IS) was used as positive control.
D B ■ex
Figure 8.11 Immunoblot analysis of solubilised hepatic homogenates from tea-treated rats using 
antibodies to the peroxisomal trifunctional protein. Homogenate proteins (80 pig) from control and green, 
black, decaffeinated black tea-treated rats were resolved by electrophoresis in a 3 % SDS-polyaciy lamide
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gel and transferred electrophoretically to nitrocellulose. The immunoblot was performed with rabbit 
antisera to the trcms-2-Qnoy\ CoA hydratase trifunctional protein (diluted 1: ICXX)) followed by peroxidase- 
linked anti-rabbit IgG (diluted 1: 2(KX)) and visualised with 3,3 -diaminobenzidine. Control (C); green tea 
(G); black tea (B); decaffeinated black tea (D); clofibrate (CL) was used as positive control. The molecular 
weight markers were: (1) triosephosphate isomerase (26 600), (2) lactate dehydrogenase (36 500), (3) 
fumarase (48 500), (4) pyruvate kinase (58 000), (5) fructose 6-phosphate kinase (84 500), (6) ^  
galactosidase (116 000), (7) a  2 -macroglobulin (180 (KX)).
8.4.4 Effect of increasing concentration of green tea on rat hepatic phase 
II and antioxidant enzyme activities
The effect of aqueous green tea extracts, administered orally at different 
concentration levels, on phase II conjugation reactions is illustrated in Table 8.5. Hepatic 
glutathione S-transferase activity, determined using CDNB and DCNB as substrates, was 
significantly enhanced following treatment with the two higher doses of green tea 
extracts. Similarly, at the highest concentration only, the activities of both 
sulphotransferase and epoxide hydrolase were modestly increased by treatment with green 
tea extracts. At the two lower doses, green tea administration also significantly induced 
glucuronyl transferase activity but only when measured using 2-aminophenol as the 
accepting substrate. However, the same treatment did not stimulate this enzyme activity 
when 4-methylumbelliferone served as the accepting substrate.
Oral administration of green tea infusion gave rise to a significant decrease in 
catalase activity at the two higher doses of treatment (Table 8.6). The inhibition of the 
enzyme activities was maximal in the 5 % green tea-treated animals. Glutathione 
peroxidase and superoxide dismutase activities, however, were not significantly 
modulated following the administration of green tea extracts (Table 8.6).
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8.4.5 Acomparison of the effects of green, black and decaffeinated black
tea on rat hepatic phase II and antioxidant enzyme activities
Among the different tea types, treatment with aqueous black tea infusion 
significantly increased glutathioneS-transferase activity measured using CDNB or DCNB 
as the acceptor substrates (Table 8.7). Significant increases were also observed in 
glucuronyl transferase activity following black tea or green tea administration, but only 
when monitored using 2-aminophenol as the accepting substrate, but the effect was much 
more pronounced with the black tea (Table 8.7). Administration of decaffeinated black tea 
infusion, however, did not significantly increased the activity of glucuronoyl transferase 
in the presence of 2-aminophenol. In contrast, this enzyme activity was not effectively 
modulated by the three types of tea when 4-methylumbelliferone served as the accepting 
substrate (Table 8.7). Hepatic sulphotransferase and epoxide hydrolase activities were 
also not significantly affected by all three tea treatments (Table 8.7).
The data presented in Table 8.8 indicate that oral administration of black or 
decaffeinated black tea extracts caused a marked decrease in catalase activity. A slight 
decrease was also seen in catalase activity following the administration of green tea but 
this was not statistically significant (Table 8.8). Moreover, treatment with black tea, green 
tea, and decaffeinated black tea had no major effect on superoxide dismutase and 
glutathione peroxidase activities (Table 8.8).
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8.4.6 Modulation of the activation of food carcinogens by different doses 
of green tea extracts
Hepatic S9 and microsomal preparations derived from rats treated with green tea, 
at different dose levels, were markedly more effective than controls in converting the 
carcinogen IQ to its mutagenic intermediate(s) in the Ames test (Figure 8.12). The S9- 
mediated mutagenicity of IQ was significantly increased following the treatment with 5% 
(w/v) green tea extracts, but the mutagenic response was similar to that seen with 
preparations from animals treated with 2.5 % (w/v) green tea infusion. Pretreatment with 
green tea significantly enhanced the microsomal activation of IQ in a dose-dependent 
pattern. In contrast, microsomal fractions from rats exposed to 2.5 and 5 % (w/v) green 
tea extracts were modestly less efficient than control preparations in converting 
nitrosopyrrolidine to mutagenic intermediates (Figure 8.13). A slight decrease was also 
observed in the mutagenic potential of nitrosopyrrolidine following metabolism by S9 
fraction from animals pretreated with 7.5 % (w/v) of green tea extracts.
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Figure 8.12 Metabolic activation of IQ by hepatic S9 and preparations from control (A), 2.5 % ( • ) ,  5 
% (A) and 7.5 % (■ )  green tea-treated rats. The mutagenicity of IQ in the Ames test was carried out 
using the Salmonella typhimurium strain TA 98 and 10 % (v/v) activation systems. When microsomal 
fractions were used as activation systems, they were supplemented with (1 unit/plate) glucose-6-phosphate 
dehydrogenase. Activation system, promutagen and bacteria were preincubated for 30 minutes at 37 ®C in 
a shaking waterbath. The spontaneous reversion rates of I5±5, 17±4, 16±9 and I8±l for control, 2.5 %, 
5 %, and 7.5 % green tea-treated respectively, have already been subtracted. Results are presented as 
mean±SD of triplicates.
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Figure 8.13 Inhibition of nitrosopyrrolidine mutagenicity by green tea extracts. The test was performed 
using Salmonella typhimurium strain TA 1530 in the Ames test employing either hepatic S9 or 
microsomal activation systems (25 % v/v) derived from control (A) and pretreated rats with 2.5 % ( • ) ,  5 
% (A) and 7.5 % (■ )  green tea extracts. The activation systems were supplemented with glucose-6- 
phosphate dehydrogenase (1 unit/plate) when isolated microsomes were utilised. Activation systems, 
promutagens and bacteria were preincubated for 30 minutes at 37 ®C in a shaking waterbath. The 
spontaneous reversion rates of 10±2, 9±3, 9±1, and 10±3 for control , 2.5 %, 5 %, and 7.5 % green tea- 
treated respectively, have already been subtracted. Results are presented as mean±SD of triplicates.
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5.4.7 Effect of treatment with different types of tea on the bioactivation 
)f food mutagens
A comparison study revealed that the S9 and microsomes-mediated mutagenesis 
)f IQ was markedly increased following the administration of 2.5 % (w/v) black or green 
;ea extracts, and this increase was more evident when microsomes were used (Figure 
5.14). Decaffeinated black tea-treated S9 preparations however were clearly less efficient 
than controls in activating IQ to mutagens. However, the IQ-mediated mutagenic response 
was not significantly modulated in the presence of an activation system comprising 
microsomes from decaffeinated black tea-pretreated animals. When nitrosopyrrolidine 
was employed as the promutagen, S9 preparations from black or green tea-treated rats 
were considerably less effective than control preparations in converting this cyclic 
nitrosamine to mutagens, so that the inhibitory effect of black tea was comparable to some 
extent with that of green tea (Figure 8.15). A similar, but more pronounced, decrease was 
observed in the nitrosopyrrolidine mutagenicity in the presence of S9 fractions from rats 
treated with decaffeinated black tea extracts. However, the microsomal activation of the 
same carcinogen was significantly inhibited by decaffeinated black tea treatment, and to a 
lower extent by pretreatment with black tea, with no effect being evident following the 
administration of green tea as compared with control microsomes.
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Figure 8.14 Metabolic activation of IQ by hepatic S9 and microsomal preparations from control and 
different tea-treated rats. Mutagenic response of IQ was determined in the Ames test using Salmonell a 
typhimurium TA 98 strain and 10 % activation systems derived from control (A), green tea ( • ) ,  black 
tea (A) and decaffeinated black tea (■ ). When isolated microsomes were employed as activation systems, 
they were supplemented with glucose-6-phosphate dehydrogenase (I unit/plate). The activation system, 
promutagen and bacteria were preincubated for 30 minutes at 37®C in a shaking waterbath. The 
spontaneous reversion rates of 15±5, 17±4, I6±I and 15±4 for control, green tea, black tea and 
decaffeinated black tea respectively, have already been subtracted. Results are presented as the means±SD 
of triplicates.
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Figure 8.15 Metabolic activation of nitrosopyrrolidine by hepatic S9 and microsomal preparations 
from control and different tea-treated rats. The mutagenic response of nitrosopyrrolidine was determined in 
the Ames test using Salmonell typhimurium TA 1530 strain and 25 % activation systems derived from 
control (A), green tea ( • ) ,  black tea (A) and decaffeinated black tea (■ ) . When isolated microsomes were 
employed as activation systems, they were supplemented with glucose-6-phosphate dehydrogenase (1 
unit/plate). The activation system, promutagen and bacteria were preincubated for 30 minutes at 37®C in a 
shaking waterbath. The spontaneous reversion rates of 10±2, 8±1, 11 ±3 and 9±2 for control, green tea, 
black tea and decaffeinated black tea respectively, have already been subtracted. Results are presented as the 
means±SD of triplicates.
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8.5 DISCUSSION
The results presented herein lend support to the view that aqueous tea extracts can 
influence the incidence of chemically induced carcinogenesis by modulating the enzyme 
systems responsible for the biotransformation of chemical carcinogens. It was therefore 
pertinent to determine the dose-response relationship of aqueous green tea extracts on 
hepatic cytochrome P450 and phase II conjugation reactions. In the present study, oral 
administration of green tea at dose levels of 2.5, 5, and 7.5 % as the sole source of 
drinking fluid for four weeks did not impair animal growth or display appreciable 
morphological changes in the liver even in rats treated with the highest concentration of 
green tea. Changes in cytochrome P450 isoforms were monitored by the use of 
representative marker substrates and immunologically by specific polyclonal antibodies 
for each particular isoform studied. Green tea treatment caused a substantial dose-related 
increase in the O-demethylation of methoxyresorufm, a reaction selectively catalysed by 
the CYP1A2 isoform (Namkung et al., 1988). Immunoblot analysis indicated that 
microsomes from rats pretreated with 7.5 % green tea exhibited the highest CYP1A2 
apoprotein levels. A dose response stimulation was also observed in the 0-depentylation 
of pentoxyresorufin, a probe for CYP2B activity (Lubet et al., 1985),but the effect was 
less pronounced. The increased CYP2B activity by green tea administration may be 
consistent with the induced levels of CYPl proteins, since inducers of CYPl to a much 
lesser extent stimulate this enzyme activity (Lubet et al., 1985). However, the possibility 
that CYP2B induction has taken place cannot be ruled out The same treatment gave rise 
to a dose-independent induction of the O-deethylation of ethoxyresorufm, a diagnostic 
probe for CYPIAI activity (Philipson et a t, 1984), although the catalytic activity of 
CYPIAI was much more higher at the highest dose of treatment. Since no CYPIAI 
apoproteins were detected in the immunoblot, it may be inferred that the increase in 
ethoxyresomfm O-deethylation is due to the higher level of CYP1A2, which to a small 
extent also dealkylates this resonifm analogue (Namkung et al., 1988). Treatment with 
green tea also enhanced the lauric acid hydroxylase, a specific indicator of CYP4A1
224
ramburini et al., 1984), but once again the extent of induction did not parallel the 
ncreasing dose. Immunological studies also demonstrated that induction of CYP4A1 
ipoprotein levels was relatively lower following the administration of 5 % green tea 
extracts. It is thus conceivable that the enhanced activity of CYP4A1 may be 
compensated, at least in part, by a parallel decrease in the activity of other constitutive 
cytochrome P450 isoforms. Indeed, at this dose level, the p-nitrophenol hydroxylase 
icdvity, a probe for CYP2E (Koop et al., 1989), was markedly inhibited by the 
administration of green tea and this was supported by the immunoblot analysis which 
showed lower CYP2E1 apoprotein level. A similar effect was observed in eiythromycin 
"^-demethylase activity following treatment with 5 % green tea infusion. Since the total 
cytochrome P450 levels was not effectively modulated by tea treatment, it seems likely 
that induction of CYPIA and CYP4A have occurred, at least partly, at the expense of 
CYP2E1 and CYP3A isoforms.
It has been demonstrated that administration of tea, including black tea and 
decaffeinated black tea, extracts markedly inhibited 4-(methylnitrosamino)-1 (3-pyridyl)- 
1-butanone (NNK)-induced lung tumourigenesis (Wang et al., 1992). This profound tea 
action might be related to the ability of tea components to perturb the cytochrome P450- 
dependent monooxygenase system. The results of the present study therefore revealed 
that black tea extracts administration suppressed effectively the hydroxylation of the 
CYP2E substrate p-nitrophenol, while treatment with decaffeinated black tea or green tea 
extracts had lower inhibitoiy effect on this enzyme activity. Neither green tea nor black tea 
infusion significantly decreased the N-demethylation of erythromycin. In agreement with 
these findings, Sohn et al. (1994) showed that green and black tea extracts treatment of 
rats had no pronounced effect on CYP2E1 and CYP3A4 catalytic activities. However, a 
marked inhibition was seen in the erythromycin N-demethylase activity following the 
treatment with decaffeinated black tea extracts. Nevertheless, administration of black tea 
effectively increased the activity of methoxyresorufm O-demethylase. A similar increase 
was also observed in this enzyme activity by the treatment with green tea but the
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enhancement was not statistically significant. The activity of lauric acid hydroxylase was 
also induced in a similar potency by green and black tea treatments, while these two tea 
types were less effective in stimulating the ethoxyresorufin O-deethylase activity. 
Consistent with this inductive effects of black and green tea infusions, immunological 
experiments showed a relative increases in the CYP1A2 and CYP4A1 apoprotein levels, 
as well as a parallel decrease in the apoprotein level of CYP2E1 in case of black tea 
administration. Conversely, there was no respective apoprotein level of CYPIAI 
following tea ingestion and therefore it is likely that the increase in ethoxyresorufin O- 
deethylase activity is a consequence of the induction of CYP1A2 isoenzyme. The results 
also indicated that the activity of pentoxyresorufin O-depentylase was not effectively 
influenced by black tea treatment, despite being significantly enhanced after the 
administration of green tea infusion. However, in contrast treatment of rats with 
decaffeinated black tea extracts displayed a moderate decrease in the O-dealkylations of 
alkoxyresorufins except for the hydroxylation of lauric acid where a slight increase was 
evident. Alternatively, decaffeinated black tea was a potent inhibitor of erythromycin N- 
demethylase activity. However, inhibition was less marked following green tea or black 
tea treatment showing that the inhibitory effect may be compensated, at least partly, by 
simultaneous increase in the activity of other P450 enzymes. In view of the fact that total 
cytochrome P450 levels were not significantly affected by the administration of tea, it 
appears possible that induction of CYPIA and CYP4A may have occurred, to some 
extent, at the expense of CYP3A subfamily. It could be also postulated that the differential 
changes in Cytochrome P450 activities among tea types may contribute to the slight 
decrease in NADPH-cytochrome c reductase activity, indicating that black tea polyphenols 
or their metabolites act as electron acceptors and therefore perturb specific reactions 
catalysed by selective forms of cytochrome P450-dependent enzymes.
As reported in previous chapter, treatment of rats with 2.5 % green tea extracts 
induced cytochrome P4504A activity (CYP4A1) and peroxisomal proliferation. With 
respect to this context, it was considered necessary to address whether increasing green
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ea concentration would exert higher inductive peroxisomal proliferation. The possible 
)roIiferative effect on peroxisomes by black tea and decaffeinated black tea extracts was 
ilso investigated, hence the activity of CYP4A enhanced following the ingestion of these 
wo tea kinds. Interestingly, treatment with each increasing dose of green tea failed to 
îlicit dramatic effects on peroxisomal proliferation as exemplified by relatively similar 
ncreases in CN-insensitive palmitoyl CoA oxidation, being slightly more effective at the 
[WO highest doses of treatment This finding provided evidence that the peroxisomal 
proliferative capacity of green tea was not conventionally dependent on treatment dose. 
Similarly, administration of 2.5 % black tea or decaffeinated black tea infusion enhanced 
the CN'-insensidve palmitoyl CoA activity showing their ability to induce peroxisome 
proliferation. The stimulated peroxisomal enzyme activity was further supported by 
immunoblot analysis where a parallel increases in the levels of the frww-2-enoyl CoA 
hydratase trifunctional protein was evident following the administration of tea. 
Accordingly these results indicate that black tea, green tea, and decaffeinated black tea 
have similar inducing potency on peroxisomal proliferation. Furthermore, morphological 
studies performed on the livers of control and tea pretreated rats displayed no marked 
structural subcellular changes between the groups even at the highest dose level of green 
tea treated group. However, tea pretreatment caused a remarkable increase in the number 
of peroxisomes. It should be pointed out that the increase in the number of green tea- 
induced peroxisomes was not correlated well with treatment dose. Apparently, the 
enhanced peroxisomal p-oxidadon of CN'-insensitive palmitoyl CoA was proportional to 
the increases in peroxisomes number. These results therefore suggest that the marked 
induction of specific cytochrome P450 isoforms and peroxisomal proliferation was not 
accompanied by any signs of hepatotoxicity.
Considering the fact that most of chemical carcinogens are activated by CYPIA 
subfamily, it is possible that green tea as well as black tea and decaffeinated black tea may 
enhance the metabolic activation of carcinogens catalysed by the same CYP protein 
involved in their activation. This hypothesis was therefore ascertained by evaluating the
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lutagenicity of the food mutagen and carcinogen IQ whose activation through N- 
xidation is mediated preferentially by CYPIA2 (Kato et al., 1983; Abu-Shakra et al., 
986). With respect to the increased hepatic mixed-function oxidases activities, 
lutagenicity studies were conducted using microsomal fraction as the activation system, 
t was also considered relevant to assess the IQ mutagenicity action in the presence of S9 
reparations to ensure that any tea component present in the hepatocyte was not eliminated 
luring the isolation of microsomes. Thus, treatment with green tea at different dose levels 
reduced effective enhancement in the IQ-mediated mutagenicity when activated by S9 
ind microsomal hepatic preparations. At a dose level of 5 % green tea extracts, hepatic 
nicrosomal fraction apparently was much more efficient than S9 preparations in activating 
Q to mutagenic intermediates. However, the S9-mediated activation of this carcinogen 
vas equally enhanced by the administration of 2.5 and 5 % green tea extracts. It seems 
X)ssible that green tea, at 5 % dose level, can profoundly stimulate the cytosolic enzymes 
esponsible for detoxicating the mutagenic intermediates of IQ and therefore competitively 
nhibiting the metabolic activation of the carcinogen. Clearly, these results indicate that the 
increase in the mutagenicity is consistent with the induced activity and apoprotein levels of 
CYP1A2 following green tea treatment. Furthermore, hepatic preparations from rats 
pretreated with black tea extracts, whether S9 or microsomes, markedly enhanced the 
activation of IQ and this once again is compatible with the observed increase in CYPl A2 
levels. This finding therefore demonstrate that black tea and green tea extracts have a 
similar potency in increasing the metabolic activation of IQ. It should be pointed out that 
the microsome-mediated activation of IQ were more effectively enhanced by black tea , 
and to a less extent by green tea extracts, although the increased mutagenic activation by 
S9 preparations was not markedly different between these two treatments. Whereas the 
mutagenicity of this carcinogen was not affected by the administration of decaffeinated 
black tea extracts due to the detected low level of CYP1A2 in hepatic microsomal fraction. 
This raised the possibility that caffeine, a constitutive component of green tea and black 
tea, may contribute to the induced mutagenic potential of IQ. Such speculation might be 
supported by the evidence that caffeine N-demethylation is catalysed to some extent by
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CYP1A2 isoenzyme (Berthou et al., 1992).Instead, hepatic S9 preparations from rats 
treated with 2.5 and 5 % green tea infusion decreased similarly the mutagenesis of 
nitrosopyrrolidine, but this effect was not observed following the same treatment at high 
dose level. In contrast, when isolated microsomes were employed, an inhibitoiy effect 
was clearly evident only at high doses of green tea exposure. Moreover, treatment of rats 
with black tea and decaffeinated black tea extracts effectively inhibited the metabolic 
activation of nitrosopyrrolidine mediated by isolated microsomes rather than the post- 
mitochondrial supernatant (S9), indicating the ability of black tea phenols to purturt^ the 
microsomal activation of nitrosopyrrolidine. Consistent with the relatively low levels of 
CYP2E in black tea-treated rats and the fact that the activation of this carcinogen is 
catalysed by CYP2E1 isoenzyme, it is therefore conceivable that the reduced mutagenicity 
of nitrosopyrrolidine is largely due to the marked decrease in CYP2E activity after black 
tea treatment. Interestingly, the most pronounced inhibition in the carcinogen mutagenic 
response was observed following the administration of decaffeinated black tea infusion. It 
might be considered more likely that the potent inhibitoiy effect of decaffeinated black tea 
on nitrosopyrrolidine mutagenesis resulted from a parallel inhibition of cytochrome P450 
enzymes other than CYP2E, such as CYP2B ( Ayrton et al., 1987), since the catalytic 
activity of CYP2E was not significantly modulated by the treatment of decaffeinated black 
tea. This andmutagenic effect may also indicate that components of black tea may 
scavenge the reactive inteimedaite(s) of this carcinogen and therefore competitively 
suppressed its metabolic activation.
With regard to these results, it may be inferred that stimulation of phase II 
conjugation enzymes may contribute to the reported protective effects of tea against 
mutagenesis and carcinogenesis. This speculation is apparently supported by the evidence 
that green tea and black tea treatments showed significant enhancement in the UDP- 
glucuronosyltransferase activity (Sohn et al., 1994). In agreement with this finding, 
continuous administration of green tea extracts produced no effects on phase II enzymes, 
except for a marked increase in the activity of UDP-glucuronosyltranseferase. However,
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such inductive potency was determined at a single dose levels of green tea. It therefore 
appears more informative to establish whether this induction is dependent on the dose or 
requires relatively high doses of tea extracts to produce effective alterations in phase II 
conjugation reactions other than UDP-glucuronosyltransferase system. In this respect, 
pretreatment with green tea infusion, at the two highest concentration levels effectively 
enhanced the activity of glutathione-S-transferases towards DCNB and CDNB substrates 
respectively. While the same treatment significantly stimulated the UDP- 
glucuronosyltransferase activity measured with 2-aminophenol as the accepting substrate 
only at the two lowest doses. Alternatively, no remarkable influence on this enzyme levels 
had occurred in the presence of 4-methylumbelliferone at any doses of the treatment. 
Significant increases, however, were observed in sulphotransferase and epoxide 
hydrolase activities after the administration of green tea at the highest dose level. These 
results thus suggests that higher doses of green tea are required for the inducing effect to 
be noted in particular forms of phase II enzyme activities, although this specific 
stimulation was not dependent on the dose. Furthermore, black tea treatment of rats 
increases the activity of glutathione-S-transferases, being much more effective towards 
the DCNB accepting substrate. This is inconsistent with the results of Sohn et al. (1994) 
study which showed no appreciable effect on glutathione-S-tranferases activity. 
Treatment with black tea infusion similarly enhanced the glucuronidation of the planar 
molecule 2-aminophenol, albeit more efficiently than green tea extracts, but neither of 
these tea kinds did modulate the 4-methylumbelliferone glucuronidation activity. These 
results may therefore reflect the differences in substrate specificity of particular UDP- 
glucuronosyltranferase inducible forms by tea polyphenols. On the other hand, the 
catalytic activities of sulphotransferase and epoxide hydrolase were not affected 
significantly after the exposure of black tea. In view of the fact that oral administration of 
decaffeinated black or green tea exerted a similar strong inhibitoiy effect on 4- 
(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone-induced lung tumorigenesis (Wang et al., 
1992), it is possible that this protective action of tea may be correlated with the ability of 
tea polyphenols rather than caffeine to stimulate the detoxication enzyme activities.
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lowever, this appears unlikely since no marked increase in the levels of these enzymes 
ctivity was observed following the decaffeinated black tea extracts administration.
Moreover, the anticarcinogenic potential of tea may be related to the antioxidant 
)roperties of tea components which can function as scavengers of reactive oxygen 
ntermediates (Ruch et al., 1989; Yuting et al., 1990). Several of the polyphenolic 
substances in green tea and black tea have been shown to exhibit antioxidant activity 
Wang et al., 1989; Xu et al., 1992; Laskin et al., 1992). Subsequent studies thus 
ndicated that green tea, black tea, as well as decaffeinated green and black tea extracts all 
tiad a similar superoxide anion radicals trapping ability (Wang et al.. Unpublished data). 
These results suggested that stimulation of the antioxidant enzymes system may be an 
alternative mechanism of reducing the incidence of carcinogenesis by tea. In contrast to 
this proposed mechanism of action, the present study demonstrated that green tea 
administration at normal concentration levels of 2.5 % (w/v) failed to influence the activity 
of catalase, an enzyme which degrades hydrogen peroxide, despite the same treatment at 
doses of 5 % and 7.5 % markedly decreased this enzyme activity. It is important to note 
that green tea at the highest dose level elicited lower inhibitoiy effects in this respect. 
However, treatment with tea at the different studied dose levels did not significantly affect 
glutathione peroxidase and superoxide dismutase activities. In comparison, oral 
administration of green tea polyphenolic fraction to mice induced the levels of many 
enzymes, including catalase, glutathione peroxidase, and glutathione-S-transferase (Khan 
et al., 1992; Katiyar et al., 1993). Furthermore, the activity of glutathione peroxidase and 
superoxide dismutase was not effectively influenced by the exposure of 2.5 % aqueous 
extracts of black tea or decaffeinated black tea. While, in contrast these two tea types were 
equally effective in suppressing the catalase activity, being more significant with 
decaffeinated black tea extracts. It may be therefore considered that caffeine had no 
influence or play a marginal role in the modification of tea antioxidant activities. On the 
other hand, the present study provided evidence that black tea and green tea are equally 
effective in their ability to modify drug-metabolising enzymes
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8.6 CONCLUSION
The result of the present study have established that oral administration of 
infusions prepared from different kinds of tea can effectively modulate the drug- 
metabolising enzyme activities. Interestingly, this pronounced modifying effects of tea did 
not produce concomitant morphological changes in the liver apart from an increase in the 
number of peroxisomes, indicating no toxic action of the various tea extracts employed in 
the present study. The results demonstrates further the selective dose-dependant induction 
of hepatic CYP1A2 and CYP2B activities following the administration of green tea 
aqueous at higher doses or similar to that consumed usually by humans. However, a 
very marked increase in the activity of CYPlAl was only observed in rats treated with the 
highest dose of green tea. The same treatment also significantly stimulated CYP4A1 
activities as well as peroxisomal proliferation but this enhancement was not varied greatly 
at higher green tea doses, providing an additional evidence that CYP4A1 induction and 
proliferation of peroxisomes are closely associated. In contrast, the activity of CYP2E1 
was considerably inhibited by green tea at the modest dose only. In addition, glutathione 
S-transferases activities were increased at 5 % green tea treatment dose, whereas the 
activity of UDP-glucuronosyl transferase towards the substrate 2-aminophenol was 
enhanced at the dose level of 2.5 % and this enzyme activity increased disproportionately 
at 5 % treatment dose. However, this increase did not attenuate statistical significance 
after treatment with 7.5 % green tea infusion. In contrast, epoxide hydrolase and 
sulphotransferase activities were enhanced at 7.5 % dose. Moreover, exposure of rats to 
green tea markedly inhibited the activity of the antioxidant enzyme catalase at the two 
highest doses, being more effective at 5 % dose level. The apparent anticarcinogenic 
potential towards nitrosamines is accordingly related to the decreased metabolic activation 
of these carcinogens. Indeed, the present study indicated that nitrosopyrrolidine was less 
efficiently activated by hepatic preparations from rats pretreated with 5 % green tea
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extracts, whereas the mutagenicity of IQ enhanced markedly as a result of consumption of 
green tea, being more efficient at higher doses of treatment.
On the other hand, the present study showed that treatment of rats with 2.5 % 
black tea aqueous extracts increased the O-dealkylation of methoxyresorufin and, to a 
lesser extent, the O-dealkylations of ethoxyresorufin and pentoxyresorufin. Black tea, but 
not decaffeinated black tea, produced a marked enhancement in lauric acid hydroxylation 
while the p-nitrophenol hydroxylase activity was inhibited by the same treatment. The 
erythromycin N-demethylase activity was decreased only following the administration of 
decaffeinated black tea extracts. Immunoblot analysis also showed similar changes in the 
apoprotein levels of the corresponding CYP isoenzyme. Significant induction was also 
seen in the activities of glutathione S-transferases and 2-aminophenol UDP- 
glucuronosyltransferase following treatment with black tea. Alternatively, black tea and 
decaffeinated black tea extracts similarly suppressed catalase activity. However, 
glutathione peroxidase and superoxide dismutase activities were not affected by any of 
these tea kinds. In addition, black tea and decaffeinated black tea treatments induced the 
CN"-insensitive palmitoyl CoA oxidation and this was consistent with the increased levels 
of the peroxisomal trifunctional protein as revealed by immunological determinations. 
Hepatic S9 and microsomal preparations from black tea-treated rats were much more 
efficient than controls in activating IQ to mutagenic intermediates. It is important to 
emphasise that treatment with black tea produced higher IQ mutagenic activity than that of 
green tea. Pretreatment with decaffeinated black tea, however, did not influence the 
mutagenicity of IQ when isolated microsomes comprised the activation system, despite a 
significant inhibition was observed following the activation by S9 fraction. When isolated 
microsomes served as the activation system, the mutagenic response of nitrosopyrrolidine 
was inhibited more effectively by the administration of decaffeinated black tea rather than 
black tea but this inhibition was less pronounced when its mutagenicity was mediated by 
S9 preparations.
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CHAPTER 9
GENERAL DISCUSSION
2 3 4
It is now becoming increasingly acceptable that plant phenolics present naturally in 
)od commodities may provide protection against a number of major human diseases 
icluding heart disease and cancer. The possibility that tea plant might be effective in 
reventing the onset of these diseases cannot be ruled out since tea contains a large variety 
f  polyphenolic substances. While epidemiological studies suggests the contribution of 
ja consumption in reducing the oesophageal cancer risk, other correlative studies have so 
ar yielded inconsistent and inconclusive results concerning the effect of tea consumption 
•n human cancer risk (Yang and Wang, 1993). It was reported that excessive 
onsumption of tea or tannin-containing foods, such as sorghum, may be a causative 
actor for the high incidence of oesophageal cancer in the zone extending from Iran to 
iorthem China. A geographical correlation study in the Caspian littoral of Iran indicated 
hat increased intake of tea is associated with a higher risk of cancer incidence compared 
vith individuals consuming less tea, but the differences were not significant (Yang and 
lYang, 1993). A positive association between black tea consumption and stomach cancer 
vas observed in London as reported by Kinlen et al. (1988). However, in an earlier 
correlative study, there was no statistically significant association between tea ingestion 
md cancer of the stomach in both sexes (Stocks, 1970). A case-control study in Nagoya, 
lapan displayed that black tea and green tea did not increase the risk for stomach cancer 
[Tajima and Tominaga, 1985). Subsequent studies in Shizuuoka Prefecture of Japan 
where green tea is the staple product, indicated that the cancer death rate in this area, 
especially from stomach cancer, is markedly lower than in the rest of the Japanese people 
(Oguni et al. (1988). Studies in Kyushu, Japan showed that individuals drinking green 
tea more frequently or in large quantities tended to have a lower risk for gastric cancer 
(Kono et al., 1988). Yet another study in Taipei, Taiwan suggested that consumption of 
green tea is a risk factor for gastric cancer (Lee et al., 1990). No relationship between the 
frequency of tea consumption and other types of cancer was found, except that of liver 
and kidney cancer incidence (Yang and Wang, 1993). Concerning lung cancer, both 
positive and negative associations with tea have been reported by several investigators 
(Yang and Wang, 1993). A recent study in Hong Kong (Tewes et al., 1990) indicated
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lat green tea consumption, but not black tea, increased lung cancer risk in females rather 
lan males. Other epidemiological investigation, however, demonstrated that lung cancer 
lortality among males in Japan is much lower than in the U.S.A even though the average 
onsumption of cigarette among the Japanese males is considerably higher than in the 
J.S.A. (Wynder et al., 1991). It appears that the consumption of green tea in Japan is an 
mportant factor contributing to the difference in lung cancer risk between these two 
ountries. Consumption of very hot green tea-gruel is also reported as a causative factor 
or oesophageal cancer in the Nara and Wekayama Prefectures in Japan (Segi, 1975). 
Several case-control studies, however, showed that there was no relation between 
Irinking of tea at normal warm temperature and oesophageal cancer (Dhar et al., 1993). It 
s thus more likely that the hot temperature of tea , rather than the components in tea , is 
ui etiological factor in human oesophageal cancer. Tea has been also reported to possess 
antimutagenic activities. Green and black tea preparations or their polyphenolic 
constituents suppressed the mutagenicity of several chemicals in bacterial test systems 
(Wang et al., 1989; Weisburger et al., 1996; Constable et al., 1996). With respect to 
these results, it would appear that tea or tea polyphenols can suppress the initiation of 
carcinogenesis by inhibiting the enzyme systems involved in the formation of 
carcinogenic metabolites. It is also possible that tea exhibit the chemoprotective effects 
through stimulation of the enzyme systems catalysing the detoxication of electrophilic 
reactive intermediates. However, scavenging of electrophiles and reactive oxygen species 
cannot be excluded in the anticarcinogenic activity of tea. In the light of aforesaid 
conflicting epidemiological and experimental data on antimutagenic / anticarcinogenic 
potential of tea extracts, the present study was undertaken to address the mechanism(s) 
involved in such actions narrated below in conjunction with the global view.
In most of the experiments described in chapter 4, aqueous extracts of green tea 
possess strong antimutagenic potential against a number of structurally diverse chemical 
carcinogens, including food carcinogens such as heterocyclic amines e.g. IQ, polycyclic 
aromatic hydrocarbons e.g. benzo(a)pyrene, and nitrosamines e.g. nitrosopyrrolidine.
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dthough the possible mechanism(s) of the green tea antimutagenic activity is not fully 
lucidated, it is believed that inhibition of cytochrome P450 dependent metabolism may be 
esponsible for the antimutagenic activity of green tea. The present study, however, 
ndicates that the inhibitory effects of green tea on mutagenesis is apparently due to 
nhibition in the metabolic activation of various chemical carcinogens as a result of the 
uppression of the cytochrome P450-dependent mixed-function oxidases, the enzyme 
lystem catalysing their activation. Earlier studies have established the potency of tea 
lavanols such as (+)-catechin in suppressing the activity of the cytochrome P450 system 
Steele et al., 1985). The antimutagenicity of green tea is also related to its nucleophilic 
component (s) which interact directly and thus neutralise the reactive intermediates 
generated from the microsomal metabolism of the chemical carcinogens. These results are 
veil correlated with the reported anticarcinogenic properties of green tea extracts and 
green tea polyphenols such as (-)-epigallocatechin gallate (EGCG) against spontaneous 
and chemically-induced tumours in animal models (Narisawa and Fukaura, 1993; 
Pingzhang et al., 1994; Nishida et al., 1994; Wang et al., 1994). The results of the 
present investigation further indicate that green tea epigallocatechin gallate (EGCG) is the 
most responsible component for the antimutagenicity of green tea (Chapter 6). To some 
extent, the mutagenic potential of carcinogen models was also inhibited by another 
epicatechin derivatives, namely epicatechin gallate (ECG). In this respect, Kada et al., 
(1985) reported that EGCG is the antimutagenic principle of green tea leaves. As indicated 
above the observed antimutagenic activity of green tea resulted more prominently due to 
inhibition in monooxygenases activities, suggesting that tea polyphenols had selective 
suppressive effects on microsomal enzyme activities.
An examination of the structure activity relationship of (+)-epicatechin derivatives 
demonstrates that the potency of inhibition of specific tea polyphenols is dependent on 
substitutions at the 2,3-position of 5,7-dihydroxy-benzflavan and on the numbers of 
hydroxyl groups present in these substiuents (Wang et al., 1988). These phenolic groups 
may bind to the catalytic sites of cytochrome P-450 and the inhibition of particularly
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letected enzyme activities may be contributed, at least partly, to such interactions. This 
assumption was further supported by the fact that the O-di hydroxy groups in the natural 
annin molecules were the sites for interacting with enzyme systems (Haslam, 1974).
As mentioned earlier green tea is not frequently consumed in the Western World 
3r in the Middle East countries where it is replaced by black tea and, increasingly, by 
decaffeinated black tea. These types of tea have not received the same attention as green 
tea even though their potential inhibitory effect on tumorigenesis has been found to be 
similar than that of green tea (Wang et al., 1994; Cao et al., 1996). As described in 
Chapter 5, all three types of tea preparations displayed significant antimutagenic potency 
against the indirect-acting carcinogens Glu-P-1, benzo(a)pyrene and N-nitrosopyrrolidine; 
no difference, however, could be discerned among the three varieties of tea, except in the 
case of N-nitrosopyrrolidine where the decaffeinated black tea extracts was slightly less 
effective. Moreover, recently Apostolides et al. (1996) reported that black and green tea 
extracts were equally effective inhibitors of PhIP mutagenicity. However, black tea 
polyphenols were more potent inhibitors of PhIP mutagenicity than the polyphenols of 
green tea. In line of these results, aqueous extracts of green, black, oolong and 
decaffeinated tea displayed veiy potent antimutagenic effects against most heterocyclic 
aromatic amines (Starvic et al., 1996). It is therefore obvious that inhibition of CYPl 
proteins, the A1 and A2 isoforms, mainly involved in the bioactivation of benzo(a)pyrene 
and Glu-P-1 to carcinogenic metabolites (Yamazoe et al., 1984; Battula et al., 1987) and 
other carcinogens would be, at least in part, a consequence of tea antimutagenic potential. 
The ability of tea preparations to inhibit these activities was thus evaluated using the O- 
dealkylations of methoxy-ethoxyresorufin as chemical probes for CYPlAl and CYP1A2 
respectively (Namkung et al., 1988). Both P450 isoenzyme activities were profoundly 
reduced by the three varieties of tea, with the decaffeinated black tea being slightly less 
effective. The modest suppressive effect of decaffeinated black tea on the activity of 
CYPIA enzymes can be attributed to the absence of caffeine that act as an excellent 
metabolic probe and specific inducer of the CYP1A2 protein (Tassaneeyakul et al., 1994;
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\yaIogu et al., 1995). In the case of green and black tea extracts, caffeine could 
contribute in the O-dealkylation of the alkoxyresorufm substrates by acting as a 
competitive inhibitor. It has been clearly demonstrated that nitrosamines bioactivation is 
catalysed essentially by CYP2E1 and CYP2B (McCoy et al., 1979; Kokkinakis et al., 
1985; Yang et al., 1985; Flammang et al., 1993). The three types of tea similarly inhibited 
the CYP2B activity as determined by the O-dealkylation of pentoxyresorufin (Lubet et al., 
1985), but the decaffeinated black tea was once again the least effective. Owing to the 
ability of caffeine to induce CYP2B catalytic activity, at relatively high doses (Ayalogu et 
al., 1995). it may be inferred that caffeine interacts with low affinity with CYP2B 
proteins and it is conceivable that the extraction of caffeine from tea, at least partly, 
responsible for the lower inhibitoiy potential of decaffeinated black tea. However, the 
modulation of CYP2E1 activity by tea aqueous extracts was not determined because of the 
interference of tea components with the substrates employed in the spectrophotometric 
assays of this activity such as p-nitrophenol, aniline or dimethylnitosamine (Chapter 4). 
It is noteworthy to point out that caffeine did not induce CYP2E1 activity (Ayalogu et al., 
1995), despite its metabolism is catalysed by this enzyme at high doses (Tassaneeyakul et 
al., 1994). Furthermore, the cytochrome P450 inhibition elicited by the three tea infusions 
may be partly ascribed to their tendency to impair the flow of electrons to cytochrome 
P450, as monitored by the inhibition of cytochrome c reductase, presumably due to the 
presence of catechins which function as electron acceptors (Steele et al., 1985).
An alternative mechanism of the antimutagenic action of tea extracts may involve 
direct interaction between the genotoxic reactive intermediates of mutagens and 
nucleophiles present in tea. Such a mechanism has already been invoked to partly explain 
the antimutagenic effects of plant polyphenols ellagic acid and flavonoids (Huang et al., 
1983; Sayer et al., 1982). Tea polyphenols are not only able to suppress carcinogens 
bioactivation by inhibiting CYPIA enzymes activity, but they also have the capacity to 
decrease the mutagenic potential of procarcinogens through scavenging of genotoxic 
electrophiles (Chapter 4 & 5). Green tea aqueous extracts inhibited the mutagenicity of the
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iirect-acting mutagens MNNG and 9-aminoacridine, although the antimutagenic response 
was not as pronounced as with the indirect-acting promutagens (Chapter 4). Inhibition of 
the mutagenicity of the direct-acting mutagen 9-aminoacridine was evident with all types 
of tea extracts, but green tea infusion was clearly less potent (Chapter 5). This finding 
may indicate that aqueous extracts of tea contain nucleophilic component(s) capable of 
interacting chemically and thus neutralising inherently electrophilic compounds such as 9- 
aminoacridine and MNNG. The ability of the three tea extracts to function as electrophiles 
scavenger is supported by the observations that all the three types of tea infusions 
suppressed the mutagenicity of microsome-activated metabolite(s) of all mutagens studied 
in the present study. In this regard, a marked and concentration-dependent inhibition of 
the mutagenic response was observed with all carcinogens following the incorporation of 
all three types of tea aqueous extracts (Chapter 5). In agreement with the above results, 
Huang et al.(1983) reported that plant-derived compounds could depress the mutagenicity 
of bay-region diol epoxides, the ultimate mutagens of polycyclic aromatic hydrocarbons. 
The extent of inhibition, however, was not as marked as in the case of adding tea extracts 
to the activation system prior to microsomal activation, emphasising that the principal 
mechanism of tea antimutagenicity in vitro is inhibition of the bioactivation of chemical 
carcinogens . This view is further supported by the fact that tea preparations exert their 
protective effects against N-nitrosomethylbenzylamine (NMBzA) through inhibition of 
carcinogen activation rather than direct interaction of tea components with the carcinogen 
NMBzA (Wang et al., 1995).
The substantial anticarcinogenic properties of tea has been essentially attributed to 
the biologic activities of the polyphenols in tea. Catechins and their gallate esters, the 
major substances of green tea (Graham, 1992), are considered to be responsible, to a 
large extent, for the antimutagenic and anticarcinogenic activity of green tea. This 
noteworthy actions of tea catechins has been related, at least partly, to their antioxidant 
activities (Terao et al., 1994). Inhibition of the in vitro oxidation of lipoproteins by tea 
flavonols has been recently reported by Vinson et al. (1995). The concept that tea
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compounds inhibit carcinogenesis through their antioxidative properties is supported by 
the finding that (-)-epigallocatechin gallate diminished the carcinogenicity of N-ethyl-N'- 
nitrosoguanidine in mouse duodenum (Fujita et al., 1989). The same catechin also 
produced a significant decrease in the mutagenicity of the hydroxylamines of several 
carcinogenic ami nocompounds (Hayatsu et al., 1992). Further study showed that a 
number of tea catechins attenuated the binding of benzo(a)pyrene to calf thymus DNA as a 
result of inhibition of the bioactivation process (Mukhtar et al., 1992). In the manufacture 
of black tea, however, the levels of these flavanols are much lower than in green tea due 
to the metabolism by tea polyphenols oxidases, leading to the formation of theaflavins, 
thearubigens and theasinensis (Graham, 1992). Since both green and black tea displayed 
similar degree of potential antimutagenic action against a number of carcinogens, it may 
be realised that flavanols and their gallate esters are not the major mediators of tea 
antimutagenic activity. However, the possibility that the metabolic products of catechins 
oxidation retain the antimutagenic response cannot be excluded. As the flavonol contents 
of the three types of tea studied is similar, it is conceivable that these compounds are, at 
least partly, responsible for the antimutagenicity displayed by the aqueous extracts of tea. 
It may be also concluded that caffeine plays no major role in the antimutagenic activity of 
green and black teas. In view of the above in vitro observations, the anti carcinogenesis 
activity of black and decaffeinated black teas appeared to be as efficient as green tea 
towards the model carcinogens investigated. Indeed, in studies where the anticarcinogenic 
response of these teas was compared in animal models, black tea was as effective as green 
tea in antagonising the ultraviolet B light-induced skin carcinogenesis in 7,12- 
dimethylbenz(a)anthracene initiated mice, while decaffeinated tea was slightly less potent 
in this regard (Wang et al., 1994). In additional study, green tea and decaffeinated black 
tea showed comparable protective effects against the tobacco-specific nitrosamine 4- 
(methylnitrosamino)-l-(3-pyridyl)-l-butanone (Wang et al., 1992). Green tea, on the 
other hand, acts at the promotion stage of carcinogenesis (Lea et al., 1993) and whether 
black and decaffeinated black tea can produce similar effects in vivo situations remains to 
be established.
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As already described in previous chapters, a wide range of dietary components 
rave been shown to prevent chemically induced carcinogenesis by their influence on 
specific xenobiotic metabolising enzyme system, of which cytochrome P450 enzymes and 
phase II drug-metabolising enzymes are the most important (Morten et al., 1996; Dean et
il., 1996). Thus, the anticarcinogenic potential of tea extracts can be related to its ability 
to modulate the initiation stage of chemical carcinogenesis by inhibiting the enzyme 
systems that catalyse the bioactivation process. Indeed, selective inhibition in cytochrome 
P450-mediated mixed-function oxidase activity appeared to be the most closely 
mechanism accounts for the in vitro tea antimutagenesis against a number of 
environmental promutagens. It should be noted, however, that this mechanism of action 
may not always be achievable in the in vivo situations as many inhibitors of cytochrome 
P450 system when they administered in vivo induce the same enzyme systems that they 
inhibit in vitro. In accord with this observation, anthraflavic acid has been shown to 
inhibit the metabolic activation of IQ in vitro by inhibiting its cytochrome P450-dependent 
activation, while the same plant phenol stimulated the bioactivation of IQ by selectively 
inducing the CYPl proteins that catalyses the metabolic activation of this carcinogen 
following the in vivo administration (Ayrton et al., 1988). It is generally recognised that 
dietary constituents which can modulate the metabolism of chemical carcinogens show 
very selective stimulatory or inhibitoiy effects on the activities of CYP450 enzymes. 
Therefore, tea or its major components might be of importance in the modulation of 
individual hepatic CYP450 enzyme activities. According to the in vivo studies described 
in Chapters 7&8, the administration of green tea aqueous extracts to Wistar albino rats 
resulted in a dose-dependent increase in the activities of CYP1A2 isoform, being highly 
significant at the 7.5 % dose level. However, a significant increase in CYPlAl activity 
was observed only at the two highest dose levels (5% and 7.5%) of green tea treatment 
The profound enhancement in CYP1A2 activity was consistent with the increased 
apoprotein levels determined by immunoblot analysis. To a lesser extent, treatment with 
green tea markedly stimulated the activity of CYP2B in dose-related manner. It is
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Ote worthy to point out that the observed induction in this enzyme activity is more likely 
) be a consequence of CYPIA induction (Lubet et al., 1985). The CYP2E1-catalysed p- 
itrophenol hydroxylation, however, was markedly inhibited only following the treatment 
dth 5 % green tea infusion although this decrease was not supported by the immunoblot 
nalysis where the level of CYP2E1 expression did not influenced by this treatment. The 
ick of inhibition in this enzyme apportion levels could be explained by the fact that the 
ydroxylation of p-nitrophenol, which is catalysed by P4502E1 (Koop et al., 1989), is 
ompetitively catalysed by CYP2B isoenzyme as previously suggested by Haber et al. 
1994). Moreover, the N-demethylation of the CYP3A substrate eiythromycin was 
imilarly decreased by the 5 % green tea administration, whereas the lauric acid 
lydroxylase activity (CYP4A1) was not significantly increased by this treatment It is 
empting to conclude that induction of CYPIA and 4A proteins by green tea 
idministration may have occurred, at least to some extent, at the expense of other 
cytochrome P450 isoforms such as CYP2E and 3A. Such hypothesis is therefore 
supported by the fact that total cytochrome P450 levels were unaffected by the treatment 
vith green tea extracts.
As the metabolic activation of a wide range of environmental chemical carcinogens 
Is generally catalysed by the CYPl enzymes, these results raise the possibility that green 
tea treatment may stimulate the mutagenic activation of chemical carcinogens which rely 
on the same CYP protein for their bioactivation. In this respect, pretreatment of rats with 
extracts of green tea at the three studied concentration levels produced a marked increase 
in the S9-and microsomes-mediated mutagenicity of IQ, which is predominantly catalysed 
by the CYP1A2 isoform, although the S9-mediated activation of this mutagen was 
moderately enhanced by tea administration at the 5 % concentration level. It is important 
to point out that this pronounced bioactivation of IQ is compatible with the observed 
increase in CYP1A2 levels. However, the metabolic activation of N-nitrosopyrrolidine, a 
low molecular weight suspect nitrosamine carcinogen selectively activated by CYP2E 
subfamily, was effectively inhibited by the administration of 5 % green tea extracts. This
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ilhibitory action is in agreement with the reduced CYP2E catalytic activity as measured by 
[le hydroxylation of p-nitrophenol, despite the lack of green tea to suppress the 
xpression of CYP2E levels. The explanation for the discrepancy between the decrease in 
he nitrosopyrrolidine bioactivation and lack of change in the CYP2E expression levels is 
inclear, but one possibility is that tea constituents may be present in the hepatic tissue and 
mpair the activity of CYP2E or directly interacted with nitrosopyrrolidine reactive 
ntermediate(s) and thereby reduces the carcinogen mutagenesis. It is also more likely that 
he increase in mixed-function oxidase activities and carcinogen bioactivation following 
;ea treatment may be compensated to some extent with a similar changes in the phase II 
conjugation systems.
Glutathione conjugation is probably the most effective metabolic pathway for the 
detoxication of highly reactive intermediates. In fact, treatment with green tea aqueous 
extracts markedly stimulated the activity of glutathioneS-transferases measured towards 
the two substrates CDNB and DCNB at high concentration levels, whereas no influence 
has been observed by the treatment at normal tea concentration. On the basis of this 
finding, it might be expected that minor form of these enzymes could have been 
modulated by the treatment with green tea at normal concentration level. However, the 
increase in green tea concentration did not effectively modulate the sulphotransferase 
conjugation. These results also indicate that the same green tea treatment failed to 
modulate the epoxide hydrolase activity, except a significant enhancement was evident by 
tea treatment at the highest dose level. In contrast, a low green tea concentration (2.5 %) 
significantly enhanced the glucuronidation of the planar substrate 2-aminophenol and this 
stimulatory effect becomes even much more significant at the moderate concentration of 
tea treatment (5 %). Non of the tea concentration levels did modulate the 4- 
methylumbelliferone glucuronidation which is also a planar molecule, demonstrating the 
differential induction of glucuronosyl transferase isoforms by green tea constituents. On 
the basis of these results, it appears likely that increased glucuronidation capacity may be 
responsible for the anticarcinogenic action of green tea infusion by facilitating the
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deactivation of the the chemical carcinogen and/ or its metabolites which may act as 
precursors for the ultimate carcinogens such as phenols and dihydrodiols of polycyclic 
aromatic hydrocarbons.
Green tea, on the other hand, may inhibit chemical carcinogenesis by stimulating 
the antioxidant enzyme systems activity which inactivate reactive oxygen species, since 
many green tea polyphenols have been shown to counteract the reactive oxygen radicals 
and accordingly exhibit antioxidant activity (Ruch et al., 1989; Yuting et al., 1990; Xu et 
al., 1992). However, this alternative mechanism appears to be unlikely in view of the 
present results where treatment of rats with green tea at all three concentrations studied 
failed to influence the catalytic activity of glutathione peroxidase and superoxide 
dismutase, whereas a significant decrease in catalase activity was noted following the 
treatment with 5 % green tea extracts.
With the realisation that both black and green tea, despite their markedly different 
flavanol content (Lunder 1992), have similar degree of antimutagenic potency, it appears 
possible that tea polyphenols other than tea epicatechins such as theaflavins and 
thearubigins present in black tea are responsible for black tea anti carcinogenesis effect 
against a number of major classes of chemical carcinogens. In order to address this 
possibility, the present investigation was extended to determine the role of these tea 
components as exemplified by green tea or black tea and decaffeinated black tea aqueous 
extracts on the xenobiotic metabolising enzymes activity. The differential modulatory 
effects of regular or decaffeinated black tea on the activities of cytochrome P450 isoforms 
as well as phase 11 enzymes has been clearly evident. While it is considered reasonable to 
expect that water extracts of black tea would be an effective inhibitor of CYPIA proteins, 
the present study showed that pretreatment with black tea resulted in a marked induction 
of CYPl A2 catalytic activity. Similar results were also observed in the CYPlAl activity, 
except that induction by black and green tea extracts was much less marked. Decaffeinated 
black tea treatment, however, inhibited the activity of CYPIA isoenzymes but this effect
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y as not statistically significant. Therefore, the pronounced induction in CYPl A2 activity 
>y black tea or green tea could be related to the presence of caffeine since these two tea 
extracts contain all the components of decaffeinated tea in addition to caffeine. It is 
mportant to point out that the modifying effect of tea on CYPIA activity was supported 
jy the immunoblot analysis where an increase in the CYP1A2 apoprotein level was 
:learly evident after the treatment with regular tea extracts (whether green tea or black tea), 
vhereas the expression level of this enzyme was suppressed by the decaffeinated black 
tea treatment. Of the three tea types studied, green tea gave rise to slight, but significant, 
increase in the activity of CYP2B isoenzyme. However, this enhancement might occur as 
a result of CYPIA induction as many inducers of CYPl family to a less extent also 
stimulate this enzyme activity (Lubet et al., 1985). No statistically significant effect was 
observed for decaffeinated black tea on the activity of CYP2B isoform. All tea types 
inhibited the CYP2E1 activity but black tea was clearly the most potent inhibitor in this 
respect. A marked decrease in CYP3A4 activity was only observed following the 
administration of decaffeinated black tea infusion. Furthermore, the activity of CYP4A1 
was increased by all types of tea extracts but black tea appears to be the most potent, 
being as effective as green tea. Immunoblot analysis provided evidence that these changes 
in particular CYP enzymes are well correlated with an increase or a decrease in the 
corresponding apoprotein levels. These results appear to be greatly different from the 
reported anticarcinogenic action of tea, especially against chemical carcinogens that are 
activated by the CYP1A2 protein. As expected, hepatic S9 and microsomal preparations 
from black tea or green tea-treated rats were equally much more efficient than controls in 
activating IQ to its mutagenic intermediates. It should be noted, however, that treatment 
with black tea produced higher IQ mutagenic activity than that of green tea. The increased 
bioactivation of IQ as a result of CYP1A2 induction might be expected to enhance the 
formation of IQ-DNA adducts. However, this effect appears unlikely in view of the fact 
that extracts of green tea and, to a lesser extent black tea, inhibited the DNA adducts 
formation induced by IQ (Xu et al., 1996). The lack of induction of CYP1A2 by 
decaffeinated black tea, on the other hand, resulted in a significant inhibition in the
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netabolic activation of IQ following its activation by S9 preparations, although the same 
reatment did not influence the mutagenicity of IQ when isolated microsomes comprised 
he activation system. This might suggest that tea polyphenols preferentially induced 
CYPlAl which less effectively catalyses the N-hydroxylation of IQ (McManus et al., 
1990; McKinnon et al., 1995) leading to a competing detoxication reaction involving ring 
hydroxylation and subsequent conjugation by phase II enzymes (Xu et al., 1996).
Another consideration which may be of greater relevance in the preventive effects 
of tea against chemical carcinogens such as the heterocyclic amine IQ is that the produced 
IQ-reactive metabolite(s) is effectively detoxicated by phase II conjugation reactions and 
therefore decreasing their availability for interacting with DNA molecule. In agreement 
with this speculation, the present study indicated that black tea aqueous extracts treatment 
, at the concentration consumed by humans, markedly stimulated the activities of 
glutathione S-transferases and glucuronosyltransferase (Chapter 8). However, the 
treatment with green tea increased moderately glucuronosyltransferase activity only when 
administered at the concentration level of 5 % but this enzyme activity was not influenced 
at higher concentration of green tea treatment. No statistically significant effect was 
observed for any of the three types of tea used in this study on the activity of epoxide 
hydrolase enzyme system. Treatment with green tea, but not black tea and decaffeinated 
black tea, slightly increased the conjugation of sulphotransferase, although the same 
treatment failed to modulate this enzyme activity in previous investigation (Chapter 7).
In addition to the modulation of carcinogens activating enzymes, scavenging of 
reactive intermediates including reactive oxygen species is considered as alternative 
possible mechanism for the anticarcinogenic potential of tea. This mechanism of action is 
usually equated with inhibitory effects during the post-initiation phase of carcinogenesis, 
as many anticarcinogenic compounds are effective antioxidants (Wattenberg, 1992). 
However, scavenging of free radicals also can be of importance in the initiation stage of 
chemical carcinogenesis. This finding has been supported by the fact that heterocyclic
247
imines can be metabolised to free radicals, which are possible substrates for the various 
intioxidants in tea (Yuting et al., 1990), by the NADPH-cytochrome P450 reductase 
mzyme system (Maeda et al., 1995). Scavenging of hydroxyl radicals and other reactive 
)xygen species has been shown to correlate with the antimutagenic activity of various tea 
extracts towards the food carcinogen IQ in the Ames test (Yen and Chen, 1995). While 
:atechin, one of the major components of tea, is a competitive inhibitor of NADPH- 
cytochrome P450 reductase (Steele et al., 1985), it seems unlikely that this mechanism of 
action would participate in the anticarcinogenic activity of tea extracts where treatment of 
rats with any of the three tea types did not antagonise the activity of NADPH-cytochrome 
c reductase enzyme system (Chapter 8). Stimulation of the enzyme systems which 
deactivate reactive oxygen species might be a responsible mechanism involved in the 
pronounced anticarcinogenic action of tea polyphenols. However, this proposed 
mechanism appears unreasonable since green tea treatment as well as black tea and 
decaffeinated tea extracts failed to affect the activities of glutathione peroxidase and 
superoxide dismutase enzymes (Chapter 8). In contrast, black tea and decaffeinated tea 
treatments decreased the catalase activity but this decrease was less marked by black tea 
administration. These studies therefore indicate that the modifying effects of both types of 
tea were comparable, even though black tea appeared to be slightly more effective in 
inducing glutathinoe S-transferase and glucuronosyl transferase enzymes activity. 
Treatment with decaffeinated tea, on the other hand, showed a considerable decrease in 
the activities of some drug metabolising enzymes. Thus, it is reasonable to infer that the 
effect of tea reflects differential changes on cytochrome P450 and specific phase II 
enzymes. Taken together, the significant enhancement of several phase II conjugation 
enzymes appeared to be the most likely operative mechanism associated with the ability of 
all tea types to decrease the carcinogenic potential of carcinogens metabolised by these 
enzyme systems.
A number of studies have demonstrated that proliferation of hepatic peroxisomes 
is most likely related to epigenetic carcinogenesis, at least in small rodents such as rats.
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caused by a diverse array of chemicals that modulate fatty acids metabolism (Gibson 
1989; Lock et al., 1989; Parke and loannides, 1990; Rao and Reddy 1991; Moody et al., 
1992). Many of these peroxisome proliferators are known as oxyisobutyrate 
hypolipidemic drugs (clofibrate), phthalate ester plasticizers [mono-(2-ethylhexyl) 
phthalate], chlorophenoxy acid herbicides (2,4,5-T), tertrazole leukotriene antagonists, 
naturally occurring steroids (dehydroepiandrosterone), perfluorinated fatty acids 
(perfluorodecanoic acid), and other compounds including certain dietary components 
(Reddy and Lalwani, 1983; David et al., 1992; Bentley et al., 1993). Induction of 
peroxisome proliferation is however accompanied by dramatic hepatic changes. The 
induced peroxisomal proliferators responses includes hepatomegaly, proliferation of 
smooth endoplasmic reticulum and induction of P450 4A-dependent fatty acid co­
hydroxylase activity (Orton et al., 1979; Gibson et al., 1982; Reddy et al., 1982; Sharma 
et al., 1988). Increasing the propensity of the hepatocyte to metabolise fatty acids by 
inducing certain peroxisomal enzymes is also a charactristic change associated with 
peroxisome proliferators (Edwin and Gibson, 1991). One of the postulated mechanisms 
is that peroxisome proliferators mediate their proliferative response through perturbation 
of intermediary lipid metabolism, which then results in increased cellular concentration of 
long-chain dicarboxylic acids. It should be noted, however, that the co-hydroxylation of 
long-chain fatty acids, which are further oxidised in the cytosol to dicarboxylic acids, is 
preferentially catalysed by the microsomal cytochrome P450 4A enzyme system 
(Robbins, 1968). The produced dicarboxylic acid can therefore directly modulate CYP4A 
gene expression or indirectly by combining with the peroxisome proliferators activated 
receptor(s) and hence interacting with 5'flanking regulatory segments of CYP4 A genes 
(Lock et al., 1989). As long-chain dicarboxylic acids are preferentially degraded by 
peroxisomal p-oxidation system, it has been suggested that dicarboxylic acids function as 
the proximal stimulus for peroxisome proliferation in order to maintain cellular lipid 
homeostasis (Sharma et al., 1988).
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Proliferation of peroxisomes appears to be closely related to induction of 
cytochrome P450 4A subfamily (Bacher and Gibson 1989; Sharma et al. 1989). This 
nverse association therefore suggests that tea extracts could induce peroxisomal 
prolifération, since treatment of rats with all studied tea types increased the CYP4A 
ictivity (Chapter 8). Proliferation of hepatic peroxisomes is usually accompanied by 
{elective increases in the specific activities of certain peroxisomal enzymes, particularly 
:hose involved in fatty acids oxidation such as acyl-CoA oxidase. The measurement of 
icyl-CoA oxidase with palmitoyl CoA as substrate provides a rapid and direct assessment 
of peroxisome proliferation (Lock et al., 1989). In this study, all types of tea extracts 
were similarly induced peroxisomal proliferation as exemplified by an increase in CN- 
insensitive palmitoyl CoA activity, a marker peroxisomal enzyme, and this effect was 
supported by immuonological analysis where an increase in the expression level of the 
trcm -2-enoyl CoA hydratase trifunctional protein was observed in the rats exposed to the 
tea preparations. It is pertinent to point out that the increased peroxisomal enzyme activity 
was clearly confirmed by electron microscopy analysis where a remarkable increase in the 
individual number of peroxisomes was observed in liver sections from rats treated with 
different tea varities. It should be noted, however, that the peroxisomal proliferative 
activity of tea extracts did not elicit hepatocytes enlargement or morphological changes in 
the liver tissue. These results might suggest that the induced peroxisome proliferative 
effect by tea extracts administration may be viewed as an adaptive response by the rats to 
ameliorate the perturbation in lipid metabolism. In agreement with this hypothesis, 
treatment of rats with either green or black tea extracts decreased the plasma triglcerides 
level (Sohn et al., 1994).
Increased production of hydrogen peroxide is believed to be a general 
consequence of peroxisomal proliferation, which could eventually lead to oxidative DNA 
damage (Reddy and Rao, 1989). In concert with the above findings, it is reasonable to 
infer that the peroxisome proliferative response of tea may have also occurred as a result 
of reduced catalase activity in tea-treated rats hepatocyte since this enzyme is one of the
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îllular defence mechanisms responsible for destroying most of hydrogen peroxide 
)rmed in the proliferated peroxisome. However, this possible mechanism of action 
ppears unlikely according to the observation that treatment of tea failed to produce 
epatotoxic action. It is noteworthy to emphasise that the induced peroxisomal 
roliferation by tea extracts appears to be greatly different from its reported 
nticarcinogenic potential. It would be therefore possible that enhancement of certain 
ihase II enzyme systems is more predominant over the increased peroxisomal 
•roliferation. In view of the fact that humans are insensitive or unresponsive, at 
herapeutic dose levels, to peroxisome-proliferator-induced hepatic effect, it is tempting to 
onclude the encountered levels of exposure to these non-genotoxic chemicals did not 
mpose a hepatocarcinogenic hazard to humans (Bentley et al., 1993).
Going by the existing and investigating mechanisms of antimutagenic / 
mticarcinogenic action of black and green tea extracts, time of tea ingestion relative to that 
3f carcinogen seems to be of paramount significance. Since metabolic activation of 
promutagens by the xenobiotic metabolising phase I system appears to be the first step in 
the carcinogenicity of a wide variety of chemicals, consumption of tea prior / during 
metabolic activation may be expected to inhibit the activation by interacting with metabolic 
system as outlined in the aforementioned. Qin et al. (1997) showed that feeding of green 
tea inhibits initiation of AFBi-induced hepatocarcinogenesis in rat by modulation of 
AFBi metabolism, thereby inhibiting AFBi-DNA binding and AFBi-induced 
glutathione-S-transferase placental form (GST-P) positive hepatocytes as detected by 
imumunohistochemical method. Effect of green tea catechins (GTCs) on the late promotion 
or progression stage of mammary gland carcinogenesis were reported in female sprague- 
Dewley rats pretreated with DMBA. GTCs were not effective at inhibiting progression of 
rat mammary carcinogenesis, but polyphenon E might exert a weak inhibitory effect on 
the early promotion stage. GTCs were also reported to slightly lower the multiplicity of 
rat mammary tumors when applied after initiation with a single intra-gastric dose of 25 
mg/Kg DMBA but not during initiation stage. Differences in catechin components can
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ffect inhibition of carcinogenesis as the antioxidant action (Katiyar et al., 1994), 
ntiflammatory activity (Huang et al., 1992) and anti-ODC induction potential of EGCG 
Agarwal et al., 1992; Huang et al., 1992; Hu et al., 1995) are the greatest among 
^techin derivatives. EGCG may be expected to be one of the strongest chemopreventors. 
Recently, Hirose (1997) demonstrated that continuous oral administration of 0.1 or 1 % 
)olphenon 100 selectively reduced the incidences and multiplicities of small intestinal, but 
lot colon, lung, thyroid and kidney tumors, without apparent toxicity when given either 
luring or after carcinogen exposure in their rat multi-organ carcinogenesis model (Hirose 
it al., 1993). Green tea polphenols or extracts have also been shown to inhibit the 
promotion stage of carcinogenesis in the duodenum (Fujita et al., 1989) and lung (Wang 
et al., 1992) of mice, and in the esophagus (Wang et al., 1995), glandular stomach 
(Yamane et al., 1995) and (Narisawa and Fukaura, 1993; Yamane et al., 1991) in rats 
after initiation with a variety of carcinogens.
The present study lend support to the view that environmental chemical 
mutagenesis and/or carcinogenesis can be profoundly modulated by dietaiy plant phenols 
or their structural analogues. In this study anthracene showed a potent inhibitory effects 
against IQ mutagenicity and that was due to its ability to inhibit the CYPlA-mediated 
bioactivation of the food mutagen IQ. Anthracene could alternatively exert its 
antimutagenic activity by interacting directly with the mutagenic metabolite(s) of IQ 
which, in turn, facilitate their inactivation. In contrast to the in vitro study, treatment of 
rats with anthracene failed to modulate the mutagenicity of IQ, as anthracene lacks the 
ability to inhibit CYPIA proteins and other constitutive forms of cytochrome P450 that 
might contribute to the activation of IQ.
Intake of both black and green tea infusions over a 6-week period enhanced the 
level of phase I and phase II xenobiotic metabolising enzymes in rats (Sohn et al., 1994) 
and also elevated glutathione levels (Prestera et al., 1993). Other biochemical mechanisms 
e.g. induction of DNA repair, binding with activated carcinogens and the like (Steele et
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1., 1985; Nagabushan et al., 1988; Hayatsu et al., 1992; Yang and Wang, 1993; Hu et
1., 1995) as hypothesised along with the present study on mechanistic basis of 
ntimutagenic potential of tea extracts are enough justification to recommend moderate tea 
onsumption (5 cups / day or an extract of about 11 gm of tea) as a posible, potential and 
impie additional means of reducing the risk of some types of human cancer.
However, due to paucity of enough data on the molecular basis of intervention at 
îach stages of cancer by different tea extracts or their components, the following studies 
nay further be recommended for the use of tea extracts or their active ingredients, natural 
JT synthetic, as chemopreventors of carcinogenesis:
1. The studies on the absorption, distribution, binding and metaboism of active 
components from green and black teas in animals and human will be of great importance 
to determine dose-response effect and bioavailability of active components at the target 
site.
2. More well-designed case-control and cohort studies are needed to address the issue of 
whether tea consumption enhances or inhibits the development of specific cancers in 
specific population.
3. Intervention studies are required to determine the protective effects of tea on cancer.
4. Additional studies on chemical properties and biological activities of tea are needed to 
provide a sound background for examining the effects of tea on human health.
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